The role of Rtr1 and Rrp6 in RNAPII in transcription termination by Fox, Melanie Joy
  
 
THE ROLE OF RTR1 AND RRP6 IN RNAPII TRANSCRIPTION TERMINATION 
 
 
 
 
Melanie J. Fox 
 
 
 
 
 
 
Submitted to the faculty of the University Graduate School 
in partial fulfillment of the requirements 
for the degree 
Doctor of Philosophy 
in the Department of Biochemistry and Molecular Biology 
Indiana University 
 
October 2015 	  	  	  	  	  	  	  	  
ii 
Accepted by the Graduate Faculty, of Indiana University, in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
 
 
________________________________ 
                                                                   Amber L. Mosley, Ph.D., Chair 
 
 
 
________________________________ 
                                                                   Mark G. Goebl, Ph.D.                 
Doctoral Committee 
 
 
________________________________ 
                                                                   Yunlong Liu, Ph.D.              
August 31, 2015    
 
 
________________________________ 
                                                                   Ronald C. Wek, Ph.D.                            
 
 
 	   	  
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2015 
 
Melanie J. Fox 	   	  
iv 
DEDICATION 
 
 
 
To my husband, Justin King, who woke me with coffee in the morning and 
welcomed me home with a beer at night. 
 
To the greatest dog in the world, Rupert Fox. My sidekick. My best friend. 
 
 	   	  
v 
ACKNOWLEDGEMENTS 
 
This thesis was only possible through the guidance and support and many 
individuals. I would like to express my sincerest gratitude to: 
My mentor, Dr. Amber Mosley, for her guidance, support, and friendship 
throughout this work. She always encouraged me to think outside the box and 
follow my heart, in both research and life. 
 The members of my committee, Dr. Mark Goebl, Dr. Yunlong Liu, and Dr. 
Ron Wek, for their invaluable advice on my project. 
 Everyone in the Mosley Lab for support over the years. Working with fun, 
helpful people made the difficult times bearable and the good times a blast. 
Whitney Smith-Kinnaman, Jerry Hunter, Megan Zimmerly, Jason True, Mary 
Cox, Michael Berna, Gigi Cabello, Lynn Bedard, Rachel Chan, Elizabeth 
DeVlieger, Asha Boyd, Gabi Mazur, Sarah Peck, and Jose Victorino. 
 Many members of my family and close friends I consider family who have 
supported me endlessly during the best and worst of times. 
 Everyone in the Department of Biochemistry and Molecular Biology, 
including Dr. Charlie Dong, Dr. Nuria Morral, Dr. Maureen Harrington, Dr. Tim 
Corson, Dr. Mark Goebl, Jack Arthur, Sandy McClain, Melissa Tarrh, Sheila 
Reynolds, and Darlene Lambert for equipment use and support. 
 The founding members of Central Indiana Science Outreach and the Staff 
and Volunteers in the Dinosphere at the Children’s Museum of Indianapolis for 
always reminding me that science is a lot of fun.	    
vi 
Melanie J. Fox 
THE ROLE OF RTR1 AND RRP6 IN RNAPII TRANSCRIPTION TERMINATION 
RNA Polymerase II (RNAPII) is responsible for transcription of messenger 
RNA (mRNA) and many small non-coding RNAs. Progression through the 
RNAPII transcription cycle is orchestrated by combinatorial posttranslational 
modifications of the C-terminal domain (CTD) of the largest subunit of RNAPII, 
Rpb1, consisting of the repetitive sequence (Y1S2P3T4S5P6S7)n. Disruptions of 
proteins that control CTD phosphorylation, including the phosphatase Rtr1, 
cause defects in gene expression and transcription termination. There are two 
described RNAPII termination mechanisms. Most mRNAs are terminated by the 
polyadenylation-dependent cleavage and polyadenylation complex. Most short 
noncoding RNAs are terminated by the Nrd1 complex. Nrd1-dependent 
termination is coupled to RNA 3’ end processing and/or degradation by Rrp6, a 
nuclear specific subunit of the exosome. The Rrp6-containing form a 3’-5’ 
exonuclease complex that regulates diverse aspects of nuclear RNA biology 
including 3’ end processing and degradation of a variety of noncoding RNAs 
(ncRNAs). It remains unclear whether Rrp6 is directly involved in termination. We 
discovered that deletion of RRP6 promotes extension of multiple Nrd1-dependent 
transcripts resulting from improperly processed 3’ RNA ends and faulty transcript 
termination at specific target genes. Defects in RNAPII termination cause 
transcriptome-wide changes in mRNA expression through transcription 
interference and/or antisense repression, similar to previously reported effects of 
Nrd1 depletion from the nucleus. Our data indicate Rrp6 acts with Nrd1 globally 
vii 
to promote transcription termination in addition to RNA processing and/or 
degradation. Furthermore, we found that deletion of the CTD phosphatase Rtr1 
shortens the distance of transcription before Nrd1-dependent termination of 
specific regulatory antisense transcripts (ASTs), increases Nrd1 occupancy at 
these sites, and increases the interaction between Nrd1 and RNAPII. The 
RTR1/RRP6 double deletion phenocopies an RRP6 deletion, indicating that the 
regulation of ASTs by Rtr1 requires Rrp6 activity and the Nrd1 termination 
pathway.	  
Amber L. Mosley, Ph.D., Chair	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INTRODUCTION 
 
1. Transcription by RNAPII and Regulation of the CTD   
RNA Polymerase II (RNAPII) is responsible for the transcription of 
messenger RNA (mRNA) from protein coding genes and several forms of small 
non-coding regulatory RNAs. RNAPII transcription is divided into three steps, 
initiation wherein RNAPII, aided by general and gene-specific transcription 
factors, is recruited to the promoter of genes, facilitating initial de novo synthesis 
of the nascent pre-mRNA.  Following initiation, RNAPII proceeds to elongation 
where the bulk of the RNA synthesis occurs, following by termination of 
transcription. A scheme of terms used to describe transcribed regions throughout 
this thesis is shown in Figure 1.  
This thesis focuses on key events regulating transcription elongation and 
termination, and how these events modulate the transcriptome. Recruitment of 
factors involved in transcription elongation and termination is orchestrated by the 
phosphorylation state of the C-terminal Domain (CTD) of the largest subunit of 
RNAPII, Rpb1, which has the repetitive sequence (Tyrosine1-Serine2-Proline3-
Threonine4-Serine5-Proline6-Serine7)n where n = 26 in yeast and n = 52 in 
humans (Reviewed in [1]). The phosphorylation pattern of the CTD sequence has 
been shown to be specific to the location of RNAPII along the transcribed region 
of the gene (Figure 2) [2]. For example, in the model eukaryotic organism 
Saccharomyces cerevisiae it has been shown that the RNAPII CTD is 
hypophosphorylated when the initiation complex forms at the promoter. Once  
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Figure 1: Schematic of terms. This thesis focuses on the transcribed region of 
genes, from transcription start site (TSS) to transcription termination site (TTS), 
and the resulting RNA transcripts. When referring to the 5’-end or 3’-end of a 
gene, this is regarding the orientation of the coding strand and the RNA, as 
shown here. An extended transcript, as discussed here, is assumed to start at 
the same TSS and have a longer 3’-end due to improper termination. Gene and 
transcript names are always written in italics. Protein names are capitalized and 
not italicized.  
 3 
elongation begins, serine 5 phosphorylation (Ser5-P, in Figure 2) is highest at the 
beginning of the transcription. However, during the early phase of transcription 
elongation, levels of Ser5-P decrease as RNAPII travels towards the transcription 
termination site [3]. Coincident with lowered Ser5-P during transcription, Ser2 of 
the CTD of RNAPII becomes phosphorylated so that by the mid- to late- phase of 
transcription elongation there is a mixture of both Ser5- and Ser2- 
phosphorylation. Ultimately, Ser2-P RNAPII predominates at the end of 
transcription of long genes (generally over 1000bp) (Figure 2) [4]. Ser7 has also 
recently been shown to be phosphorylated, peaking at the beginning of the gene 
similarly to Ser5-P with a slight increase at the end of transcription with Ser2-P. 
Together these phosphorylation patterns in the CTD of RNAPII serve as a 
binding platform to recruit the protein complexes required for each stage of 
transcription, facilitating association between the transcription machinery and key 
protein complexes that carry out mRNA capping, pre-mRNA splicing, cleavage of 
the nascent RNA, and polyadenylation [2].  
  
 4 
 
 
Figure 2: Schematic of RNAPII CTD phosphorylation patterns across an average 
gene in S. cerevisiae. The phosphorylation state of the CTD (each site is 
represented by a different color as indicated in the legend on the bottom right) as 
well as the major known kinases and phosphatases are shown. 
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Collectively, protein kinases and phosphatases that add and remove Ser2, 
Ser5, and Ser7 phosphorylation marks in the CTD of RNAPII determine the 
levels of CTD modification and efficiency of RNAPII transcription. As illustrated in 
Figure 2, Ser5-P and Ser7-P are added early in elongation by TFIIH, specifically 
its Kin28 subunit [5-7]. In the mid- to late phase of transcription elongation, some 
Ser5-P is removed by Rtr1, coordinate with Ser2-P addition by Ctk1, a subunit in 
the CTDK1 complex [8-10]. The protein kinase Bur1 adds new Ser7-P as RNAPII 
nears the end of gene transcription [11]. Subsequently, the protein phosphatase 
Ssu72 removes Ser5-P and Ser7-P, and Fcp1 eliminates Ser2-P [11] in a step 
that is proposed to be important for recycling RNAPII for initiation of another 
round of transcription. It is not clear why three separate protein phosphatases are 
required for regulation of RNAPII CTD when there is apparent overlap in their 
functions. There is also uncertainty about how the protein phosphatases interact 
physically and/or genetically to orchestrate their activities on transcription 
elongation. 
How do these changing compositions of CTD phosphorylation affect 
transcription elongation and termination? Are there CTD modifications yet to be 
discovered that affect these key transcription processes? Two post-translational 
modifications of proteins have recently been proposed to play important roles in 
termination of RNAPII transcription. As noted above, the regulation of the CTD 
phosphorylation state requires interplay between protein kinases and 
phosphatases, but has also been suggested to involve proline isomerases [2]. 
The Ser5 phosphatase Ssu72 binds the CTD of RNAPII when Pro6 of the CTD is 
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in cis conformation following recruitment of the proline isomerase Ess1 [12]. 
Second, in vivo studies have indicated that Tyr1-P of the CTD may modify the 
way that termination factors interact with Ser2-P and RNAPII [13]. Using ChIP-
chip, Ser2-P and Tyr1-P were seen to increase as RNAPII elongation proceeds 
across the length of genes based studies featuring on genome-wide averaging of 
997 genes classified by length. Tyr1-P signals were found to peak in vivo about 
180 nucleotides (nt) upstream of the poly(A) site and then were significantly 
lowered, whereas Ser2-P occurred at the same point during transcription 
elongation but were maintained throughout- 200 nt downstream of the poly(A) 
site [13]. Although Ser2-P levels were consistent across this region, CTD-
interacting proteins were not recruited until Tyr1-P signals dropped, leading the 
authors to hypothesize that Tyr1-P of RNAPII inhibits recruitment of the 
termination factors to “fine-tune” the timing of transcription termination [13].  
Phosphorylation at Tyr1 may be removed by the phosphatase Glc7 in 
yeast [14]. Glc7 is a type 1 serine/threonine protein phosphatase that is also a 
member of the cleavage and polyadenylation factor complex along with the 
RNAPII CTD phosphatase Ssu72 [15, 16]. Of interest, it has also been shown 
that Tyr1-P can be dephosphorylated in vitro by the atypical phosphatase Rtr1 
[17]. Additional studies are needed to determine the role of these protein 
phosphatases in the regulation of Tyr1-P levels and overall RNAPII transcription 
in vivo. In summary, multiple protein modifications of the CTD of RNAPII, 
including protein phosphorylation at serine and tyrosine and proline 
 7 
isomerization, are suggested to modulate elongation and termination phases of 
transcription. 
 
2. RNAPII Transcription Termination 
In the model organism, Saccharomyces cerevisiae, two mechanisms are 
suggested to terminate RNAPII transcription. These mechanisms involve the 
Cleavage and Polyadenylation Factor (CPF) complex or Nrd1, along with specific 
sequences embedded within the nascent RNA (Figure 3) [4, 18-20]. Table 1 
highlights a list of protein complexes and their subunits involved in RNAPII 
transcription termination. Current ideas about the functions of these proteins and 
RNA sequences directing transcription termination will be discussed more fully 
below.  
 8 
Yeast 
Complex 
Yeast 
Protein 
Human 
Homolog 
Protein Function Role in P(A) 
Dependent 
Termination 
Role in 
Alternate 
Termination 
Ref 
CPF Cft1 CPSF160 Binds RNAPII Ser5-
P and Ser2-P CTD, 
Binds Poly(A) site 
RNA 
Promotes 
RNAPII 
pausing and 
RNA cleavage 
for Rat1 entry 
N.D. 21 
  Cft2 CPSF100 Interacts with 
RNAPII CTD, Binds 
cleavage site RNA, 
Bridges CPF with 
Pcf11 
Promotes 
RNAPII 
pausing and 
RNA cleavage 
for Rat1 entry 
N.D. 22 
  Fip1 FIP1 Bridges Pap1 with 
rest of CPF 
Interacts 
directly with 
Pap1 to 
improve 
polyadenylation 
N.D. 23 
  Glc7 PP1 Ser-Thr 
phosphatase, 
Dephosphorylates 
Sen1 
N.D. Promotes 
Sen1 
Recruitment 
and/or 
helicase 
activity 
21 
  Mpe1 - RNA-binding protein Promotes link 
between CPF 
complex and 
pre-mRNA 
N.D. 24 
  Pap1 PAP1 RNA 
polyadenylation, 
implicated in RNA 
export 
Polymerase 
responsible for 
polyadenylation 
of mRNA 
N.D. 25 
  Pfs2 - Scaffolding protein Promotes 
formation of 
CPF 
N.D. 26 
  Pta1 Symplekin Scaffolding protein, 
Bridges CF1A and 
CPF 
N.D. Maintains 
integrity of 
CPF 
21 
  Pti1 - Scaffolding protein, 
Bridges Ref2 and 
Pta1 
N.D. Maintains 
integrity of 
CPF 
27 
  Ref2 - RNA-binding 
protein, Scaffolding 
Protein, Bridges Pti1 
and Glc7 
N.D. Maintains 
integrity of 
CPF 
21 
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Yeast 
Complex 
Yeast 
Protein 
Human 
Homolog 
Protein Function Role in P(A) 
Dependent 
Termination 
Role in 
Alternate 
Termination 
Ref 
CPF Ssu72 SSU72 RNAPII Ser5-P 
CTD Phosphatase 
Promotes 
recruitment 
of Pcf11 to 
RNAPII 
Promotes 
recruitment of 
Pcf11 to RNAPII 
21 
  Swd2 WDR82 Scaffolding protein, 
Subunit of histone 
methylation 
complex Set1 
N.D. Maintains 
integrity of CPF 
21 
  Syc1   Scaffolding protein Maintains 
integrity of 
CPF 
Maintains 
integrity of CPF 
21 
  Ysh1 CPSF73 Endoribonuclease, 
Cleaves poly(A) site 
RNA 
Provides 
entry point 
for Rat1 
Provides entry 
point for 
exoribonuclease 
21 
  Yth1 CPSF30 Binds poly(A) site 
RNA and RNAPII 
Promotes 
RNAPII 
pausing 
N.D. 21 
NNS Nrd1 SCAF8 
and 
SCAF4 
Binds RNAPII Ser5-
P CTD, RNA-
binding Protein 
No effect 
observed 
Bridges CTD 
and RNA to 
release RNAPII, 
Recruits Sen1 
to RNAPII 
21 
  Nab3 - RNA-binding 
protein 
N.D. Bridges Nrd1 
and Sen1 
21 
  Sen1 Senataxin Binds RNAPII CTD, 
5'-3' RNA:DNA 
helicase 
Promotes 
Rat1 activity 
by exposing 
RNA 
Unwinds 
RNA:DNA 
hybrid in 
RNAPII 
21 
  Sto1 
(aka 
Cbc1) 
CBP80 Member of Cap-
binding protein, 
binding partner of 
Cbc2 
Acts with 
Npl3p to 
export 
mRNA 
Binds AT to 
promote 
degradation of 
downstream 
RNA 
28 
  Cbc2 CBP20 Member of Cap-
binding protein, 
binding partner of 
Sto1 
Acts with 
Npl3p to 
export 
mRNA 
Binds AT to 
promote 
degradation of 
downstream 
RNA 
28 
CF1a Pcf11 PCF11 Binds RNAPII  
Ser2-P CTD, 
Scaffolding protein 
Promotes 
RNA 
cleavage 
and Rat1 
recruitment, 
Bridges CTD 
and RNA to 
release 
RNAPII 
Bridges CTD 
and RNA to 
release RNAPII 
21 
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Yeast 
Complex 
Yeast 
Protein 
Human 
Homolog 
Protein 
Function 
Role in P(A) 
Dependent 
Termination 
Role in 
Alternate 
Termination 
Ref 
CF1a Rna14 CSTF77 Scaffolding 
protein 
Promotes RNA 
cleavage 
Maintains 
integrity of 
CF1A 
21 
  Rna15 CSTF64 Binds Poly(A) 
site RNA 
Promotes RNA 
cleavage and 
Rat1 
recruitment 
Maintains 
integrity of 
CF1A 
21 
  Clp1 CLP1 Scaffolding 
protein, 
Bridges CF1A 
and CPF 
Contributes to 
CF1A formation 
and interaction 
with CPF 
N.D. 29 
  Hbs1 (?) HBS1L GTPase, 
implicated in 
mRNA no-go 
decay 
    29 
  Yra1 (?) - RNA binding 
protein, 
involved in 
RNA export 
Couples mRNA 
export to 
3'processing 
through 
interaction with 
Pcf11 
N.D. 29 
  Hrp1 (?) - RNA binding 
protein 
Binds poly(A) 
sequence 
Maintains 
integrity of 
CF1A 
29 
Exo-
nuclease 
Rtt103 - Binds RNAPII 
Ser2-P CTD, 
Bridges Rat1 
to RNAPII 
CTD 
Recruits Rat1 
and Pcf11 to 
RNAPII 
N.D. 21 
  Rat1 XRN2 5'-3' 
Exoribonuclea
se, Degrades 
Ysh1-
generated 
downstream 
cleavage 
product 
Promotes 
Pcf11 and 
Rna15 
recruitment, 
Collides with 
RNAPII near 
RNA exit 
channel 
No effect 
observed 
21 
  Rai1 DOM3Z De-capping 
endoribonucle
ase, 
Pyrophospho-
hydrolase 
Promotes Rat1 
stability and 
activity 
N.D. 21 
 
Table 1: Relevant proteins known to be involved in RNAPII transcription 
termination. Table adapted from [21] with updated information from 
Saccharomyces Genome Database (http://www.yeastgenome.org) and listed 
references.  
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Figure 3: Representation of the two current models of RNAPII transcription 
termination. Top panel: Polyadenylation-dependent model. Bottom panel: Nrd1-
Nab3-Sen1 (NNS)-dependent termination.  
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2.1. Cleavage and Polyadenylation Dependent Termination 
CPF in complex with Cleavage Factor Ia (CFIa) is thought to facilitate 
general termination of long (>1000 bp) polyadenylated mRNAs by a mechanism 
integrating the polyadenylation process [15, 22, 30-32] [33]. Current models of 
RNAPII transcription termination suggest a coupling of transcription of the 3’ end 
of the transcript to the recruitment of 3’ end processing proteins such as the CPF. 
RNAPII pausing due to transcription of the poly(A) site facilitates recruitment of 3’ 
end processing machinery [34, 35]. It has been proposed upon transcription of 
the 3’-portion of genes that Ser2-P on the CTD of RNAPII recruits Rtt103 through 
a CTD-Interacting Domain (CID). Recruitment of Rtt103 to the transcribing 
RNAPII is suggested to cooperate with the CID of the protein Pcf11, which then 
culminates to recruit the CFIa complex [32]. An additional feature of this model is 
that Tyr1-P of the RNAPII CTD may inhibit recruitment of the termination 
complexes. In this view, the possible dephosphorylation of Tyr1 by the Glc7 
phosphatase may help to fine-tune timing of transcription termination [14]. Such 
regulation could facilitate processes such as alternative polyadenylation site 
usage, a known regulator of mRNA transcript stability [36]. At the same time, 
CPF associates with paused RNAPII and recognizes the poly(A) signal sequence 
[37].  
Recruitment of Rtt103 is thought to also facilitate association of additional 
proteins, including the 5’ à 3’ exoribonuclease Rat1 and its activating partner 
Rai1. Rat1 has been proposed to degrade the nascent RNA downstream of the 
CPF cleavage site while the RNA is still attached to RNAPII, causing the 
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disassociation of RNAPII, an event termed the “torpedo termination model” [38, 
39].  
 
2.2. Alternative Termination through the NNS pathway 
One way to address the specific roles of Rtr1 and Ssu72 is to determine 
the effects of loss of Rtr1 activity on pathways dependent on proper regulation of 
Ser5-P. For example, we previously showed that deletion of RTR1 results in 
increased Ser5-P toward the transcription termination site, leading to disruption 
of termination at studied genes [8]. As highlighted above, transcription 
termination is carried out by two pathways orchestrated by the CTD code. 
Transcription of long, polyadenylated mRNAs are terminated in a cleavage and 
polyadenylation-dependent mechanism that occurred independent of Rtr1 and 
Ssu72 [15, 22, 30-32]. Shorter RNAPII transcripts (<1000 bp) including some 
small protein-coding genes, snRNAs, and many types of non-coding RNAs are 
terminated by an alternative Nrd1, Nab3, and Sen1 (NNS) -dependent 
mechanism [20, 40-44].  
In the current model of NNS-dependent termination, Nrd1 and Nab3 are 
recruited to the termination complex by the CID of Nrd1 that binds the Ser5-P 
CTD, and RNA Recognition Motifs (RRM Domains) present in Nrd1 and Nab3 
that recognize specific sequences in the nascent RNA [4, 19, 45-50]. The 
helicase Sen1 participates by unwinding RNA:DNA hybrids formed by the 
nascent RNA and template strand promoting RNAPII termination [51-54]. RNAPII 
transcribes beyond the 3’ end of the functional RNA into the “termination zone” of 
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the gene before transcription is actually terminated [51]. It has been shown in 
vitro that an interaction between Sen1 and RNAPII alone can lead to transcription 
termination by facilitating RNAPII release from the DNA template and 
synthesizing RNA, suggesting that Sen1 can trigger termination independently of 
Nrd1 and Nab3 [51, 55]. These data suggest that in vivo Nrd1 and Nab3 may aid 
in the recruitment of Sen1 to termination sites of genes or expedite the process, 
but Nrd1 and Nab3 are not required per se to carry out the termination reaction.  
The nascent terminated RNA is then polyadenylated by the TRAMP 
complex, and the nuclear exosome trims the ends of stable transcripts, such as 
snRNAs and SUTs (Stable Unannotated Transcripts) or completely degrades the 
transcript in the case of CUTs (Cryptic Unstable Transcripts) (Figure 3) [20, 42, 
43, 51, 56-60]. The Nrd1 CID has also been shown to mediate the interaction 
between the NNS complex and the TRAMP subunit Trf4, coordinating 
transcription termination with RNA degradation and processing [61]. The Nrd1-
Nab3 complex also requires the function of the CFIa subunit Pcf11.  Disruption of 
the Ser2 binding CID of Pcf11 leads to Nrd1 retention on chromatin suggesting 
that wild-type Pcf11 prevents the localization of Nrd1 to terminator distal (3’) 
regions [62]. Competition for CTD-binding between Nrd1 and Pcf11 may be 
regulated by the CTD prolyl isomerase Ess1 [63]. Ess1 isomerizes the S5-P-P6 
bond resulting in a conformational change favored by Ssu72. Subsequent 
removal of S5-P by Ssu72 releases Nrd1 from the CTD and may allow Pcf11 to 
bind adjacent S2-P. It has been suggested that this ordered Nrd1-binding, then 
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release, followed by Pcf11 recruitment is somehow required for NNS-dependent 
termination [63] 
 
3. The Nuclear RNA Exosome 
The RNA exosome is a 3’-5’ ribonuclease complex involved in termination 
of short RNAs, RNA quality control surveillance, and RNA degradation (first 
described in [64]). The core of the RNA exosome is a multi-subunit complex 
similar in structure to the proteasome that features a channel that leads the RNA 
substrate to the catalytic subunit Dis3 (also known as Rrp44), similar in structure 
to the proteasome [65-68]. In yeast, there are two forms of the RNA exosome: 
the cytoplasmic exosome consists of the core complex only, and the nuclear 
exosome contains of the core exosome with the addition of Rrp6. The human 
RNA exosome exists in three forms localized to the cytoplasm, nucleoplasm, and 
nucleolus, with the Rrp6-containing complex localized to the nucleolus (reviewed 
in [69]).  
Although Rrp6 is not essential for viability in yeast, it has been shown to 
be required for proper 3’ end trimming of primary sn/snoRNAs [45, 70], 
degradation of short-lived, non-coding CUTs [71-75] and improperly terminated 
RNAs [70, 76], as well as regulation of polyA tail length [77, 78] and termination 
of specific short transcripts. Recent studies using high-resolution tiling arrays 
found that Dis3 and Rrp6 have both shared and distinct roles in the degradation 
and processing of various RNAs [79, 80]. Rrp6 has also been implicated in the 
termination and 3’ end processing of a variety of noncoding RNAs, most that are 
 16 
not terminated by traditional polyA-dependent termination mechanisms [43, 74]. 
Furthermore, a number of studies have uncovered important mechanistic details 
regarding the cellular implications of transcriptome regulation by Rrp6 and the 
RNA exosome. Rrp6 and other exosome subunits are required for proper meiosis 
[81] and cellular differentiation [82]. Additionally, inhibition of exosomal proteins, 
either by mutation or production of autoantigens, can lead to a variety of human 
diseases [83-86]. Here we will discuss the latest research on the structure and 
function of the RNA exosome and key associating subunits, such as Rrp6 and 
Dis3. 
 
3.1. Nuclear Exosome Structure in Yeast 
Exo9, the Core Barrel 
The nine-subunit non-catalytic core is organized in to a central channel 
that directs the RNA to the Dis3 nuclease. As noted above, the RNA exosome 
has a barrel structure similar to the proteasome with a core that is composed of 
two stacked rings lacking nuclease activity [87]. The bottom ring includes six 
proteins with homology to RNase PH, a phosphorylitic  3’-5’ exonuclease, but 
amino acid changes in the active sites in eukaryotes render them inactive. These 
RNase PH-like proteins include Rrp41, Rrp42, Rrp43, Rrp45, Rrp46, and Mtr3. 
The top ring includes cap proteins containing S1 and KH domains that are often 
found in RNA binding proteins [88-90]. These ring proteins form a stable core 
that adjoin with cap proteins Rrp4, Rrp40, and Csl4. The RNase PH-like proteins 
form a stable core with the cap proteins Rrp4 and Rrp40, and a third cap protein, 
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Csl4, which is more loosely bound [91-93]. These proteins are well conserved 
among eukaryotes, and Table 2 lists the names of the homologous subunits from 
yeast and humans. 
 
Dis3, aka Rrp44 
In the cytoplasm of Saccharomyces cerevisiae, the core Exo9 barrel is 
associated with the Dis3 exonuclease (Exo10Dis3). All Exo10 subunits (barrel plus 
Dis3) are essential in yeast [64, 107-109]. Dis3 is the only catalytic subunit of the 
RNA exosome that is a part of the exosome complex in both the cytoplasm and 
nucleus. It binds with the RNase PH proteins in the Exo9 core structure on the 
opposite side of the barrel from the cap proteins [90, 92]. It has processive 
exoribonuclease activity through RNase II-like domains as well as 
endoribonuclease activity in its PIN domain [87, 94, 110-112]. An in vivo RNA 
crosslinking study using cleavable proteins (described below) has shown that 
Dis3 is capable of using both endonuclease and exonuclease activities on most 
substrates [80]. The authors used the CRAC (crosslinking and analysis of 
cDNAs) technique to purify protein-RNA complexes. By utilizing cleavage sites 
introduced in the target proteins, these “split-CRAC” studies identified specific 
domains in the exosome subunits that interact with the RNA substrates to 
determine their individual contributions to RNA decay. After crosslinking the full-
length protein to its RNA targets, Dis3 was cleaved into two fragments, 
separating the PIN and RNB domains. The transcriptome-wide profiles of RNA 
substrates bound to these fragments were compared to substrates bound to full- 
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length Dis3. All three profiles were found to be similar, indicating that the same  
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Complex S. cerevisiae Human Description Disease Association 
E
x
o
9 
E
x
o
1
0 
E
x 
o
1
1 
Rrp41 Rrp41 
(EXOSC4, 
Ski6) 
RNase PH-like 
protein in barrel 90 
- 
Rrp42 Rrp42 
(EXOSC7, 
EAP1) 
RNase PH-like 
protein in barrel 90 
- 
Rrp43 Rrp43 (OIP2, 
EXOSC8) 
RNase PH-like 
protein in barrel 90 
Pontocerebellar 
hypoplasia 85 
Rrp45 Rrp45 
(PM/Scl75, 
EXOSC9) 
RNase PH-like 
protein in barrel 90 
Autoantigen in 
polymyositis, 
scleroderma, and PM/Scl 
overlab disease 98-100 
Rrp46 Rrp46 
(EXOSC5) 
RNase PH-like 
protein in barrel 90 
Up-regulated in lung 
cancer, melanoma, and 
prostate cancer 101 
Mtr3 Mtr3 
(EXOSC6) 
RNase PH-like 
protein in barrel 90 
- 
Rrp4 Rrp4 
(EXOSC2) 
S1/KH cap proteins 90 - 
Rrp40 Rrp40 
(EXOSC3) 
S1/KH cap proteins 90 Mutations in 
pontocerebellar 
hypoplasia 84,102 
Csl4 Csl4 
(EXOSC1) 
S1/KH cap proteins 90 - 
 Dis3 (Rrp44) DIS3 
(EXOSC11) 
3'-5' 
Endo/Exonuclease, 
localized in the 
nucleus 80 
Mutations in multiple 
myeloma 43,44 
 DIS3L1 3'-5' 
Endo/Exonuclease, 
localized in the 
cytoplasm 94,95 
- 
 DIS3L2 3'-5' 
Endo/Exonuclease, 
localized in the 
cytoplasm 94,95 
Renal hamartomas 
nephroblastomatosis and 
fetal gigantism; Wilms 
tumor 105 
  Rrp6 hRRP6 
(PM/Scl100, 
EXOSC10) 
3'-5' Exonuclease 96 Autoantigen in 
polymyositis, 
scleroderma, and PM/Scl 
overlab disease 98-100 
   Rrp47 (Lrp1) C1D Rrp6-interacting 
partner 97 
Autoantigen in PM/Scl 
overlab disease 106 
 
Table 2: Subunit homology in the S. cerevisiae and human nuclear exosomes. 
Yeast protein names are given in the first column. Human protein names are 
given in the second. Names used throughout this review are listed first, and 
alternative names used in the literature are listed in parentheses. A brief 
description of the role of the protein within the exosome is listed as well as any 
known links to disease in humans. 
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RNA substrates can be targeted by both endonucleolytic and exonucleolytic 
activities. It is proposed that the exonuclease activity is the major function of 
Dis3, and the endonuclease activity may function primarily to release stalled 
exosome substrates [80]. 
In vitro analysis and structural studies has suggested that Dis3 is also 
capable of degrading RNAs independently of the core Exo9 complex [64, 87, 90, 
113]. Interestingly, isolated Dis3 has been shown to have increased exo-
nucleolytic activity on certain substrates when it is not in a complex with the core 
barrel [90]. It was speculated that the structure of the core proteins partially 
inhibited Dis3 access to RNA substrates. In this context, it has recently been 
shown that there may be a second route for RNA digestion by Dis3 that is 
independent of the core [114]. This has lead to two distinct models for Dis3 
degradation of RNA. The first model involves a substrate-specific degradation 
mechanisms in the RNA exosome with longer (>14 nt) single-stranded RNA 
substrates entering the exosome channel, inducing a conformational change in 
Dis3 so that the catalytic exonuclease site faces the base of the channel. When 
RNA substrates shorter than 12 nt were analyzed, the RNA is suggested to enter 
the Dis3 exonuclease site directly, without entering into the exosome channel 
and as a consequence did not induce a conformational change that was distinct 
from the isolated Dis3 structure.  
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Addition of Rrp6 in Yeast 
Rrp6 is an RNase D family member that is also involved in mRNA decay 
via the exosome [96]. In S. cerevisiae, the Rrp6 exonuclease is only present in 
the nucleus, and it is hypothesized to hydrolyze RNA via metal ion catalysis 
[115]. Rrp6 contains an exoribonuclease domain (EXO), and HRDC domain and 
a C-terminal domain that associates with the Exo9 core (labeled Rrp6-CTD in 
Figure 4) [67, 116]. The EXO and HRDC domains have been shown to be the 
catalytic module through structural studies [117, 118]). However, it is not clear if 
the channel is used to direct RNA to the Rrp6 exonuclease.   
Makino et al. solved a crystal structure of Exo10Dis3 plus the C-terminal 
region of Rrp6 and an RNA duplex with a 31 nt 3’ overhang [67]. To obtain this 
2.8 Å resolution structure, the authors used the Exo9 core complex and a 
catalytically inactive Dis3 (D171N/D551N) mutant lacking both endo- and 
exonucleolytic activity (blue in Figure 4). Addition of the C-terminal region of Rrp6 
was found to stabilize the interaction between the exosome and the RNA 
substrate. The structure of the Rrp6 C-terminal domain showed that it forms two 
regions that fold into the Exo9 core barrel: an α-helix that binds to Csl4 and an α-
helix and β-hairpin that bind Mtr3 and Rrp43. The authors suggest that although 
this region does not bind RNA directly, it may play a role in stabilizing Csl4 and 
the path taken by the long RNA substrate through the barrel. Furthermore, it was 
noted that the addition of Rrp6 results in a rotation of the structure of Dis3 to 
closed conformation with the endonucleolytic PIN domain exposed to solvent. 
The duplexed RNA with 3’ overhang allowed the capture of the exosome  
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Figure 4: Composite structure of the nuclear exosome including Rrp6 and Dis3 
exonucleases and RNA. This composite structure was modeled by overlaying 
figures containing the core barrel, a catalytically inactive Dis3 
(Dis3(D171N/D551N)), an RNA duplex with a 31 nt overhang, and the CTD of 
Rrp6 [67] and the core barrel, Rrp6, and a 24 nt single-stranded poly(A) RNA 
[119]. The core barrel subunits are in gray. Dis3 and the path of the RNA from 
the structure containing Dis3 are in blue. Rrp6 and the path of the RNA from the 
structure containing Rrp6 are in red. A hypothetical path for the RNA through the 
core barrel is shown as a dashed line. 
  
Rrp6
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RNA from
Dis3-containing
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structure with single stranded RNA threaded through the barrel core. In addition, 
this crystallography arrangement allowed for melting and visualization of the 
most 5’- nt on the complementary strand at the entry pore formed by the cap 
proteins. These results suggest that the cap proteins serve to unwind RNA 
duplexes for entry into the core, analogous to proteins entering the proteosome. 
However, these ideas have not yet been confirmed in vivo. The RNA unwinding 
activities have been shown to be carried out by the Ski and TRAMP complexes 
that regulate exosome (or Exo10) function [120-123]. 
To better understand the role of Rrp6 in RNA degradation, Wasmuth et al. 
recently reported a crystal structure of a complex consisting of the Exo9 core, 
Rrp6, and 24 nt-long single-stranded poly(A) RNA molecule (poly(A)24) [119]. The 
Makino et al. and Wasmuth et al. structures have been superimposed to make 
the composite structure shown in Figure 4. Wasmuth et al. previously proposed 
that Dis3 and Rrp6 use an overlapping channel within the core ring structure to 
interact with RNA substrates. Furthermore, it is also suggested that Rrp6 activity 
is modulated by its association with the Exo9 core complex, and Rrp6 stimulates 
Dis3-RNA binding and degradation [109].  
Wasmuth et al. were able to obtain a 3.3 Å structure of the Exo10Rrp6 
complex (Exo9 core barrel plus Rrp6), using an Rrp6 (128-685) mutant lacking 
the PMC2NT domain (1-127), the last C-terminal residues, and exoribonuclease 
activity (D238N). In their structure, Rrp6 sits atop the S1/KH cap proteins of the 
Exo9 core (red in Figure 4). The poly(A)24 RNA is positioned within the S1/KH 
ring with the active site of Rrp6 interacting with the 3’end of the RNA (pink in 
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Figure 4). This confirmation allows for the catalytic domain of Rrp6 to bind 
directly to the fourth-most 3’-nucleic acids in the poly(A)24 chain, while the 
interactions between Rrp6 and the remainder of the RNA chain are non-specific 
to accommodate the degradation of any RNA sequence. The RNA substrate then 
passes through the Exo9 core channel, similar to that proposed for the Dis3 RNA 
substrates. In fact, the paths used by substrates for Rrp6 and Dis3 overlap within 
the S1/KH channel, with the RNA oriented in opposite directions to accommodate 
the location of the targeting exonuclease. Figure 4 illustrates the theoretical path 
marked in the core barrel by a dashed line. It was also proposed that the 
overlapping paths commit the exosome targets to degradation by either Rrp6 or 
Dis [119]. In the nucleus, interactions with cofactors such as Mpp6, Rrp47, and 
TRAMP are proposed to guide the RNA substrate toward a particular path, 
depending on the substrate and the required exosome function: editing, 
processing, or degradation. 
 
Shared and Distinct Roles between Rrp6 and Dis3 
Rrp6 is a distributive 3’-5’ exonuclease (repetitive binding and release) 
and Dis3 is a processive 3’-5’ nuclease [109]. Rrp6 can stimulate Dis3 binding 
and decay activities [109]. This may be due to a conformational change in the 
core that results in an increase in channel width when Rrp6 is bound. This 
theoretical mechanism of exosome regulation through channel gating in the 
exosome has also been seen in protein degradation in the proteasome (reviewed 
in [68, 124]).  
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Both Rrp6 and Dis3 appear to have some non-nucleolytic activity. Full 
deletions of either protein have more severe phenotypes than inactive mutants 
[87, 125]. This is supported by the structural data that indicates a requirement for 
specific fragments of Rrp6 and Dis3 for proper RNA exosome structural integrity 
and stability of their binding partners. A more recent study confirmed the 
independent functions of Rrp6 and Dis3 in a comprehensive manner. Gudipati et 
al. used high-resolution tiling arrays to study the effects of Rrp6 and Dis3 
mutants on RNA degradation genome-wide [79]. The RRP6 gene was fully 
knocked out, but catalytic mutations in both the endo- and exonucleolytic 
domains of Dis3 are lethal in yeast. Therefore, mutants were expressed in a 
doxycycline-repressible (Tet-DIS3) background strain. Mutants studied contained 
an inactivating mutation in the exonucleolytic domain (D551N), endonucleolytic 
domain (D171N), or both. Rrp6 and Dis3 mutants have similar effects at CUTs 
and SUTs, but distinct roles at other transcripts. Rrp6 appears to be the 
predominant nuclease in the processing of snRNAs while Dis3 plays a larger role 
in degrading tRNAs and intron-containing (i.e. unspliced) pre-mRNAs. 
 
3.2. Other Cofactors in the Nucleus 
 As described above, Rrp6 and the nuclear exosome carry out a number of 
functions. The mechanisms underlying how a specific substrate is handle by the 
exosome remain unclear, but it is likely that proteins associated with the 
exosome aid in target/function specificity. Here, we discuss proteins associated 
with the nuclear exosome that aid in substrate recognition and Rrp6 activity. 
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Rrp47, aka Lrp1 
Rrp6 interacts with the cofactor Rrp47 [97] (Figure 5). Rrp6 activity has 
been found to be at least partially dependent on Rrp47, but the impact of this 
interaction on the catalytic activity of Rrp6 are unclear. Rrp6 contains an N-
terminal PMC2NT domain that interacts with Rrp47 [126]. Rrp47 can bind 
structured amino acids, and it is possible that Rrp47 facilitates Rrp6 activity by 
aiding in structured RNA recruitment [126]. It was suggested that this interaction 
is required to stabilize both Rrp6 and Rrp47 proteins [127-129]. Rrp6 expression 
is markedly decreased in yeast lacking Rrp47 when grown in minimal media, 
although this effect is not seen in rich media conditions [127]. Loss of Rrp47 has 
also been reported to decrease both transcription of RRP6 and the stability of the 
Rrp6 protein. Interestingly, over expression of Rrp6 was found to suppress many 
of the phenotypes reported for Rrp47 mutants [127]. These results suggest that a 
primary function of Rrp47 is to stabilize and maintain sufficient Rrp6 expression 
levels. However, it has also been reported that Rrp47 may play roles in RNA 
processing and surveillance independent of Rrp6 [128]. Garland et al. developed 
a technique they termed DECOID (decreased expression of complexes by 
overexpression of interacting domains) in which they overexpress the Rrp6 N-
terminal region shown to be the Rrp47-interacting domain to titrate Rrp47 out of 
Rrp6/Rrp47 complexes [128]. Once removed from Rrp6, the isolated Rrp47 was 
able to rescue synthetic lethal double mutants.  
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The N-terminal regions of Rrp6 and Rrp47 form a closely intertwined unit 
[130]. This structural unit was found to bind to the N-terminal region of the RNA 
helicase Mtr4, which can associate with the TRAMP complex to target RNA 
substrates to the exosome for degradation. Mutations in the N-terminal region of 
Rrp6, a portion that is important for Rrp47 binding, result in defects in 5.8S RNA 
processing in vivo suggesting that this intertwined structural unit is important for 
coordinating interactions with Mtr4 and proper substrate processing. 
 
Mpp6  
M-phase Phosphoprotein 6, or Mpp6, has also been shown to associate 
with the nuclear exosome [131] (Figure 5). Mpp6 was initially identified in a cDNA 
cloning screen performed in HeLa cells where it localized in the nucleus of 
interphase cells [132]. Schilders et al. found that human Mpp6 was important for 
the proper processing of the 3’ ends of 5.8S rRNAs [133]. In 2008, Milligan et al. 
identified the homolog in Saccharomyces cerevisiae [134]. The yeast homolog of 
Mpp6 was found to be an RNA-binding protein required for proper surveillance of 
pre-mRNAs, pre-rRNAs, and the degradation of cryptic non-coding RNAs 
transcribed from ribosomal DNA spacer heterochromatin [134]. It has been 
suggested that Mpp6, and probably other cofactors like it, play a role in 
specifying the function to be carried out by the exosome regarding specific 
substrates [59]. 
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Figure 5: Schematic representation of the S. cerevisiae nuclear exosome and its 
known cofactors. The core barrel structure (also known as Exo9), in green, 
consists of nine subunits: Rrp41, Rrp42, Rrp43, Rrp45, Rrp46, and Mtr4 (the six 
RNase PH-like proteins), and Rrp4, Rrp40, and Csl4 (the three S1/KH cap 
proteins). The nuclease Dis3 joins the core barrel in both the cytoplasm and the 
nucleus. This complex is also called the (Exo10). Rrp6 only joins the core 
exosome in the cytoplasm, in a complex also known as Exo11. The cofactor 
Rrp47 (dark red) binds to Rrp6 and structured RNA and improves the stability of 
Rrp6. Nrd1 and its binding partner Nab3 (gray) interact with Rrp6, both together 
and independently of one another to coordinate termination and processing of 
short (<1000 nt) RNAs. The Cap Binding Complex (purple) interacts with Rrp6 
during co-transcriptional processes. The Cap Binding Complex also interacts with 
Nrd1 and Nab3, which may lead to an alternative, indirect interaction with Rrp6. 
Mpp6 (dark green) is a general nuclear exosome cofactor involved in a number 
of exosome-dependent mechanisms such as processing and degradation of a 
RNA arising from rDNA arrays.  
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The TRAMP Complex 
In the nucleus, the RNA exosome interacts with an RNA helicase, Mtr4, 
and an associated complex known as TRAMP (the Trf4/5, Air1/2, Mtr4 
Polyadenylation Complex, reviewed in [66]) (Figure 5). Mtr4 can function alone to 
unwind RNA substrates or it can act as part of the TRAMP complex [135, 136]. 
Mtr4 contains a ‘ratchet helix’ and arch domain required for RNA processing, 
although the specific roles for each of these domains in Mtr4 function remain 
unclear [137-139]. The TRAMP complex aids in substrate specificity of the 
exosome [140], and prepares some target RNAs for processing by the nuclear 
exosome by adding a short (3 – 50 nt) poly(A) tail which is thought to provide an 
unstructured starting point for the exosome to thread the substrate RNA through 
the core barrel of the exosome [60, 71, 122, 141]. This poly(A) tail is added by 
one of two poly(A) polymerases in the TRAMP complex, Trf4 or Trf5. Trf4 and 
Trf5 exist in separate complexes, called TRAMP4 and TRAMP5, respectively. 
The TRAMP complex has been shown to be important for degradation of pre-
tRNAiMet [142, 143] as well as for the decay of rRNA and small 
nuclear/nucleolar RNAs [71, 122, 141]. 
 
3.4. Roles of the Nuclear Exosome in Transcription 
Rrp6 May Have Some Function Apart From the Core Exosome  
 The TRAMP complex and core exosome barrel help to target specific RNA 
degradation substrates to Rrp6 and Dis3, but there is evidence that Rrp6 may be 
capable of performing some of its functions apart from the core exosome. 
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Callahan et al. studied the effects of disrupting, individually or in combination, the 
exosome subunits Rrp6, Dis3, Rrp43 [116]. While the individual mutants each 
significantly altered the transcriptome, there were changes in distinct classes of 
transcripts. Disruption of Rrp6 and Dis3 in combination resulted in a synergistic 
increase of the Dis3- and Rrp43-specific transcripts. The expression of the Rrp6-
specific transcripts remains the same when RRP6 is deleted, whether or not Dis3 
or Rrp43 are present. These findings suggest that Rrp6 may have exosome-
independent functions that are therefore, not dependent on Dis3 and Rrp43. In 
support of this hypothesis, they also found that an Rrp6 mutant that disrupts the 
interaction between Rrp6 and the core exosome can carry out 3’ end processing 
of 5.8S rRNA and snRNAs. However, this mutant is no longer capable of 
degrading transcripts shown to require both Dis3 and Rrp6 function. This 
suggests that specific Rrp6-dependent activities require interaction with the 
exosome, and some activities do not. This may prove to be important in 
understanding the role of Rrp6 in RNAPII transcription termination. 
 
Interactions with Nrd1 
Rrp6 has been found to interact with the RNAPII transcription termination 
factor Nrd1 by immunoprecipitation [70] (Figure 5). Nrd1 interacts with Nab3 and 
Sen1 as well as the Cap Binding Complex (CBC) and is responsible for RNAPII 
termination of short RNA target genes (<1000bp) [4, 44, 144-146] including 
snRNAs and CUTs [41, 147]. As noted above, Nrd1 binds Ser5-P in the CTD of 
RNAPII through the Nrd1 CID, as well as consensus sequences in the nascent 
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RNA through an RNA Recognition Motif (RRM Domain) in the Nrd1 protein. 
Because Nrd1 is a sequence-specific RNA binding protein, it has been 
suggested that Nrd1 binding may block Rrp6-dependent degradation from 
proceeding past specific sequences [70]. This could be a mechanism to allow 
Rrp6 and the nuclear exosome to distinguish between RNA targets for 
degradation or those for 3’ end processing. Intriguingly, it has been shown that 
misprocessed transcripts in yeast caused by ectopic expression of the bacterial 
RNA Polymerase termination factor Rho are degraded by Rrp6 and the nuclear 
exosome [148], and the formation of these transcripts results in increased 
recruitment of Nrd1 to the transcription machinery by the Nrd1 CID and RRM 
domain [56]. Association of Rrp6 was also increased at these complexes. This, 
taken in context with the known interaction between Rrp6 and Nrd1, suggests 
that Nrd1-interaction with RNAPII and the nascent RNA may be an important 
step in recruitment of Rrp6 and the nuclear exosome to the RNA substrate. In 
support of this model, Heo et al. has shown that disrupting the normal Nrd1-
RNAPII CTD interaction by replacing the Nrd1 CID with the CID derived from 
Rtt103 that recognizes Ser2-P RNAPII CTD, reduces binding of the chimeric 
Nrd1 to Rrp6 [45]. 
The Nrd1 binding partner, Nab3, may also interact with Rrp6 
independently of Nrd1 [149]. Fasken et al. recently found that overexpression of 
Nab3 in strains carrying mutations in the TRAMP RNA-binding subunits Air1 and 
Air2 can suppress the slow growth phenotype and decrease the amount of 
extended transcripts. This effect was not observed for Nrd1 or Sen1 and does 
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not require the Nrd1-interacting domain of Nab3, but it does require the RNA-
binding domain of Nab3 and Rrp6. Deletion of the Nrd1 binding domain of Nab3 
revealed that Nab3 is capable of interacting with Rrp6 independently of Nrd1 
[149]. 
 
3.5. Transcription Termination 
Gene Regulation by Early Termination 
Studies in human cells suggest that Rrp6 and SetX (the human homolog 
of Sen1) may cooperate with Microprocessor to regulate RNAPII elongation via 
RNAi at some genes [150]. The Microprocessor complex is required for 
processing of functional microRNAs and includes the RNase II Drosha and the 
dsRNA-binding protein Dgcr8 [151]. Typically, RNA regulates protein expression 
post-transcriptionally by binding to the target mRNA and inducing RNA 
degradation or inhibition of mRNA translation. However, Wagschal et al. reported 
that cooperation between Microprocessor, Rrp6, and Setx regulate HIV-1 
transcription by inducing premature termination [150]. The authors propose a 
model in which Microprocessor is recruited to the nascent stem-loop TAR RNA 
located in the most 5’ portion of the HIV-1 gene, triggering RNAPII pausing and 
subsequent cleavage of the RNA by Rrp6. Studies in yeast suggest that this 
mechanism of promoter-proximal pausing followed by premature termination 
induced by cooperation between Microprocessor and Rrp6 and Setx and/or other 
NNS-dependent termination factors may function to regulate transcription 
elongation of a number of genes [44, 47, 152, 153]. 
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3.6. Nuclear RNA Processing and Surveillance 
With recent advances in deep sequencing technology, it has become 
obvious that the majority of the genome can be transcribed into RNA. Rrp6 and 
the nuclear exosome have been found to have multiple roles in regulating the 
fate of these transcripts. The exosome must identify and properly respond to 
signals that delineate which transcripts are to be completely degraded, which 
should have their 3’ ends partially degraded and precisely how far, and which 
should avoid the activities of the exosome altogether. A summary of some of 
known RNA processing and degradation activities of Rrp6 and the nuclear 
exosome is shown in Figure 6. 
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Figure 6: Multiple mechanisms by which Rrp6 processes or degrades its many 
RNA substrates. (A) The 18S, 5.8S, and 25S rRNAs are transcribed as one 
molecule and cleaved and processed by several nucleases in the sequence of 
events leading to the rRNA that are incorporated into ribosomes. Specifically, 
Rrp6 is required for proper processing of the 3’ end of the pre-5.8S product. (B) 
Improperly processed tRNAs in the nucleus are targeted by the TRAMP complex 
which adds a short polyA tail to the pre-tRNAs for targeting to the exosome for 
complete degradation by Rrp6. (C, left) Exo11 interact directly with the 
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spliceosome to degrade introns co-transcriptionally. (C, right) Rrp6 also degrades 
mRNAs that cannot be exported from the nucleus and accumulate at the 
transcription site as a consequence of improper processing 3’ ends or inhibition 
of nuclear export of the mRNA. (D, left) Rrp6 is required for proper transcription 
termination by Nrd1. The mechanism by which Nrd1 causes RNAPII termination 
is not known. It may require an Nrd1 interaction with Rrp6 to properly terminate 
transcription by a process involving release of DNA and RNA from RNAPII and 
the termination factors. (D, right) Rrp6 processing of the 3’ end of snRNAs 
terminated in a heterogeneous “zone.” The extended 3’ ends of the pre-snRNA 
are trimmed back by Rrp6. (E) Cryptic Unstable Transcripts (CUTs) and unstable 
nuclear lncRNAs are both targeted to the Exo11 by the TRAMP complex. 
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rRNA 
Rrp6 and the other 10 subunits of the RNA exosome are required for 
proper 3’ end processing of the 5.8S rRNA [96, 133, 135, 154, 155] (Figure 6A). 
In eukaryotes, rRNA precursors (all but the 5S precursor) are transcribed by RNA 
Polymerase I from an array of precursor units that contain the 18S, 5.8S, and 
25S products separated by transcribed spacer regions. Each unit is transcribed 
as one molecule, and hundreds of these units may exist in the genome. These 
large precursor transcripts are then processed by a series of cleavage and 
nucleolytic reactions. The 3’ end of the 5.8S precursor is heterogeneous after 
cleavage separating it from the 25S precursor. The exosome processes the 3’ 
end to a specific length resulting in a functional 5.8S rRNA [154]. Furthermore, 
depletion of individual subunits of the exosome each results in inhibition of early 
pre-rRNA cleavage [156]. None of the affected cleavage steps require 3’ – 5’ 
degradation, but the exosome degrades improperly processed rRNA precursors 
that form following the inhibition of rRNA processing factors [156]. 
The 5S rRNA is transcribed by RNAPIII, and has been shown to be 
targeted by the TRAMP complex when the 5S rRNA is improperly processed 
[157]. Using the CRAC technique to identify RNA-protein binding sites, Wlotzka 
et al. identified RNA transcripts bound to Rrp6, the Trf4 component of the 
TRAMP complex, and Nrd1 and Nab3 that were required for termination of short 
RNAPII transcripts [60]. This study found that Nrd1, Nab3 and Trf4 crosslinked to 
5S rRNA sequences that often contained a short poly(A) tail, suggesting that 
these transcripts were intermediate forms of exosome-degradation targets.  
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tRNA 
Rrp6 and other components of the exosome and TRAMP complexes have 
also been shown to play important roles in 3’ end processing and turnover of 
tRNAs transcribed by RNAPIII [141-143, 157-159] (Figure 6B). Pre-tRNAs 
contain 5’ and 3’ leader sequences, and a few tRNA genes have introns. During 
processing, these sequences are removed, a 3’ CCA tail is frequently added, and 
specific base modifications are made. The TRAMP complex is suggested to 
function in the recognition of improperly processed tRNAs (reviewed in [36]). The 
study initially identifying the TRAMP complex found that Trf4 preferentially 
targeted misfolded tRNAs while avoiding properly processed tRNAs [141]. As 
with other targets, TRAMP adds a short poly(A) tail to the RNA, targeting it for 
degradation by Rrp6 and the exosome.  
In the CRAC study by Wlotzka et al., Nrd1, Nab3, and Trf4 were found to 
bind to many pre-tRNA sequences containing 5’ and 3’ leaders and introns [60]. 
However, almost none of the bound pre-tRNAs contained the 3’ CCA tail but did 
have a short poly(A) tail. The authors suggest that pre-tRNA sequences are 
targeted by the TRAMP/exosome system after improper processing. An RNA-
binding protein called La binds to the 3’ end of all RNAPIII transcripts protecting 
them from degradation. It has been found that La-binding can protect mildly 
defective pre-tRNAs from degradation by Rrp6 [158], and it is perhaps the 
interplay between La and the TRAMP complex that allows for the specific 
targeting of improperly processed tRNAs.   
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sno/snRNAs 
Rrp6 activity and the Rrp47 cofactor are required for 3’ end processing of 
sn/snoRNAs. These snRNAs are highly transcribed and abundant non-coding 
RNAs that facilitate rRNA processing. Some snRNAs are transcribed as part of a 
larger transcript and subjected to processing, originating either from an intron of 
a protein-coding gene, or as a polycistronic transcript containing several 
snRNAs. The snRNAs originating from larger transcripts must be processed at 
the 5’ and 3’ ends by a number of different exonucleases [160-164]. For 
example, Rrp6 and its cofactor Rrp47 are required for proper 3’ end trimming of 
some of these snRNAs [165, 166]. 
Other snRNAs are transcribed individually, in genes with their own 
promoter and terminator. These individually transcribed snRNAs are terminated 
by the NNS pathway [70] (Figure 6D). As mentioned above, Nrd1 is thought to 
terminate within a non-discrete zone dependent on the kinetic interaction 
between Sen1 and RNAPII [51]. Termination within a zone results in 
heterogeneous 3’ transcript ends that are processed by Rrp6 [165, 166]. As with 
other exosome targets, the polyadenylation of pre-snRNAs by the TRAMP 
complex aids in targeting snRNAs to the exosome [58]. Interestingly, the poly(A) 
binding protein Pab2 may also play a role in processing snRNAs in yeast [167]. It 
has been suggested that Nrd1 binding at specific sites on the 3’ end of pre-
snRNA transcripts may signal termination of processing by the exosome, 
resulting in homogeneous 3’ends [45, 70].  
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CUTs 
Increased sensitivity of microarrays and sequencing technologies have 
uncovered that much of the eukaryotic genome can be transcribed into RNA. 
Many non-coding RNAs can be stabilized in the absence of Rrp6, suggesting that 
these RNAs are frequently synthesized and rapidly degraded in wild-type cells. 
Multiple reports have used tiling microarray technology to identify novel exosome 
targets by knocking out RRP6. [71, 72, 147, 153, 168, 169] (Figure 6E). Many 
CUTs originate from intergenic regions previously thought to be untranscribed 
[71], especially around promoter regions of protein coding genes [75]. Like other 
targets of Rrp6, these cryptic transcripts are targeted for degradation by subunits 
of the TRAMP complex. In 2009, it was found that many of these cryptic 
transcripts were initiated at bidirectional promoters in nucleosome free regions 
[72, 73]. Many of these bidirectional promoters correlate with promoters of 
protein-coding genes where the CUTs were transcribed in the divergent 
orientation from the opposite strand. Other CUTs found to begin upstream of the 
mRNA start site, antisense to the protein-coding gene and overlapping the 5’ 
end, have been implicated in regulation of mRNA expression [41, 152, 170, 171]. 
These studies and the discovery that the Nrd1 termination pathway is involved in 
CUT termination [147] have led to a transcription attenuation model in which 
transcription and rapid degradation of non-coding RNAs result in the differential 
expression of neighboring protein-coding genes. Interestingly, it was recently 
shown that Rrp6 plays a greater role in degrading these antisense CUTs present 
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within protein-coding genes than CUTs originating from bidirectional promoters 
[172].  
 
lncRNA 
Long noncoding RNAs (lncRNAs) are defined as RNAs longer than 200 nt 
with no detectable protein-coding potential [173]. Many transcripts that fall into 
this category have no known function as of yet, but others have been shown to 
play important roles in gene regulation, both transcriptionally and post-
transcriptionally [174, 175]. Many of these functional lncRNAs are capped and 
polyadenylated analogous to protein-coding mRNAs [176-178]. Expression of 
some lncRNAs is thought to be regulated by Rrp6-dependent degradation 
(Figure 6E). Deletion of RRP6 results in an increase in the half-life of specific 
lncRNAs [179]. However, most lncRNA transcripts escape nuclear degradation 
and are instead exported to the cytoplasm. There, they can be decapped and 
degraded to regulate their activity [180]. It has been suggested that lncRNAs are 
transcribed from 10- to 20-fold more genomic sequence than protein-coding 
RNAs [175], and Rrp6 surveillance may be an important quality control step in 
lncRNA function. 
 
4. Regulation of CTD Phosphorylation by Rtr1 
Our lab and others have shown that Rtr1 is a novel regulator of CTD 
phosphorylation that dephosphorylates Ser5 during early transcription elongation 
in S. cerevisiae [8, 181-184]. Deletion of RTR1 results in extension of Ser5-P 
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levels as RNAPII proceeds toward the transcription termination site. In some 
cases extended Ser5-P correlates with improper transcription termination, 
yielding RNA transcripts with 3’ ends that extend beyond the proper Transcription 
Termination Site (TTS). Such extended transcripts can include extended 3’ 
untranslated regions (UTR) as well as parts of the 5’ UTR and coding regions 
from downstream genes [8]. These findings support the hypothesis that after 
deletion of RTR1, the altered pattern of phosphorylation across the RNAPII CTD 
disrupts the function of the termination machinery. However the precise 
mechanisms by which Rtr1 regulates the RNAPII termination machinery are yet 
to be determined. 
 
4.1. The Yeast Serine 5 Phosphatases: Rtr1 and Ssu72 
As highlighted above, two known phosphatases in S. cerevisiae, Rtr1 and 
Ssu72, remove Ser5-P at different stages of the RNAPII RNA transcription cycle 
(Figure 2). Rtr1 is an atypical phosphatase required for proper removal of Ser5-P 
from RNAPII during early elongation and removes the anti-termination mark, 
tyrosine 1 phosphorylation [8, 17]. Rtr1 and its human homolog, RPAP2, are both 
capable of removing the Ser5-P mark, but not Ser2-P or Ser7-P [8, 181, 183]. 
RTR1 is nonessential in budding yeast. Deletion of Rtr1 in yeast, or knockdown 
of RPAP2 (via siRNA) in human cells results in the spread of Ser5-P RNAPII into 
the 3’-end of RNAPII target genes, including PMA1, ACT1, and PYK1 in yeast 
and β-actin and the U2 snRNA gene in humans [8, 183]. Rtr1 interacts primarily 
with RNAPII, and deletion of nonessential RNAPII subunits Rpb4 or Rpb9 display 
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negative synthetic genetic interactions with deletions of the RTR1 gene [9, 185]. 
In addition, RPB9, RPB7, and RPB5 can act as high-copy suppressors of RTR1 
knockout phenotypes [185].  
Affinity purification mass spectrometry data has revealed that recruitment 
of Rtr1 to RNAPII requires the Ser2 kinase Ctk1 in vivo, and Rtr1 recognizes a 
specific phosphorylated form of RNAPII not recognized by the other Ser5 
phosphatases Fcp1 and Ssu72 [9]. Of interest, RPAP2 has also been shown to 
require other CTD-binding proteins for its recruitment to dephosphorylate Ser5. 
The proteins RPRD1A, RPRD1B, and RPRD2 bind RPAP2 and Ser2- and Ser7-
phosphorylation marks [184, 186]. RPRD1A and RPRD1B act as a scaffold to 
position RPAP2 on the CTD and have been shown to facilitate RPAP2 activity 
[184]. There are no RPRD homologs in S. cerevisiae or Kluyveromyces lactis. 
The precise catalytic mechanism of Ser5 dephosphorylation by Rtr1 is yet to be 
determined. Structural studies on Rtr1-substrate complexes to date have been 
unsuccessful, and the K. lactis Rtr1 that have been crystalized were found to be 
inactive or showed low activity in vitro [17, 187].  
The phosphatase Ssu72 removes both Ser5 and Ser7 phosphorylation in 
budding yeast and appears to be involved in multiple stages of RNAPII 
transcription [182, 188-191]. Ssu72 is essential in budding yeast but is 
dispensable for viability in the fission yeast Schizosaccharomyces pombe [192]. 
Ssu72 has been shown to be a subunit of the CPF complex responsible for 
proper termination of polyadenylated RNAs and snRNAs [15, 193]. Within the 
CPF complex, Ssu72 interacts closely with Pta1 in yeast or its human homolog 
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Symplekin [12, 194]. Ssu72 activity is promoted by the CTD prolyl isomerase 
Ess1 that changes the conformation of the CTD to one more favorable to Ssu72 
[63]. Ssu72 activity is also affected by adjacent Thr4-P, the presence of which 
decreases Ser5-P dephosphorylation on a CTD peptide 4-fold [195]. It remains 
unclear why there are two Ser5 phosphatases with seemingly overlapping 
functions, but it is likely that the specific activities of the phosphatases are 
modulated by the complex variations of post-translational CTD modifications. 
Additionally, the RNAPII subunits Rpb4/7 may help recruit Ssu72 [196], while 
Rtr1 interacts with a 10-subunit form of RNAPII lacking Rpb4/7 as characterized 
by mass spectrometry [9, 197]. 
 
4.2. Effect of the Loss of Rtr1 
Deletion of RTR1 results in continued Ser5 phosphorylated RNAPII toward 
the 3’-end of target genes and in many cases into or past the 3’-UTR [Hunter, 
G.O. and Mosley A.L., unpublished data]. An example of these data is illustrated 
in Figure 7. To study genome-wide the extent to which Ser5-P persists in to the 
3’ end of transcripts, we performed Chromatin Immunoprecipitation (ChIP) using 
antibodies against Ser5-P RNAPII CTD peptides and identified the regions of the 
genome immunoprecipitated by high-density microarray analysis. The microarray 
allows for the identification of regions with Ser5-P RNAPII in the 5’- and 3’-ends 
of genes independent of the genes length using multiple probes per gene 
(resolution is 50 nt). In wild-type strains, Ser5-P RNAPII peaks shortly after 
transcription elongation begins and gradually decreases along the length of the 
 44 
gene until it rapidly decreases at the TTS. However, when RTR1 is deleted, 
Ser5-P remains high throughout the length of the gene and past the TTS into the 
intergenic region. The change in Ser5-P distribution in the absence of RTR1 is 
shown in black (Figure 7).  
We previously observed that deletion of RTR1 results in improper RNAPII 
termination at NRD1 [8]. This defect in transcription results in a product with 3’-
ends that extend beyond the proper TTS and includes the 3’-UTR and part of the 
adjacent gene MRPL17 [8]. Read-through transcription was also observed in 
human cells at the U2 snRNA gene followed knock down of RPAP2 [183]. Taken 
together with the global persistence of Ser5-P into the 3’-ends of transcribed 
regions in downstream genes, these findings support the hypothesis that after 
deletion of RTR1 alters the pattern of phosphorylation across the RNAPII CTD, 
disrupting RNAPII function and/or recruitment of the termination machinery. The 
mechanisms through which the termination machinery is disrupted in the 
absence of Rtr1 are yet to be determined.  
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Figure 7: Ser5-P RNAPII increases across transcribed regions in strains with 
RTR1 deleted. Ser5-P pattern measured by Chromatin-immunoprecipitation 
followed by microarray. The Ser5-P CTD profile shown is for YTA7, a moderately 
transcribed RNAPII target gene. The figure is drawn to scale with the 
transcription region for YTA7 at the top. The transcription start site (TSS) and 
transcription termination site (TTS) are also labeled as determined by RNA-Seq 
by [35]. The distribution of Ser5-P RNAPII across YTA7 in wild-type cells is 
shown in blue. Ser5-P RNAPII is most abundant at the 5’-end of the transcribed 
gene and begins to drop off steadily across the gene as transcription proceeds. 
Levels of Ser5-P are the lowest just proximal to the TTS and then are sharply 
lower distal to the TTS. The altered distribution of Ser5-P RNAPII across YTA7 in 
rtr1Δ cells is shown in black. The abundance of Ser5-P in the 5’end is similar to 
that in wild-type cells, but it does not decrease as transcription of the gene 
proceeds. As illustrated in the diagram, Ser5-P continues into the 3’end of the 
gene, and even extends into the intergenic space that is 3’- to the transcribed 
gene. 
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METHODS 
 
1. Yeast Strains 
All yeast strains used are isogenic to BY4741. RRP6 deletion strain is 
from the yeast knockout collection (Open Biosystems) [198]. RTR1 was knocked 
out of wild type (WT) and the RRP6 deletion strain by homologous recombination 
with a kanamycin cassette to create the RTR1 deletion and RTR1/RRP6 double 
deletion strains. The Rpb3-FLAG WT strain was produced by yeast 
transformation and homologous recombination with a tagging cassette containing 
sequences for a 3X-FLAG tag upstream of the URA3 gene from the plasmid 
pBS1539 (all primer sequences available upon request) [199]. The Nrd1-TAP 
strain is from the yeast TAP-tag collection (Open Biosystems). The Rpb3-FLAG 
and Nrd1-TAP RTR1 deletion strains were made by amplification of the RTR1 
knockout cassette from the RTR1 deletion strain and transformation into the wild-
type Rpb3-FLAG and Nrd1-TAP strains respectively. All transformations were 
confirmed by PCR genotyping. FLAG-tagged strains were made by homologous 
recombination using plasmids obtained from Funakoshi and Hochstrasser [200] 
to insert the 3xFLAG tag DNA sequence from the pFA6a plasmid into the 
genome at the 3’-end of the SSU72 gene, just prior to the stop codon, in both WT 
(BY4741) and rtr1Δ strains (Open Biosystems). All TAP-tagged proteins were 
previously described and obtained from the Open Biosystems TAP-tagged library 
(http://www.openbiosystems.com).  
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2. Protein Purification and Proteomics Analysis 
2.1. Protein Complex Identification by Affinity Purification 
Cells were grown overnight in YPD to OD600 ! 1.5 and then collected by 
centrifugation for 10 minutes at 4000 x g,. Cell pellets were washed in H2O and 
resuspended in in 25mL TAP lysis buffer per 2.5 grams of pellet (40mM Hepes-
KOH, pH 7.5; 10% glycerol; 350mM NaCl; 0.1% Tween-20; fresh yeast protease 
inhibitors (diluted to 1X) and 0.5mM DTT). The cells were slowly transferred to 
liquid nitrogen using a syringe. The frozen cells were pulverized with a mortar 
and pestle and lysed further in a Waring Blender with dry ice. The frozen lysate 
was transferred to a new container and allowed to thaw at room temperature. 
The resulting extract was treated with 100units DNase I and 10μL of 30mg/mL 
heparin for 10 minutes at room temperature and clarified by centrifugation as 
previously described [201, 202].  
To purify Ssu72 and interacting proteins, the lysate was incubated with 
FLAG-agarose resin at 4oC overnight. The resin and bound proteins were 
removed from the lysate by gravity flow through a 30mL Bio-Rad Econoprep 
column and washed on the column with 60mL TAP lysis buffer. The resin was 
resuspended 300µL of 50mM ammonium bicarbonate pH 8.0 and transfer to a 
microcentrifuge tube for on bead digestion with 5µL of Trypsin Gold (0.1µg/µL) 
overnight with shaking at 37°C. The supernatant containing the digested proteins 
was removed and treated with 20µL of 90% formic acid to inactivate the trypsin. 
The samples were separated into 3 aliquots for technical replicate LC/LC-MS/MS 
analysis.  
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2.2. MudPIT-LC/MS Analysis 
 MudPIT (Multidimensional Protein Identification Technology) is an LC/LC-
MS/MS technique that uses two-dimensional chromatography to separate 
complex peptide mixtures by both charge and hydrophobicity. Each sample was 
loaded onto a two-phase column containing strong cation exchange resin, which 
binds positively charged ions, and reverse phase C18 resin, which will retain 
peptides based on their hydrophobicity. The samples were eluted off the column 
by the MudPIT protocol of 10 steps of increasing salt concentrations (50-350mM 
ammonium acetate) followed by an organic gradient (20-80% acetonitrile). All 
chromatography solutions also contained 1% formic acid.  
During each of the 10 MudPIT steps, peptides were eluted into a 
ThermoFisher LTQ Velos for mass spectrometry (MS) analysis. Raw spectrum 
data from the MS analysis were submitted for protein identification by Proteome 
Discoverer software (Thermo) version 1.3 using SEQUEST as the database 
search algorithm. Database searches were performed against a FASTA 
database from the National Center for Biotechnology Information (NCBI) 
containing Saccharomyces cerevisiae protein sequences and sequences for 
common contaminants. Reversed versions of all non-redundant proteins were 
also searched and used to calculate False Discovery Rates (FDR). Hierarchical 
clustering was performed as previously described [197, 201].  The most highly 
enriched proteins were clustered using the Normalized Spectral Abundance 
Factor (NSAF) values calculated as previously described. 
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3. Analysis of RNA 
3.1. RNA Isolation 
RNA was extracted using the hot acid phenol method. Strains were grown 
in 100ml YPD medium to an OD600 of 0.8. Cells were collected by centrifugation, 
washed, and resuspended in 10ml AE buffer (50mM sodium acetate at pH 5.2, 
10mM EDTA) in a Nalgene™ phenol-resistant 50ml tube. Eight hundred 
microliters of 20% SDS and 10ml cold acid phenol were added to each sample 
and mixed well by vortexing. Samples were incubated at 65oC for 10 minutes 
with vortexing every minute then cooled on ice for 5 minutes. Samples were 
centrifuged for 15 minutes at 10,000 rpm. The top phase was transferred to a 
pre-spun 50ml 5 PRIME ™ Phase Lock Gel tube (Ref # 2302870). A total of 13ml 
of chloroform was added and well mixed before centrifuging for 10 minutes at 
3000 rpm. The top phase was poured into a new phenol-resistant tube, and 1/10 
volume sodium acetate at pH 5.2 and equal volume room temperature 
isopropanol was added. The precipitated RNA was collected by centrifugation for 
45 minutes at 12,000 rpm. The pellet was washed with 70% ethanol, allowed to 
dry in a fume hood, and resuspended with molecular biology grade water. The 
Ambion DNase-turbo kit was used to degrade any contaminating DNA. The 
quality of the samples was determined with an Agilent Bioanalyzer before 
preparation of the sequencing libraries.  
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3.2. SOLiD5500xl sequencing methods 
Standard methods were used for RNA-Seq library construction, EZBead 
preparation and Next-Gen sequencing, based on Life Technologies SOLiD 
5500xl system. Briefly, RNA quality was assessed with on an Agilent 
Bioanalyzer. Each sample was loaded onto a lane on a Bioanalyzer chip and 
separated by size with electrophoresis. The separated fractions result in peaks 
detected by the analyzer, and these peaks were compared to the expected size 
and intensity of RNA peaks from S. cerevisiae. The Bioanalyzer software 
compared the experimental peaks to the reference peaks to calculate an RNA 
Integrity Number (RIN) to quantitatively represent the quality of the RNA on a 
scale of 1-10, in which a higher number represent higher quality RNA.  
Five microgram of total RNA per sample (RIN equal or higher than 6.0 by 
Agilent Bioanalyzer) was applied in library preparation. Large ribosomal RNAs 
(rRNAs) were first depleted using the standard protocol of RiboMinus™ 
Transcriptome Isolation Kit for yeast (Ambion, Cat# K1550-03), and rRNA-
depleted RNA was concentrated with the PureLink RNA Micro Kit (Invitrogen, 
Cat# 12183-016) using 1 volume of Lysis Buffer and 2.5 volumes of 100% 
ethanol. Following rRNA depletion, whole transcriptome library was prepared and 
barcoded per sample using the standard protocol of SOLiD Total RNA-Seq Kit 
(Life Technologies, Cat# 4445374). Each barcoded library was quantified by 
quantitative PCR using SOLiD Library Taqman qPCR Module (Life Technologies, 
Cat#A12127), and pooled in equal molarity. Fifty microliters of 500pM of pooled 
library was used in subsequent EZBead preparation, which involves bead 
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emulsion, bead library amplification, and bead enrichment using Life 
Technologies EZ Bead™ E120 System (Cat# 4465571). Useful beads were 
amplified from one fragment, resulting in the same sequence repeated across the 
entire bead. Approximately six hundred million enriched beads then were 
deposited onto each lane of a 6-lane SOLiD 5500xl flow chip. 
Finally sequencing by ligation was carried out using standard single-read, 
5’-3’ strand-specific sequencing procedure (75 bp-read) on SOLiD 5500xl 
Sequencer. Specifically, 8 nt probes with one of 1,024 possible sequences bound 
on the 5’-end to one of four possible dyes corresponding to the two 3’-most 
nucleotides are used to determine the sequence of each fragment. First, primers 
were hybridized to the P1 adaptor on every fragment. A probe complementary to 
the fragment sequence is ligated to the adaptor primer. The fluorescent dye 
corresponding to the first two nucleotides is read by the sequencer, then the 
three 5’-most nucleotides and the adaptor are cleaved and released. The 
sequencing reaction is reset and repeated. In this way, two nucleotides are 
detected, separated by three nucleotides of undetected sequence. By 
overlapping multiple fragments per bead (amplified from the same fragment), 
each nucleotide is sequenced twice per fragment.  
 
3.3. RNA Sequencing Alignment 
The resulting 75 bp solid reads were mapped to the Saccharomyces 
cerevisiae reference genome sacCer3 using in-house mapping pipelines that 
utilizes bfast-0.7.0a [203]. Briefly, using our RNA-Seq pipeline, poor quality and 
rRNA/tRNAs reads were first discarded. The remaining reads were mapped to 
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reference genome sacCer3 and a splice-junction library, respectively; the 
genomic and splice-junction library mapping were merged at the end. In a 
different pipeline, the rRNA/tRNAs were kept and the reads were mapped to the 
reference genome sacCer3 since in yeast there is some splicing but most protein 
coding genes do not have introns. Read counts were calculated using bamutils 
from NGSUtils [204].  
Differential gene expression was analyzed using edgeR [205]. Gene 
expression was quantified using the Reads Per Kilo-base per Million mappable 
reads (RPKM) equation R= (109C/NL), where R is the expression of the gene, C 
is the number of reads that fall within the gene annotation, N is the depth of 
sequencing, and L is the length of the gene. The edgeR statistical package 
assumes a negative binomial distribution of the data. All raw and processed files 
from the RNA sequencing performed for the RRP6 deletion study have been 
deposited to Gene Expression Omnibus [GEO] under the accession number 
GSE57155. Annotations for transcripts that showed significant changes in rrp6Δ 
cells were used for subsequent differential expression analysis to generate the 
final dataset. 
 
3.4. Manual annotation of novel transcripts 
Following data alignment, snRNA transcripts were manually inspected 
individually using the Integrative Genomics Viewer [206, 207]. For all snRNAs in 
a tail-to-tail orientation with a downstream gene, the snRNA-ET annotation 
started just after the end of the snRNA annotation until continuous reads on the 
same strand were no longer detected. For all snRNAs in a tail-to-head 
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orientation, the snRNA-ET annotation started just after the end of the snRNA 
annotation and was ended just prior to the 5’ end of the annotation for the 
downstream gene. Annotations for ET for snRNAs that were encoded within 
introns were ended just prior to the 5’ end of the exon for the parent transcript. To 
identify antisense transcripts with significant changes in differential expression, 
the strand was reversed for all sense annotations for the coding region of each 
ORF-Ts and the text “AS_” was added in front of the ORF-T name. The 
annotations for the 5’ and 3’ UTR were not included. We also included an 
annotation for the transcript upstream of IMD2, known to be terminated by the 
NNS pathway [146, 170, 208]. This annotation covers 325 nt at ChrVIII:554148-
554473 and was named IMD2 upstream CUT. 
 
3.5. GOStat analysis 
GOStat analysis [209] was performed for all significantly down-regulated 
ORF-T transcripts from our dataset. In brief, the list of 995 significantly up-
regulated ORF-Ts was entered into the GOStat web interface 
(http://gostat.wehi.edu.au/cgi-bin/goStat.pl) to search for the top 30 most over-
represented GO terms and to obtain p-values to indicate the significance of 
enrichment (Table S3). Specifically, the GOStat tool counts the ratio at which 
each GO term appears in the test group and compares the counts to the 
reference gene list. A p-value is calculated for each GO term representing the 
probability that the term is enriched in the test group. A Χ2-test is used to 
calculate the p-value unless the value for a count was below 5, in which case a 
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Fisher’s exact test is more accurate [209]. GO-term enrichment analysis was also 
performed using DAVID (Database for Annotation Visualization and Integrated 
Discovery) [210]. DAVID is an integrated genomics data mining database that 
cross-references information from a number of online resources such as Gene 
Ontology (GO), NCBI, and Uniprot to extract a list of enriched biological  
processes. Similar results were obtained through GOStat and DAVID. 
 
3.6. Northern Blot Analysis  
30µg of total RNA was loaded per lane on a 1.5% agarose TBE gel and 
separated by electrophoresis at 120 volts for 1 hour at 4oC. The gel was 
equilibrated in 10X SSC (Saline Sodium Citrate: 1.5M NaCl, 150mM Sodium 
Citrate) transfer buffer for 30 minutes. The RNA was transferred to Bio-Rad Zeta-
Probe® blotting membranes by capillary overnight in 10X SSC. Transfer 
efficiency was determined by Methylene Blue staining. DNA oligonucleotide 
probes listed in Table 3 were 5’ end-labeled with gamma ATP-32P by T4 
Polynucleotide Kinase. Probes were hybridized overnight to pre-blocked in 
Roche Life Science DIG Easy Hyb buffer at 37°C. Blots were washed in 6XSSC / 
0.1%SDS once at room temperature and twice for 10 minutes at 50°C. Blots 
were exposed to a phosphorscreen overnight for snRNAs or 7 days for FMP40 
and YPL22C-A followed by scanning using a phosphorimager (GE Healthcare). 
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Name Sequence Reference 
snR13 Probe GCC AAA CAG CAA CTC GAG CCA AAT GCA CTC This study 
snR3 Probe GCT CGA TCT TCG TAC TGT CTA ATG CGG TGG This study 
snR11 Probe CTA TCA ACC GCG AGC ACG ACA GTG  This study 
FMP40 Probe GTA CCC AAC TTC TGG GGA CAA ACA ACG GG This study 
YPL222C-A 
Probe CCC GTT GTT TGT CCC CAG AAG TTG GGT AC  This study 
 
 
Table 3: Sequences for DNA oligonucleotide probes used for northern blotting. 
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4. ChIP-exo analysis of Rpb3-FLAG and Nrd1-TAP localization 
4.1. Sample Preparation 
Lysate preparation 
Chromatin IP followed by exonuclease treatment was performed using the 
protocol described by Rhee and Pugh [211]. Rpb3-FLAG WT, rtr1Δ and rrp6Δ 
strains and Nrd1-TAP WT and rtr1Δ were grown to an OD600=0.8-1 at 30oC prior 
to crosslinking with formaldehyde (1% final concentration) for 15 minutes at 25oC 
with shaking (Sigma, catalog # F8775-25ML). Crosslinking was immediately 
quenched with glycine (0.15M final concentration) for 5 minutes at 25oC with 
shaking. Cells were pelleted by centrifugation for 3 minutes at 2,829 x g at 4oC. 
Pellets were washed in 1ml ice-cold ST buffer (10mM Tris-HCl (pH 7.5),100mM 
NaCl) containing protease inhibitors, transferred to a 2ml Natural Conical tube, 
and pelleted at 2,300 x g for 2 min at 4 oC. Cells were frozen in -80 overnight to 
facilitate efficient lysis. Cells were thawed on ice and resuspended in 1ml ice-cold 
FA-lysis buffer (50 mM HEPES, 150 mM NaCl, 2 mM EDTA (pH 8.0), 1% Triton 
X-100, 0.1% Na Deoxycholate) containing protease inhibitors. One milliliter of 
0.5-mm Zirconium Silicate beads were added to the suspension to facilitate yeast 
cell lysis. Cells were lysed in a bead-beater by mechanical lysis for 3 minutes, 
chilling on ice for 3 minutes, and repeating 3 times (9 minutes of lysis total). The 
conical tube was then punctured at the bottom with a red hot 22 gauge needle, 
placed inside a 1.7ml microfuge tube, and centrifuged at 200 x g briefly at room 
temperature to remove lysate from beads.   
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Chromatin Shearing by Sonication 
 Cells were centrifuged 2,300 x g for 3 minutes at 4oC. The supernatant was 
discarded, and the cells were washed twice in 1ml ice-cold FA-lysis buffer 
containing protease inhibitors, centrifuged at 2,300 x g for 2 minutes at 4oC each 
time. The pellet was then resuspended in 1 ml of ice-cold FA-lysis buffer 
containing 0.2% SDS and protease inhibitors and transferred to a TPX® 
Polymethylpentene (PMP) 15ml conical tube. Chromatin was sheared by 
sonication in a Diagenode Bioruptor in a 4oC water bath on high for 30 cycles (30 
seconds on / 30 seconds off). Lysate was transferred to a 1.7ml microfuge tube 
and centrifuged at 2,300 x g for 2 minutes at 4oC to pellet an insoluble cellular 
debris. Supernatant was transferred back to the PMP tube, and sonication was 
repeated. Lysate was transferred to a fresh 1.5-ml microfuge tube and 
centrifuged at 2,300 × g for 10 minutes at 4°C, to pellet any remaining debris. 
 
Chromatin Immunoprecipitation 
 The resulting supernatant from the sonication steps was transferred to a 
polypropylene 15ml conical tube, and 3ml FA-lysis buffer was added to dilute the 
SDS concentration to 0.05%. Immunoprecipitation was performed with 50uL of 
anti-FLAG agarose beads (for Rpb3-FLAG) or anti-TAP sepharose beads (for 
Nrd1-TAP) (Sigma). The volume of anti-FLAG agarose used for RNAPII 
immunoprecipitation was optimized by affinity purification followed by mass 
spectrometry. Chromatin and beads were incubated overnight with rotation at 
4°C. The samples were centrifuged at 94 × g for 1 minute at room temperature to 
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collect the beads. The supernatant was removed, and beads were resuspended 
in 0.5ml ice-cold FA-lysis buffer containing protease inhibitors and transferred to 
a fresh 1.7ml microfuge tube. Beads were centrifuged at 94 x g for 1 minute at 
room temperature, the supernatant was removed, and the beads were washed in 
1ml ice-cold FA-lysis buffer containing protease inhibitors by incubating 5 
minutes at room temperature on a rotating wheel. Beads were pelleted by 
centrifugation at 94 × g for 1 minute at room temperature, resuspended in fresh 
ice-cold FA-lysis buffer containing protease inhibitors, and pelleted again to 
wash. The beads were then washed in the same manner in the following wash 
sequence, each buffer ice-cold and containing protease inhibitors: 
1) 1ml FA-high salt wash buffer: 50mM HEPES, 1M NaCl, 2mM EDTA 
(pH 8.0), 1% Triton X-100, 0.1% NaDeoxycholate 
2) 1ml FA-wash 2 buffer: 50mM Hepes/KOH, 0.5M NaCl, 2mM EDTA (pH 
8.0), 1% TritonX-100, 0.1% NaDeoxycholate 
3) 1ml FA-wash 3 buffer: 25mM LiCl, 1% NP40-Nonidet (IPEGAL), 1% 
NaDeoxycholate, 2mM EDTA, 10mM Tris-Cl (pH 8.0) 
4) Tris-EDTA (TE) buffer: 10mM Tris-HCl (pH 8.0), 1mM EDTA (pH 8.0) 
5) Tris-HCl (pH 8.0) 
Each enzymatic reaction listed below was followed by the above wash sequence. 
  
On-Bead Enzymatic Reactions – First Adaptor Ligation and Exonulcease 
Digestion for ChIP-exo 
 A diagram of these enzymatic reactions is shown in Figure 8. 
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 1) The DNA bound to the immunoprecipitated protein was subjected to 
“polishing” by T4 DNA polymerase (New England Biolabs). This reaction served 
to fill in DNA sequences in the 5’ – 3’ direction at the end of DNA fragments left 
with a 5’ single stranded overhang after sonication, resulting in blunt ends.  
2) Next, T4 Polynucleotide Kinase (PNK) (New England Biolabs) was 
used to add a phosphate to the 5’ –hydroxyl ends of the blunt ends. This step 
increases the efficiency of the ligation reaction used to add barcoded adaptors to 
the DNA for sequencing.  
3) Klenow Fragment (New England Biolabs) and dATP were used to add a 
polyA tail to the DNA 3’ ends. This polyA tail is used for ligation of the P2-T 
adaptors. 
4) T4 DNA ligase (New England Biolabs) was used to join a P2-T 
barcoded sequencing adaptor to the blunt ends of the DNA fragments. Samples 
and their corresponding barcodes are listed in Table 5. 
5) Filling in reactions were then performed with Phi29 DNA polymerase 
(New England Biolabs)  – a replicative polymerase – to fill in the adaptor 
sequence. 
6) A second T4 PNK (New England Biolabs) reaction added a phosphate 
to the 5’ –hydroxyl ends to facilitate the exonuclease reaction. 
7) Lambda exonuclease (New England Biolabs) was used to digest the 5’ 
strand of the double stranded DNA back to the location of the bound 
immunoprecipitated protein. Lambda exonuclease is capable of degrading single 
stranded DNA and unphosphorylated ends but is much more efficient digesting 
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double stranded, 5’ –phosphorylated ends according to the manufacturer’s 
instructions. 
8) A second 5’ – 3’ exonuclease reaction was performed with RecJf 
exonuclease (New England Biolabs) to maximize the efficiency of the 
exonuclease digestion. 
 
Chromatin Elution 
 Chromatin was eluted from the beads and the cross-linking was reversed by 
incubating in 450µl ChIP Elution Buffer (25mM Trizma 2mM EDTA (pH 8.0), 
200mM NaCl, 0.5% SDS) with 1µl Protease K at 65°C overnight. The DNA was 
isolated with ice-cold phenol/chloroform/isoamyl alcohol (Ambion) and 
precipitated for 1 hour with 100% ethanol. The pellets were dried, resuspended in 
11µl TE, and immediately sent to the sequencing core for the addition of the 
second sequencing adaptor, DNA quality and size confirmation by BioAnalyzer, 
and SOLiD5500xl sequencing. BioAnalyzer runs were performed according to 
the manufacturer’s instructions on a high sensitivity DNA chip. 
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Figure 8: Schematic of enzymatic reactions for ChIP-exo sample preparation. 
Reactions include adaptor ligation and exonuclease digestion of 5’ ends.   
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4.2. ChIP-exo peak calling with MACS2 
 To identify the top peaks of Nrd1-RNAPII binding in the Nrd1 ChIP-exo data set, 
we used the MACS2 (Model-based Analysis of ChIP-Seq) algorithm [212]. While 
the original MACS protocol was developed for calling narrow transcription factor 
binding sites [213], MACS2 is capable of calling broad peaks similar to the 
footprint expected of Nrd1 binding. We executed MACS2 (Version 2-2.1.0) for 
Nrd1-TAP WT (Library 29) and Nrd1-TAP rtr1Δ cells (Library 30) independently. 
Default parameters were used with the fragment extension length set to 300 
bases. This length was determined by visual evaluation of the mapped DNA 
reads in IGV. The genomic locations of the top 100 peaks as determined by fold-
change were compared to the genomic locations of the top 100 Nrd1 
Photoactivatable-Ribonucleoside-Enhanced Crosslinking and 
Immunoprecipitation (PAR-CLIP) peaks reported by Creamer et al. [50].  
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RESULTS 
 
1. Confirmation of strains and sample quality 
1.1. Transformation of knockout strains 
All yeast strains used are isogenic to BY4741, which was used as our 
wild-type in all experiments. The RRP6 deletion strain was obtained from the 
yeast knockout collection (Open Biosystems) [198]. RTR1 was knocked out of 
BY4741 and the RRP6 deletion strain by homologous recombination by using a 
kanamycin cassette (containing the KANMX gene) to create the RTR1 deletion 
and RTR1/RRP6 double deletion strains (illustrated in Figure 9). The 
RTR1::KANMX strain was previously constructed in the lab, so to knock out 
RTR1 in the rrp6Δ cells, the RTR1::KANMX locus plus 200 base pairs upstream 
of the start codon and 200 base pairs downstream of the stop codon were 
amplified by polymerase chain reaction using primers P1 and P2 (Figure 9). The 
resulting PCR product was then transformed into the rrp6Δ cells to stably delete 
the RTR1 locus by homologous recombination and transformants were then 
selected for kanamycin resistance. RTR1 is 681 nt and KANMX is 1400 nt. 
Confirmation of successful transformation was performed by PCR using primers 
P3 and P4 (Figure 9). Successful recombination of the transformed DNA resulted 
in a PCR product of 2147 nt whereas an unsuccessful transformation would 
result in a PCR product of 1428 nt. Representative PCR results are shown in 
Figure 10.  
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Figure 9: Schematic of homologous recombination and PCR confirmation. The 
KNMX sequence and 396 nt homologous to the sequence upstream of RTR1 
and 359 nt homologous to the sequence downstream of RTR1 were amplified by 
PCR using primers P1 and P2 from the available RTR1::KNMX strain. The 
resulting PCR amplicon was used to transform the RRP6::HIS3 strain that was 
obtained from the Open Biosystems yeast knockout library by homologous 
recombination. Successful transformation was confirmed by PCR using primers 
P3 and P4. 
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Figure 10: Confirmation of RTR1 knockout by PCR. PCR products resulting from 
amplification of the RTR1 region using primers P4 and P5 (Figure 9). A positive 
knockout control where RTR1 has been replaced with KNMX is in lane 1 at 2468 
bp. A negative control where RTR1 is present is in lane 2 at 1749 bp. Results for 
14 transformants tested are in lanes 3-16. Transformants with the desired 
RTR1∷KNMX recombination can be seen in lanes 10, 12, and 16. All three 
positives were frozen for future use and tested with comparable results in early 
experiments. All three performed identically in all experiments. The strain 
represented in lane 10 was used for all analysis shown here.  
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1.2. Sample quality confirmation by Bioanalyzer 
 For RNA isolation, nine biological replicates were streaked from glycerol stocks 
for each of four strains: WT, rtr1Δ, rrp6Δ, and rtr1Δ rrp6Δ . Each sample set was 
confirmed by electrophoresis and PCR amplification to be of good quality before 
sent for analysis. For ChIP-exo preparation, four replicates were performed for 
Rpb3-FLAG WT and rtr1Δ, two replicates were performed for Rpb3-FLAG rrp6Δ, 
and three replicates were performed for Nrd1-TAP WT and rtr1Δ. RNA and DNA 
quality were ascertained by BioAnalyzer. The Agilent Bioanalyzer uses a glass 
chip with multiple microchannels. The samples and a known concentration of a 
ladder are loaded into each well with fluorescent dye. A voltage gradient is used 
to separate the RNAs and DNA fragments by size, similar to gel electrophoresis. 
Each RNA and DNA molecule is detected by laser-induced fluorescence, and the 
data is translated into gel-like images and peaks. The software compares the 
unknown peaks detected in the RNA and DNA samples to the known sizes and 
concentration of the bands detected in the ladder to calculate the concentration 
of the samples. In the case of the RNA, the expected sizes and concentrations of 
the yeast ribosomal RNA bands, as well as other highly abundant bands, are 
compared to the detected sizes and concentrations to calculate the RNA Integrity 
Number (RIN) representing the quality of the RNA sample (Table 4). RINs of 6 or 
greater are considered acceptable for RNA-Seq. The best four replicates as 
determined by Bioanalyzer were selected for sequencing: P5, P6, P8, and P9 
(Figure 11, Table 4). For ChIP-exo samples, the resulting peaks were compared 
to the known peaks of the ladder to calculate the average fragment size (Figure 
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12, Table 5). An average DNA fragment size of approximately 250 nt is optimal 
for ChIP-exo experiments [211]. 
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Figure 11: RNA Bioanalyzer results. The top and bottom panels represent the 
results from one chip. Each RNA preparation is listed as P# (i.e. P3) 
corresponding to the biological replicate purification and was used for further 
analysis. The RNA ladder is in the left-most lane of each chip. The green bar 
indicates a small RNA control marker added to each lane to serve as a loading 
control. 
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Sample Barcode ID RIN 
WT prep 8 1 6.50 
rtr1Δ prep 8 2 6.60 
rrp6Δ prep 8 3 6.40 
rtr1Δ rrp6Δ prep 8 4 6.50 
WT prep 5 5 6.50 
rtr1Δ prep 5 6 6.70 
rrp6Δ prep 5 7 6.50 
rtr1Δ rrp6Δ prep 5 8 8.80 
WT prep 6 9 6.40 
rtr1Δ prep 6 10 6.40 
rrp6Δ prep 6 11 6.40 
rtr1Δ rrp6Δ prep 6 12 6.30 
WT prep 9 13 6.50 
rtr1Δ prep 9 14 6.60 
rrp6Δ prep 9 15 6.70 
rtr1Δ rrp6Δ prep 9 16 6.60 
 
 
Table 4: Summary of Bioanalyzer data for RNA samples used in this study. RIN 
(RNA Integrity Number) values were calculated by the Bioanalyzer software 
which compares the peaks shown in Figure 11 to the known sizes of the S. 
cerevisiae rRNAs. RINs of 6 or greater are considered acceptable for RNA-Seq. 
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Figure 12: ChIP-exo Bioanalyzer results. The top panel represents the results 
from one chip. The bottom panel represents two partial chips combined for 
space. The DNA ladder is in the left-most lane of each chip. Sheared DNA 
samples are shown in the other lanes. The green and purple bars indicate 
loading control markers added to each lane. 
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Sample Barcode ID 
Ave Fragment 
Size, nt 
Rpb3-FLAG WT p1 21 243 
Rpb3-FLAG rtr1Δ p1 23 225 
Rpb3-FLAG rrp6Δ p1 25 229 
Rpb3-FLAG WT p2 28 264 
Rpb3-FLAG rtr1Δ p2 27 260 
Nrd1-TAP WT p1 29 285 
Nrd1-TAP rtr1Δ p1 30 259 
 
Table 5: Summary of ChIP-exo Bioanalyzer results for samples used in this 
study. Average DNA fragment sizes were calculated by using the Bioanalyzer 
software which compares the peaks for each sample in Figure 12 to the size and 
intensity of the DNA ladder. An average DNA fragment size of approximately 250 
nt is optimal for ChIP-exo experiments [211]. The p# designates the biological 
replicate number for the samples used for analysis. 
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2. Rrp6 Is Required for RNAPII Termination at Specific Targets of the Nrd1-
Nab3 Pathway 
2.1. Genome-wide analysis of RRP6 deletion strains by RNA-Seq 
To identify classes of transcripts affected by the loss of Rrp6, we utilized 
previously published annotations for yeast transcripts and performed differential 
expression analysis using normalized sequencing reads through EdgeR [72, 205, 
214]. This analysis represented the entire transcribed region for mRNAs by 
employing annotations that include both the 5’ and 3’ untranslated region (UTR) 
for the majority of the yeast transcriptome [215]. Overall, the annotations used for 
our study include 5792 open reading frames (ORF-Ts), 658 CUTs, 648 SUTs, 
1215 NUTs, 844 Rrp6-regulated antisense transcripts, 1078 Xrn1-sensitive 
unstable transcripts (XUTs), 80 snRNAs, and 78 snRNA extended transcripts 
(ETs, manually annotated in this study). In rrp6Δ cells, we identified 136 up-
regulated open reading frame transcripts and 734 that were down-regulated 
(ORF-Ts, fold change cut-off = +/- 1.5, p-value < 0.05, FDR ≤ 0.1, Figure 13A, B). 
We also identified 622 induced CUTs out of a total of 733, in agreement with 
previous reports that CUT expression and stability is increased in the absence of 
Rrp6 ([71, 73, 75], Figure 13A). Of importance, using deep sequencing 
technology many CUTs were detected that have not previously been identified in 
WT cells using microarrays [71-73, 75]. Analysis of the NUTs revealed that the 
majority of this class of transcripts, 887/1215, were also up-regulated in the rrp6Δ 
strain (Figure 14A). We also discovered that 223/648 SUTs were significantly up-
regulated in rrp6Δ cells, identifying the specific subset of SUT transcripts that are 
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likely terminated by the NNS pathway. In rrp6Δ cells, a total of 54 sn/snoRNAs 
showed significant transcript extension. There was not significant overlap 
between Rrp6-sensitive transcripts and previously described XUTs, in agreement 
with previous work that suggests that noncoding RNAs targeted by the 
cytoplasmic 5’-3’ exonuclease Xrn1 are degraded by a separate mechanism than 
noncoding RNAs sensitive to the nuclear specific 3’-5’ exonuclease Rrp6 [216].  
Considering that Rrp6 is an exonuclease, it is expected that the majority of 
RNA expression changes in rrp6Δ cells would be due to accumulation. However, 
we were surprised to see 734 mRNAs significantly decreased ≤ 1.5-fold in rrp6Δ 
cells (Figure 13B, ORF-Ts in yellow). To better understand the classes of 
mRNAs down-regulated in rrp6Δ cells, we performed GO-term enrichment 
analysis to determine if any cellular pathways showed significant enrichment 
within the set of decreased mRNAs. Surprisingly, the most enriched GOterm was 
GO:0005830 for the cytosolic ribosome with a p-value of 6.43E-82 (Table 6).  In 
total, nine of the 30 statistically significant enriched GO-terms related to 
ribosomal protein coding genes with p-values less than or equal to 7.85E-19 
(Table 6). Differential expression analysis determined that transcript levels of 113 
out of 137 ribosomal protein coding genes were decreased more than 1.5-fold 
(Figure 13C, Table 3). Interestingly, only three ribosomal protein-coding genes 
had more than 1.5-fold increase in expression (Figure 13C). It is also interesting 
to note that the average transcript length from the down-regulated ribosomal 
protein-coding mRNAs is 916 nt putting many of the transcripts within the 
approximate length limits for the NNS pathway.  
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Figure 13: Expression plots for normalized RNA-Seq data with specific classes of 
RNA transcripts highlighted. After sequencing reads were aligned to the yeast 
genome, reads mapped to annotated open reading frame transcripts (ORF-Ts), 
cryptic unstable transcripts (CUTs), stable unannotated transcripts (SUTs), and 
Nrd1 unterminated transcripts (NUTs) were used for differential expression 
analysis using edgeR. Log2 of the fold-change values are plotted versus the 
average number of normalized reads across all biological replicates for all RNA 
transcripts in cells lacking RRP6 compared to WT (black dots). (A) RNAs 
previously annotated as CUTs, a classification based on the dependence of 
rrp6Δ for detection are shown as gray dots while all other transcripts are shown 
as black dots. (B) RNAs annotated as ORF-Ts, most of which are protein coding 
messenger RNAs are shown in yellow.  All other transcripts are shown in black. 
(C) Messenger RNA expression values for ribosomal protein coding genes, 
shown as black dots. 
  
 76 
 
Figure 14: Expression plots for normalized RNA-Seq data for Nrd1-unterminated 
transcripts (NUTs) and western blot analysis of Rpb3-FLAG strains. (A) After 
sequencing reads were aligned to the yeast genome, reads mapped to annotated 
open reading frame transcripts (ORF-Ts), cryptic unstable transcripts (CUTs), 
stable unannotated transcripts (SUTs), and Nrd1 unterminated transcripts 
(NUTs) were used for differential expression analysis in rrp6Δ versus WT using 
edgeR. Log2 of the fold-change values are plotted versus the average number of 
normalized reads across all biological replicates for all RNA transcripts in cells 
lacking RRP6 compared to WT (black dots). NUT annotations are shown as aqua 
dots. (B) Western blot analysis of whole cell extracts prepared from Rpb3-FLAG 
WT and rrp6Δ strains using anti-FLAG peroxidase coupled antibodies (Sigma).  
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Best GOs Count Total P-Value Ontology 
(Max: 30) 927 6476   
GO:0005830 115 175 6.43E-82 Cytosolic Ribosome 
GO:0044445 120 196 6.71E-77 Cytosolic Part (Cytosol Component) 
GO:0003735 122 230 9.32E-62 Structural Constituent of Ribosome 
GO:0033279 123 240 8.96E-59 Ribosome 
GO:0005842 68 97 1.37E-52 Cytosolic Large Ribosomal Subunit 
GO:0005840 139 353 2.12E-40 Ribosome 
GO:0015934 76 142 3.29E-38 Large Ribosomal Subunit 
GO:0005843 45 64 2.49E-34 Cytosolic Small Ribosomal Subunit 
GO:0043228 259 1032 1.65E-24 Non-Membrane-Bound Organelle 
GO:0043232 259 1032 1.65E-24 Intracellular Non-Membrane-Bound Organelle 
GO:0030529 177 622 1.38E-23 Ribonucleoprotein Complex 
GO:0015935 47 98 7.85E-19 Small Ribosomal Subunit 
GO:0009277 46 114 5.68E-13 Fungal-Type Cell Wall 
GO:0005618 46 114 5.68E-13 Cell Wall 
GO:0030312 46 114 5.68E-13 External Encapsulating Structure 
GO:0005829 145 623 4.07E-09 Cytosol 
GO:0044422 420 2309 5.66E-09 Organelle Part 
GO:0044446 420 2309 5.66E-09 Intracellular Organelle Part 
GO:0043229 666 4023 6.50E-09 Intracellular Organelle 
GO:0043226 666 4024 6.63E-09 Organelle 
GO:0044249 209 1009 3.93E-08 Cellular Biosynthetic Process 
GO:0032991 322 1705 4.54E-08 Macromolecular Complex 
GO:0044464 846 5490 3.67E-07 Cell Part 
GO:0006412 145 687 9.57E-06 Translation 
GO:0005737 602 3699 2.15E-05 Cytoplasm 
GO:0009058 236 1251 3.37E-05 Biosynthetic Process 
GO:0044444 458 2717 6.65E-05 Cytoplasmic Part 
GO:0009987 729 4653 6.65E-05 Cellular Process 
GO:0005199 12 19 0.000102 Structural Constituent of Cell Wall 
GO:0030150 13 22 0.000104 Protein Import into Mitochondrial Matrix 
 
Table 6: Top 30 GO-terms enriched in protein coding genes down-regulated in 
rrp6Δ compared to WT. Table includes GO identification number (“Best GOs”), 
number of hits from GOStat analysis of our list of protein coding genes down-
regulated in rrp6Δ matching the GO ID (“Count”), total number of genes assigned 
the GO ID (“Total”), p-value for the GO term, and the descriptor for the GO ID. 
Information calculated using GOstat, as described in the methods.  
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Transcript Standard RRP6 _KO RRP6 _KO RRP6 _KO 
name gene vs WT vs WT vs_WT 
  name log2_FC p-value FDR 
YLR367W RPS22B -1.992743 1.27E-06 1.34E-05 
YGL189C RPS26A -1.234646 4.08E-04 2.11E-03 
YDR012W RPL4B -1.224361 2.50E-05 1.80E-04 
YOL040C RPS15 -1.187806 1.48E-04 0.000871 
YOL039W RPP2A -1.18084 2.86E-04 1.54E-03 
YKL180W RPL17A -1.178588 2.47E-04 1.36E-03 
YLR185W RPL37A -1.138591 7.94E-05 0.000498 
YDR418W RPL12B -1.112196 1.63E-05 0.000123 
YBL092W RPL32 -1.103358 0.0002222 0.001236 
YHL033C RPL8A -1.096525 2.78E-05 0.000197 
YER131W RPS26B -1.075197 1.52E-04 0.00089 
YCR031C RPS14A -1.067605 0.0002575 0.001406 
YOL127W RPL25 -1.061722 0.0006462 0.00316 
YMR242C RPL20A -1.035553 0.0010762 0.005013 
YML073C RPL6A -1.032985 0.000519 0.002613 
YPL249C-A RPL36B -0.983926 0.0006543 0.003197 
YPL079W RPL21B -0.964466 0.0001339 0.000795 
YFL034C-A RPL22B -0.955394 0.0012336 0.005662 
YDR025W RPS11A -0.949811 0.0016071 0.007215 
YIL052C RPL34B -0.948519 0.0009384 0.004451 
YOL120C RPL18A -0.943612 0.0004191 0.002161 
YLL045C RPL8B -0.943453 0.000723 0.00351 
YNL096C RPS7B -0.938209 0.0005994 0.002957 
YNL302C RPS19B -0.93574 0.0013151 0.006009 
YER056C-A RPL34A -0.930519 0.0009908 0.004656 
YER102W RPS8B -0.928462 6.59E-04 3.22E-03 
YKL006W RPL14A -0.92515 1.58E-03 7.09E-03 
YNL178W RPS3 -0.901668 0.0025041 0.010605 
YBL087C RPL23A -0.892906 0.002011 0.008786 
YGL031C RPL24A -0.88995 0.0016174 0.007259 
YLR048W RPS0B -0.885436 0.0023533 0.010064 
YIL133C RPL16A -0.885136 0.0004631 0.002356 
YPR043W RPL43A -0.884017 0.002664 0.011217 
YOL121C RPS19A -0.883042 0.0010284 0.004808 
YER074W RPS24A -0.87574 0.0058453 0.022194 
YBR189W RPS9B -0.869864 0.0024119 0.010275 
YDR500C RPL37B -0.866716 0.0017226 0.007679 
YFR031C-A RPL2A -0.851989 0.005231 0.02018 
YPL131W RPL5 -0.843837 0.0045064 0.017737 
YOR182C RPS30B -0.835264 0.0078704 0.028345 
YDL083C RPS16B -0.834289 0.0044297 0.017518 
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Transcript Standard RRP6 _KO RRP6 _KO RRP6 _KO 
name Gene vs WT vs WT vs_WT 
  Name log2_FC p-value FDR 
YBL072C RPS8A -0.831343 0.0019911 0.008726 
YLR333C RPS25B -0.819168 0.0034659 0.014144 
YBR031W RPL4A -0.808244 0.0048695 0.018981 
YOR312C RPL20B -0.806282 0.006965 0.025671 
YLR061W RPL22A -0.803565 0.0086104 0.030498 
YDL061C RPS29B -0.798657 0.0044449 0.01755 
YLR448W RPL6B -0.798618 0.0047792 0.018658 
YDR064W RPS13 -0.791903 0.0052173 0.020134 
YNL069C RPL16B -0.789254 0.0137802 0.045367 
YIL069C RPS24B -0.787525 0.0060321 0.02279 
YJL177W RPL17B -0.786743 0.0076389 0.027709 
YBL027W RPL19B -0.786163 0.0135939 0.044915 
YER117W RPL23B -0.778262 0.0095956 0.03347 
YGR027C RPS25A -0.774556 0.0114579 0.039038 
YGL030W RPL30 -0.772552 0.0080671 0.028908 
YDL136W RPL35B -0.770191 0.0040663 0.016259 
YLR340W RPP0 -0.77013 0.0110787 0.037909 
YOR096W RPS7A -0.764428 0.0204919 0.062694 
YLR388W RPS29A -0.761878 0.0042301 0.016807 
YLR325C RPL38 -0.759297 0.0085087 0.030212 
YDL075W RPL31A -0.755111 0.0065852 0.024522 
YFR032C-A RPL29 -0.754373 0.0444649 0.11698 
YLR264W RPS28B -0.753698 0.0357407 0.098824 
YDL130W RPP1B -0.751444 0.0019945 0.00873 
YGR214W RPS0A -0.742393 0.010866 0.037321 
YOR293W RPS10A -0.74227 0.014457 0.04721 
YGR085C RPL11B -0.74147 0.0085608 0.030354 
YLR029C RPL15A -0.731306 0.0227316 0.068083 
YOR234C RPL33B -0.728371 0.0232336 0.069254 
YDR450W RPS18A -0.727014 0.0146413 0.047688 
YJR123W RPS5 -0.725396 0.0133131 0.044146 
YPL143W RPL33A -0.724666 0.0117044 0.0397 
YMR142C RPL13B -0.724028 0.0118811 0.040184 
YGL103W RPL28 -0.721152 0.0154361 0.049858 
YIL018W RPL2B -0.719007 0.0215832 0.065339 
YHR203C RPS4B -0.717286 0.009648 0.03363 
YKR094C RPL40B -0.713796 0.0177864 0.056102 
YOR063W RPL3 -0.711676 1.17E-02 3.96E-02 
YGL147C RPL9A -0.708731 1.98E-02 6.10E-02 
YNL162W RPL42A -0.701371 0.0140184 0.046031 
YGL123W RPS2 -0.699459 0.015224 0.049315 
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Transcript Standard RRP6 _KO RRP6 _KO RRP6 _KO 
name gene vs WT vs WT vs_WT 
  name log2_FC p-value FDR 
YIL148W RPL40A -0.69744 0.0256972 0.075447 
YDL081C RPP1A -0.692989 0.0138284 0.0455 
YPL090C RPS6A -0.692649 0.0128554 0.042953 
YLR167W RPS31 -0.692286 0.017123 0.054322 
YMR194W RPL36A -0.690894 0.0145699 0.047502 
YML024W RPS17A -0.685614 0.028975 0.083433 
YLR441C RPS1A -0.682298 0.01404 0.046087 
YHR141C RPL42B -0.675091 0.0171414 0.054357 
YEL054C RPL12A -0.672709 0.0089589 0.031566 
YML063W RPS1B -0.666632 0.0194106 0.060042 
YLR406C RPL31B -0.666172 0.0144954 0.047289 
YBR181C RPS6B -0.664573 0.0167511 0.053404 
YDL191W RPL35A -0.662184 0.0153436 0.049623 
YJL190C RPS22A -0.661559 0.0261498 0.076566 
YHL015W RPS20 -0.658424 0.019602 0.060523 
YLR287C-A RPS30A -0.657464 0.017669 0.055767 
YBR048W RPS11B -0.65009 0.0199817 0.061432 
YDR471W RPL27B -0.644312 0.0258483 0.075794 
YKR057W RPS21A -0.642271 0.0276957 0.080346 
YGR148C RPL24B -0.642236 0.0182273 0.057082 
YHL001W RPL14B -0.639806 0.0232776 0.069365 
YDL082W RPL13A -0.634606 0.0175214 0.055387 
YDR447C RPS17B -0.626113 0.029302 0.084242 
YOR369C RPS12 -0.624058 0.0206402 0.063052 
YBR191W RPL21A -0.622635 0.0416636 0.111294 
YGR034W RPL26B -0.61042 0.0178033 0.056138 
YPR102C RPL11A -0.608627 0.0229386 0.068598 
YLR344W RPL26A -0.603486 0.0192758 0.059735 
YHR010W RPL27A -0.601308 0.0493884 0.126694 
YMR143W RPS16A -0.599466 0.0346025 0.096177 
YDR382W RPP2B -0.589555 0.0261842 0.0766 
YPR132W RPS23B -0.583809 0.0406487 0.109395 
YOR167C RPS28A -0.576323 0.0495282 0.126891 
YHR021C RPS27B -0.560382 0.0628014 0.152233 
YGR118W RPS23A -0.559219 0.042936 0.113849 
YML026C RPS18B -0.557373 0.059988 0.146896 
YGL135W RPL1B -0.55551 0.0363786 0.100071 
YJL136C RPS21B -0.549716 0.0446804 0.117424 
YJR094W-A RPL43B -0.536115 0.0754008 0.17443 
YJR145C RPS4A -0.533175 0.0835771 0.188317 
YLR075W RPL10 -0.512194 0.0608524 0.148472 
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Transcript Standard RRP6 _KO RRP6 _KO RRP6 _KO 
name gene vs WT vs WT vs_WT 
  name log2_FC p-value FDR 
YJL189W RPL39 -0.505149 0.0831211 0.18768 
YMR230W RPS10B -0.503579 0.0968439 0.210189 
YPL220W RPL1A -0.468115 0.0691459 0.163534 
YKL156W RPS27A -0.41425 0.1248119 0.252818 
YGL076C RPL7A -0.39988 0.1361771 0.270211 
YHR062C RPP1 -0.376622 0.1612654 0.303452 
YNL067W RPL9B -0.371443 0.1648438 0.308062 
YDL133C-A RPL41B -0.319501 0.2893062 0.453218 
YBR084C-A RPL19A -0.317091 0.2983566 0.46308 
YDL184C RPL41A -0.307528 0.3224259 0.486798 
YPL198W RPL7B 0.1986869 0.5286336 0.665783 
YPL081W RPS9A 0.5890903 0.0698796 0.164873 
YNL301C RPL18B 1.060323 4.82E-05 0.000323 
YJL191W RPS14B 1.3124904 2.56E-06 2.49E-05 
 
Table 7: Differential expression information for the ribosomal protein coding 
transcripts. Table includes differential expression data expressed in log2 
rrp6Δ/WT ratio (i.e. fold change) as well as p-values and false discovery rate 
(FDR), all calculated from four replicates by the EdgeR algorithm as discussed in 
the methods. Table also includes standard gene names (or acronyms) for clarity. 
Significantly down-regulated transcripts are in red-shaded cells whereas up-
regulated sn/snoRNAs are in green-shaded cells. 
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Pearson correlation coefficients were calculated comparing the average 
log2 fold-change values in rrp6Δ versus WT obtained in our RNA-Seq dataset 
(n=4) and in a recent tiling array study by Castelnuovo et al. 2014 [217, 218]. The 
correlation coefficient when comparing these two datasets is 0.751 (Figure 15A), 
a value indicating that there is a strong positive correlation between the two 
datasets similar to the extent of correlation previously found when comparing 
RNA-Seq to the tiling array platform [219]. Interestingly, the highly abundant 
sn/snoRNA transcripts had poor correlation across the two platforms, 
represented as red dots in Figure 15A (values also given in Table 4). It has 
previously been shown that RNA-Seq has a capacity for much greater dynamic 
range than microarrays, which can be saturated by very abundant transcripts and 
may not be able to quantitatively detect transcripts expressed at low levels [56]. 
For this reason, we propose that the differences seen between our dataset and 
previously published tiling array data are due at least in part to the increased 
dynamic range obtained with deep transcriptome coverage obtained by our RNA-
Seq experiments. Considering that sn/snoRNAs are highly abundant and that 
they are one of the primary cellular targets of Rrp6 activity [14-16], the ability to 
accurately measure the abundance of snRNAs in this instance is a distinct 
advantage of using RNA-Seq.  
To compare the detection and quantification of extended 3’ ends of a 
selection of snRNAs in WT versus rrp6Δ cells, area-under-the-curve values were 
calculated for snR33 and snR37 using our RNA-Seq data compared to data from 
the previously published tiling array dataset (Figure 15B-D, [218]). The degree of 
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extended transcript accumulation in rrp6Δ cells involved the measured ET area 
which was normalized against the area under the curve for the entirety of each 
gene transcript resulting in a percent of extended transcript value (Figure 13B). 
For transcripts snR37 and snR33, which have extended 3’ ends, there are 
significantly more extended reads in the RRP6 mutant than in wild-type in both 
the sequencing and array data sets (Figure 15). This agrees with the known role 
of Rrp6 to trim 3’ ends of snRNAs after termination. However, the relative ratios 
of these extended transcripts to the sense transcript appear to be much higher in 
the tiling array data than in the sequencing data in RNA isolated from RRP6 
deletion strains. For instance, approximately 11% of snR37 transcripts appeared 
extended in the tiling arrays dataset as opposed to 0.3% when analyzed by RNA-
Seq (Figure 15B). RNA sequencing read count values in our study span 5 orders 
of magnitude while the tiling array data only covers 3-4 orders of magnitude, 
likely causing a loss of accurate detection of highly abundant fully processed 
sn/snoRNAs (compare Figure 15C, D). The highly abundant processed snR37 or 
snR33 peaks are clearly distinguished from extended products using RNA-Seq 
(Figure 15). Our data suggests that the relative effects of the loss of RRP6 on the 
steady state levels of these extended transcripts is much less dramatic than 
previously described and that quantitation of steady state levels of the processed 
snRNA upon loss of RRP6 was problematic due to limited dynamic range of the 
microarray approach.  
 84 
 
 
Figure 15: Comparison of highly abundant sn/snoRNA transcripts from rrp6Δ and 
WT strains obtained through tiling array or RNA sequencing. (A) Comparison of a 
recent rrp6Δ tiling array dataset [51] and RNA-Seq data collected in this study by 
plotting the average log2 ratio values (rrp6Δ / WT) for all transcripts. All annotated 
transcripts included in both data sets are represented by gray circles. All 
sn/snoRNAs are highlighted in red circles. The Pearson correlation coefficient (r) 
between these datasets = 0.751, indicating a modest positive correlation 
between the two data sets. (B) Area under the curve calculation for snR37 
extended transcripts (labeled as “ET”) from WT and rrp6Δ strains. The area 
calculated for snR37-ET annotation was divided by the area calculated for the 
entire snR37 to snR37-ET annotation to calculate the percentage of the entire 
transcript area located in the snR37-ET region (see diagram under (C) and (D) 
for locations of annotations). Values are shown as averages ± standard 
deviations for sequencing data are in black, tiling array data is in red. (C) 
Previously published tiling array intensity values [59] at snR37 using probe mid-
position (8 nt apart), for comparison with (D) mapped reads from RNA-Seq data 
at snR37 (single nt resolution). Tiling array data represented in log2 scale. RNA-
Seq data represented in log10 scale. In both graphs, WT expression is in black, 
and rrp6Δ is in red. Locations of annotated transcripts and the direction of 
transcription are indicated below the charts. 
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Transcript Standard RRP6 _KO_ RRP6 _KO RRP6 _KO 
class gene vs WT vs WT vs_WT 
  name log2_FC p-value FDR 
sn/snoRNA SNR81 -2.860386521 4.85E-14 4.14E-12 
sn/snoRNA SNR44 -2.230899649 2.77E-07 3.50E-06 
sn/snoRNA SNR35 -1.928146267 2.05E-10 6.41E-09 
sn/snoRNA SNR56 -1.523807602 6.39E-05 0.000413774 
sn/snoRNA SNR86 -1.462375099 8.21E-07 9.17E-06 
sn/snoRNA SNR65 -1.430941739 9.68E-06 7.85E-05 
sn/snoRNA SNR78 -1.365952969 5.82E-04 0.002888894 
sn/snoRNA SNR64 -1.364898817 2.01E-05 0.000148358 
sn/snoRNA SNR84 -1.236072278 0.000125125 0.000748372 
sn/snoRNA SNR33 -1.215933047 9.83E-05 0.000603253 
sn/snoRNA SNR66 -1.195949546 9.14E-05 0.000563868 
sn/snoRNA SNR59 -1.107521289 0.014237604 0.046625789 
sn/snoRNA SNR189 -1.048743348 0.001930926 0.008499109 
sn/snoRNA SNR191 -0.896795436 0.020416846 0.062502573 
sn/snoRNA snR61 -0.849755476 0.013504106 0.044647673 
sn/snoRNA SNR34 -0.833187075 0.014336742 0.046878903 
sn/snoRNA SNR71 -0.765950611 0.015401095 0.04976118 
sn/snoRNA SNR87 -0.675373826 0.016687617 0.053235664 
sn/snoRNA SNR46 -0.661274027 0.02844551 0.082096313 
sn/snoRNA SNR50 -0.628210692 0.029626572 0.084924341 
sn/snoRNA SNR31 -0.713728032 0.037316016 0.102087548 
sn/snoRNA SNR14 0.711639383 0.035216361 0.09758774 
sn/snoRNA SNR6 0.82703613 0.022085331 0.066560823 
sn/snoRNA SNR57 0.881604448 0.006580374 0.024512926 
sn/snoRNA SNR75 1.069032702 0.004722081 0.01845638 
sn/snoRNA SNR42-A 1.878888595 2.73E-08 4.71E-07 
sn/snoRNA SNR87-A 2.31736285 1.76E-09 4.31E-08 
sn/snoRNA SNR39B -0.909027838 0.039039925 0.106084238 
sn/snoRNA SNR40 -0.591588028 0.052996397 0.133670752 
sn/snoRNA SNR36 -0.635111023 0.058982769 0.145245968 
sn/snoRNA SNR80 -0.693626771 0.0740974 0.17212582 
sn/snoRNA SNR128 -0.574195832 0.118859877 0.243317703 
sn/snoRNA SNR42 -0.549369317 0.06806735 0.161660948 
sn/snoRNA SNR52 -0.537526624 0.120245375 0.245605501 
sn/snoRNA SNR8 -0.532345301 0.142159353 0.278487816 
sn/snoRNA SNR79 -0.527744145 0.149737192 0.287773936 
sn/snoRNA SNR18 -0.519381528 0.085166497 0.190933516 
sn/snoRNA SNR47 -0.517254433 0.143937233 0.280475953 
sn/snoRNA SNR83 -0.505712913 0.095794227 0.208546845 
sn/snoRNA SNR60 -0.487155005 0.218627515 0.374429324 
sn/snoRNA SNR9 -0.452971932 0.198883562 0.349702151 
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Transcript Standard RRP6 _KO_ RRP6 _KO RRP6 _KO 
class gene vs WT vs WT vs_WT 
  name log2_FC p-value FDR 
sn/snoRNA SNR77 -0.444248953 0.149459373 0.287404332 
sn/snoRNA SNR161 -0.423553015 0.179671466 0.326981965 
sn/snoRNA SNR43 -0.416456202 0.226726278 0.383525692 
sn/snoRNA SNR32 -0.383845798 0.2510801 0.412302527 
sn/snoRNA SNR55 -0.374299562 0.296846966 0.461555507 
sn/snoRNA SNR38 -0.355406127 0.340398658 0.504939698 
sn/snoRNA SNR190 -0.324843091 0.361747053 0.525783972 
sn/snoRNA SNR49 -0.318735612 0.313881222 0.479209424 
sn/snoRNA SNR54 -0.29666824 0.338839999 0.50344225 
sn/snoRNA SNR3 -0.269967022 0.452510653 0.603581053 
sn/snoRNA SNR70 -0.26471889 0.394224359 0.555372791 
sn/snoRNA SNR63 -0.261437558 0.403192231 0.562039045 
sn/snoRNA SNR53 -0.258692147 0.477901804 0.624237615 
sn/snoRNA SNR30 -0.24430417 0.434322121 0.588828215 
sn/snoRNA SNR76 -0.229565876 0.418323974 0.574389084 
sn/snoRNA SNR24 -0.219193244 0.503883819 0.645965476 
sn/snoRNA SNR37 -0.198166563 0.533192777 0.669193761 
sn/snoRNA SNR4 -0.125202438 0.739787893 0.827326293 
sn/snoRNA SNR41 -0.122609039 0.665292218 0.771659389 
sn/snoRNA SNR48 -0.090758158 0.808692987 0.875736692 
sn/snoRNA SNR45 -0.083113552 0.795439103 0.867438943 
sn/snoRNA SNR69 -0.079138447 0.782649698 0.859253082 
sn/snoRNA SNR67 -0.056167085 0.856106882 0.907683924 
sn/snoRNA SNR72 -0.055840218 0.859360009 0.909698334 
sn/snoRNA SNR11 -0.051426797 0.89548336 0.933960656 
sn/snoRNA SNR7 -0.038192099 0.903347021 0.93988355 
sn/snoRNA SNR82 0.020484443 0.948940617 0.970148067 
sn/snoRNA SNR17A 0.055254753 0.862752868 0.911471967 
sn/snoRNA SNR17B 0.072352447 0.81444406 0.880168674 
sn/snoRNA SNR58 0.092225721 0.760947806 0.843045229 
sn/snoRNA SNR39 0.106069082 0.71306577 0.806839679 
sn/snoRNA SNR62 0.15611664 0.674808634 0.778214861 
sn/snoRNA SNR19 0.158597522 0.586520686 0.711472945 
sn/snoRNA SNR51 0.206204667 0.507219697 0.64875741 
sn/snoRNA SNR68 0.243528938 0.498762767 0.641357274 
sn/snoRNA SNR5 0.259200468 0.481388595 0.627416647 
sn/snoRNA SNR13 0.279318313 0.418252867 0.574389084 
sn/snoRNA SNR85 0.306657293 4.10E-01 5.68E-01 
sn/snoRNA SNR74 0.374300957 2.84E-01 4.47E-01 
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Table 8: Differential expression information for the sn/snoRNAs. Table includes 
differential expression data expressed in log2 rrp6Δ/WT ratio (i.e. fold change), 
as well as p-values and false discovery rate (FDR), all calculated from four 
replicates by the EdgeR algorithm as discussed in the methods. Significantly 
down-regulated sn/snoRNAs are in red-shaded cells whereas up-regulated 
sn/snoRNAs are in green-shaded cells. 
  
 88 
2.2. Analysis of snRNA termination in RRP6 deletion mutants 
Loss of RRP6 results in improper 3’-end processing of multiple 
sn/snoRNAs. Such 3’-end processing defects could cause instability of snRNAs 
that leads to changes in their overall expression levels in cells [57,58]. Based on 
our differential expression analysis, 24 of the 78 sn/snoRNAs show decreased 
expression of at least 1.5-fold (log2 ≥ -0.6) in rrp6Δ cells versus WT cells with 
false discovery rates of ≤ 0.1 (Table 8). To better understand the role of Rrp6 in 
global snRNA 3’ end processing, the length and intensity of snRNA extended 
transcripts was analyzed in rrp6Δ cells through manual annotation of the 
extended transcripts (annotated as “ETs”) observed in our RNA-Seq dataset. The 
length of snRNA transcript extension was compared to the annotated length of 
Nrd1-unterminated transcripts (NUTs) and cryptic unstable transcripts (CUTs) 
[73, 214]. Additionally, we performed ChIP-exo according to established 
protocols to generate high-resolution maps of RNAPII localization throughout the 
yeast genomes in WT and RRP6 deletion cells with Rpb3-FLAG strains made for 
this study (Figure 15B) [211]. It was recently reported that NUT annotations were 
significantly longer than CUT annotations, suggesting that Rrp6 is required for 3’-
end processing of NNS terminated transcripts but is not directly involved in NNS 
termination [214]. Comparison of our datasets from RNA sequencing and ChIP-
exo to NUT annotations as well as direct comparison of specific transcripts in 
rrp6Δ cells to Nrd1 mutant cells via northern analysis allowed us to discover a 
regulatory role for Rrp6 on NNS-dependent RNAPII termination. 
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Kim et al previously reported [20] that some snRNAs are significantly 
longer in Nrd1-depleted cells than in rrp6Δ cells, and our dataset confirms these 
findings. It was found that there is a large extension for snR13 in SEN1 and 
NRD1 mutant strains, with the snR13 transcript extended across the transcribed 
region of TRS31 [20]. This extension at snR13 has also been reported in SSU72 
mutant strains [193, 218, 220]. NUT0167 was annotated as an Nrd1-dependent 
unterminated transcript at snR13 following Nrd1 nuclear depletion. Kim et al. also 
identified both normal length and an extended snR13 transcript in rrp6∆ cells, 
which corresponds to the pre-snRNA transcript that is not correctly processed in 
the absence of Rrp6 by northern blotting. For direct comparison of our dataset to 
previous work, we validated our RNA-Seq and ChIP-exo results by northern blot 
analysis using a strand specific probe against the processed version of snR13 
(Figure 16).  The extended transcript detected in Nrd1 nuclear depletion 
experiments was annotated as NUT0167 and is 1378 nt longer than the pre-
snR13 transcript observed in our rrp6∆ RNA-Seq samples (Figure 16A). In 
agreement, we observed a transcript approximately 1500 nt in length by northern 
blotting in the NRD1-temperature sensitive (ts) mutant (nrd1Δ151–214 that lacks 
the Nab3 interaction domain [19, 221, 222]) following 30 or 60 minute heat shock 
to inactivate the NRD1 mutant. Long extended transcripts were also observed in 
ssu72 TOV, a “terminator override” mutant previously described as deficient in 
NNS-dependent termination (kindly provided from the Reines lab) [223]. 
However, no such read-through transcripts were observed in the rrp6∆ cells by 
RNA-Seq or by northern blotting, only the unprocessed pre-snR13 (Figure 16A, 
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D). Supporting the RNA transcript data, we see no shift in RNAPII localization in 
this region as detected by Rpb3-FLAG ChIP-exo sequencing (Figure 16B). 
Previous studies to identify Nrd1 binding sites in target RNAs using PAR-CLIP 
sequencing revealed a strong Nrd1 signal just downstream of the annotation for 
the mature snR13 transcript, supporting the role of the NNS pathway in 
termination in this region ([50], Figure 16B). No significant changes were 
observed in the expression levels of snR13 or TRS31, which also suggests that 
snR13 RNA is correctly terminated in rrp6∆ cells (Figure 15C). Taken together, 
these data clearly show that Rrp6 is not required for termination of snR13 
transcription by the NNS pathway, which is in agreement with previous findings 
[20].       
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Figure 16: Transcription termination of the C/D box small nucleolar RNA snR13 
does not require Rrp6. (A) Graphical representation of strand-specific RNA-Seq 
reads mapped to snR13-YDR473C region. Reads mapped to the positive strand 
are on top in red, whereas reads mapped to the negative strand are on the 
bottom in blue. The location and direction of transcription for all analyzed 
annotations are diagrammed below the graphs to scale. Processed length of 
snRNAs and mRNAs are in black, snRNA-extended transcripts, including pre-
snRNAs and termination read-through products, are in green (labeled “ETs”), 
NUTs are in aqua, and arrows indicate annotated transcription start site. The 
dotted black line marks the transcription start site (TSS) of TRS31. (B) Rpb3-
FLAG localization as determined by ChIP-exo sequencing reads mapped to the 
same region and aligned to (A). WT reads are in black, and rrp6Δ are in orange. 
Nrd1 binding sites as determined by PAR-CLIP from [50] are shown for 
comparison in aqua. (C) Average normalized read counts ± standard deviations 
for significantly altered transcripts in rrp6Δ cells versus WT cells (n=4). Two stars 
indicate a p-value of <0.01 as determined by an unpaired, two-tailed student’s t-
test. The colors of the bars in each graph correspond to the color representing 
the related annotation. (D) Strand-specific northern blot analysis using a 5’ end 
labeled DNA oligonucleotide probe specific to the processed region of snR13 
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directly comparing rrp6Δ to mutants known to be defective in NNS-dependent 
termination. The temperature sensitive nrd1Δ151-214 strain was grown at 30C 
overnight, diluted to an OD600 of 0.5, and grown at 37C for 30 minutes or 60 
minutes. The ssu72 TOV strain has been previously shown by [223] to bypass 
NNS-dependent termination at the IMD2 locus. 
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In contrast to previous conclusions that Rrp6 is dispensable for snRNA 
termination, our data indicates that a subset of snRNA transcripts require Rrp6 
for proper RNAPII termination in vivo [20, 214]. As shown in Figure 17A, the 
apparent length of snR3 in rrp6Δ cells as revealed by RNA-Seq is 1396 nt 
whereas the annotation for NUT0426 is 3363 nt long (Figure 17A). However, the 
Rrp6-dependent snR3 extension is 246 nt longer than the three tandem CUTs 
(CUT221, 222, and 223) previously annotated from tiling array data [218]. All 
three CUTs were significantly up-regulated in rrp6Δ cells as expected (Figures 
17B, 18).  
Of interest, a comparison of the 4tU-Seq data used to annotated the NUTs 
with our RNA-Seq data clearly shows a difference in the length of the Nrd1-
unterminated transcript NUT0426 resulting from snR3 read-through than that 
observed upon deletion of RRP6 (Figure 18). It is interesting to note that the 
overall read count for the snR3 read-through product in the 4tU-Seq dataset 
decreases dramatically just 3’- to the read-through observed in rrp6Δ cells, 
suggesting that the majority of transcripts are terminated at the location indicated 
in the rrp6Δ RNA-Seq (Figures 17, 18). ChIP-exo analysis of RNAPII localization 
in this region revealed an increase in RNAPII density just downstream of snR3 in 
the rrp6Δ cells when compared to WT (Figure 17B, arrow 1). This increase in 
downstream RNAPII corresponds to the increased level of RNA detected 
downstream of snR3 in Figure 17A past the pre-snRNA transcript and previously 
mapped Nrd1 and Nab3 binding sites located ~400bp from the start of the snR3 
transcript [50, 60]. Although the RNAPII density decreases just before the 3’-end 
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of the snR3-ETs annotation, it remains slightly elevated in rrp6Δ cells compared 
to WT throughout the NUT0426 annotation region, indicated by arrow #2 (Figure 
17B).  
Differential expression analysis also revealed highly significant down-
regulation of the snR3 convergent, “tail-to-tail,” gene YJR129C likely as a result 
of extended snR3 transcripts in rrp6Δ cells (Figure 16C). These data suggest that 
extension of snR3 causes transcription interference at YJR129C as was also 
reported in Nrd1 nuclear depletion experiments [46]. To definitively determine the 
length of the snR3 transcripts and compare rrp6∆ cells directly to an NRD1 
mutant, we also performed northern blot analysis with a probe that recognizes 
the short, processed snR3. A transcript that is approximately 4000 nt long was 
detected in rrp6Δ, nrd1-ts, and the ssu72 TOV mutants (Figure 17D). This 
transcript is approximately the length expected for NUT0426. We also detected 
two shorter transcripts approximately 500 and 1000 nt long in the nrd1-ts and 
rrp6Δ cells. Together, these data clearly show that Rrp6 is required for proper 
RNAPII termination at snR3. 
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Figure 17: The H/ACA box small nucleolar RNA snR3 requires Rrp6 for efficient 
termination. (A) Graphical representation of strand-specific RNA-Seq reads 
mapped to snR3-STR2 region. Reads mapped to the positive strand are on top in 
red, while reads mapped to the negative strand are on the bottom in blue. The 
location and direction of transcription for all analyzed annotations are 
diagrammed below the graphs to scale. Processed length of snRNAs and 
mRNAs are in black, snRNA-extended transcripts, including pre-snRNAs and 
termination read-through products, are in green (labeled “ETs”), NUTs are in 
aqua, CUTs are in gray, and arrows indicate annotated transcription start site. 
The dotted black line marks the transcription start site (TSS) of YJR129C. (B) 
Rpb3-FLAG localization as determined by ChIP-exo sequencing reads mapped 
to the same region and aligned to (A). WT reads are in black, and rrp6Δ are in 
orange. (C) Average normalized read counts ± standard deviations for 
significantly altered transcripts in rrp6Δ cells versus WT cells (n=4). Two stars 
indicate a p-value of <0.01, and three stars indicate a p-value of <0.001 as 
determined by an unpaired, two-tailed student’s t-test. The colors of the bars in 
each graph correspond to the color representing the related annotation. (D) 
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Strand-specific northern blot analysis using a 5’ end labeled DNA oligonucleotide 
probe specific to the processed region of snR3 directly comparing rrp6Δ to 
mutants known to be defective in NNS-dependent termination.  
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Figure 18: Comparison of rrp6Δ RNA-Seq reads at snR3 to published 4tU-Seq 
data for NUTs. (A) Mapped reads obtained from our in-house alignment (see 
methods section) of 4tU-Seq data from [214] (top two panels) and our RNA-Seq 
data (bottom two panels) at snR3-STR2 region, forward strand reads only. The 
location and transcription direction of all annotations within this region are 
diagrammed below. Processed length of snRNAs and mRNAs are in black, 
snRNA-extended regions are in green (labeled “ET”), NUTs are in blue, CUTs 
are in gray, and arrows indicate annotated transcript state site and direction of 
transcription. The dotted green line marks the 3’ end of the extended snR3 
annotation in rrp6Δ cells. (B) Average normalized read counts ± standard 
deviations for transcripts in this region that are not significantly changed in rrp6Δ 
cells versus WT (n=4). The colors of the bars correspond to the color 
representing the annotation.   
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2.3. RRP6 deletion results in extension of snRNA transcripts leading to 
down-regulation of neighboring genes 
Several genes downstream of snRNAs transcribed from the opposite DNA 
strand were found to be significantly down-regulated when transcript extension 
was high in rrp6Δ cells. We focused on snRNAs with “tail-to-tail” or convergent 
genes because the strand specific sequencing data allows us to distinguish 
between reads mapped to the two different transcripts. As mentioned in the 
example of snR3, the expression of neighboring downstream gene YJR129C is 
down almost three-fold (Figure 17C). The detectable snR3 transcript maps 
beyond the transcription start site (TSS) for YJR129C suggesting that 
transcription interference is the likely mode of YJR129C repression as 
diagrammed in Figure 19A. Additional examples of snRNA termination defects 
causing transcription interference at downstream genes are shown in Figures 15 
and 16. As shown in Figure 15, snR11 has a downstream gene transcribed on 
the opposite strand, CMC4 (Figure 19C). snR11 has a long region of RNA-Seq 
reads in rrp6Δ cells that extends beyond the CMC4 TSS, and CMC4 expression 
is decreased by more than half (Figure 19C). However, northern blot analysis 
with a single-stranded oligonucleotide probe detecting the short, processed 
snR11 does not show read-through transcripts >1000 bp in any of the samples, 
including the mutants known to have defective Nrd1 termination (Figure 19B). 
Since there is no detectable read-through snR11 transcript in the nrd1-ts mutant, 
the transcript encoded in the region annotated “snR11-ETs” and “NUT0607” is 
likely initiated at start site downstream of the snR11 sequence recognized by our 
 99 
probe. The lack of highly extended transcripts, readily distinguishable by northern 
blot, shows the limitation of using short sequencing reads for transcript 
annotation (Figure 19). Interestingly, Rpb3-FLAG ChIP-exo data shows that the 
peak of RNAPII localization at snR11 is extended farther 3’ in rrp6Δ cells that in 
WT cells indicated by arrow #1, and this extension does indeed overlap the TSS 
of CMC4 (Figure 19D). RNAPII occupancy quickly decreases just beyond the 
CMC4 TSS but remains higher than in WT cells. The increase in RNAPII 
localization in rrp6Δ cells downstream of the native termination site for snR11 
suggests that loss of rrp6Δ decreases the efficiency of snR11 termination leading 
to a small degree of read-through that is sufficient to cause transcription 
interference at CMC4. 
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Figure 19: Transcription termination of the H/ACA box small nucleolar RNA 
snR11 shifts toward the 3’-end in rrp6Δ cells. (A) Diagram showing proposed 
mechanism where down-regulation of GeneX results from faulting termination of 
snRNA in rrp6Δ cells. Decreased NNS-termination at select snRNAs results in 
longer transcribed region, extending over transcription start site of downstream 
convergent gene, GeneX. The hypothesized resulting increased localization of 
the transcription machinery interferes with initiation at the TSS of GeneX 
(indicated with a red ‘X’). (B) Strand-specific northern blot analysis using a 5’-end 
labeled DNA oligo probe specific to the processed region of snR11 directly 
comparing rrp6Δ to mutants known to be defective in NNS-dependent 
termination. (C) Graphical representation of strand-specific RNA-Seq reads 
mapped to snR11-ICY1 region. Reads mapped to the positive strand are on top 
in red, while reads mapped to the negative strand are on the bottom in blue. The 
location and direction of transcription for all analyzed annotations are 
diagrammed below the graphs to scale. Processed length of snRNAs and 
mRNAs are in black, snRNA-extended transcripts, including pre-snRNAs and 
termination read-through products, are in green (labeled “ETs”), NUTs are in 
aqua, CUTs are in gray, SUTs are in dark blue, SRTs are in purple, and bent 
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arrows indicate direction of the TSS. The dotted black lines mark the transcription 
start sites (TSS) of CMC4. (D) Rpb3-FLAG localization as determined by ChIP-
exo sequencing reads mapped to the same region and aligned to (C). WT reads 
are in black, and rrp6Δ are in orange.  
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A substantial read-through transcript (1442 nt) was detected at snR71, a 
C/D box small nucleolar RNA gene, in rrp6Δ cells that extends well beyond the 
TSS of downstream gene LIN1, which is significantly down-regulated (Figure 
20A, C) [224, 225]. There is a 2281 nt long NUT annotated at this locus 
(NUT0349) that overlaps with a second downstream gene, REC104, which is on 
the same strand as snR71 (Figure 20A). With strand-specific sequencing, it 
cannot be absolutely determined if reads mapped to the REC104 locus are from 
REC104 transcripts, from a much longer snR71 read-through transcript, or from a 
combination of both. To answer this question and compare the effects of RRP6 
deletion to mutants with defective NNS-dependent termination directly, we 
performed northern blot analysis with a short probe specific to the processed 
snR71 transcript (Figure 20D). We see a striking band at approximately 1700 nt 
in rrp6Δ, nrd1-ts, and Ssu72 TOV cells. This suggests that a percentage of 
RNAPIIs transcribing snR71 in all of these mutant strands can escape the NNS-
dependent termination pathway and are hence terminated much farther 
downstream (Figure 20). This is supported by the Rpb3-FLAG ChIP-exo data 
that shows an increase in RNAPII localization downstream of snR71 in rrp6Δ 
cells compared to WT cells along the full length of the NUT0349 annotation 
(Figure 20B). Interestingly, the expression level of the annotated mature snR71 
region is also significantly decreased (Figure 20C), suggesting there may be 
some instability or other defects caused by improper 3’-processing and/or 
termination caused by loss of Rrp6.  
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Figure 20: Rrp6 is required for NNS-dependent termination and RNA processing 
of the snR71 transcript. (A) Graphical representation of strand-specific RNA-Seq 
reads mapped to snR71-extended region. Reads mapped to the positive strand 
are on top in red, while reads mapped to the negative strand are on the bottom in 
blue. The location and direction of transcription for all analyzed annotations are 
diagrammed below the graphs to scale. Processed length of snRNAs and 
mRNAs are in black, snRNA-extended transcripts, including pre-snRNAs and 
termination read-through products, are in green (labeled “ETs”), NUTs are in 
aqua, CUTs are in gray, and bent arrows indicate direction of the TSS. The 
dotted black line marks the transcription start site (TSS) of LIN1. (B) Rpb3-FLAG 
localization as determined by ChIP-exo sequencing reads mapped to the same 
region and aligned to (A). WT reads are in black, and rrp6Δ are in orange. (C) 
Average normalized read counts ± standard deviations for significantly altered 
transcripts in rrp6Δ cells versus WT cells (n=4). One star indicates a p-value of 
<0.05, two stars indicate a p-value of <0.01, and three stars indicate a p-value of 
<0.001 as determined by an unpaired, two-tailed student’s t-test. The colors of 
the bars in each graph correspond to the color representing the related 
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annotation. (D) Strand-specific northern blot analysis using a 5’ end labeled 
probe specific to the processed region of snR71 directly comparing rrp6Δ to NNS 
termination mutants.  
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Overall these data show that multiple transcripts downstream of snRNAs 
have significant changes in expression following deletion of RRP6. ChIP-exo 
analysis of RNAPII (Rpb3-FLAG) clearly show that RNAPII terminates 
downstream of its normal stopping point in WT cells at specific snRNAs leading 
to mislocalization and causing transcription interference at downstream genes 
(Figures 17, 19, 20). In this model, ineffective termination of the snRNAs results 
in transcription interference at the downstream gene as previously described 
following inactivation of Nrd1 (Figure 19A [46]). These findings, taken together 
with the similar lengths of Rrp6-dependent snRNA transcripts and Nrd1-
dependent transcript annotations (NUTs), support the hypothesis that Rrp6 
serves as important regulator of NNS-dependent termination at specific 
sn/snoRNAs.  
 
2.4. RRP6 is required for proper RNAPII termination of NNS-dependent 
regulatory non-coding RNAs 
In addition to extension of snRNA transcripts, changes in expression 
and/or apparent length of other previously described noncoding RNAs, such as 
CUTs, SUTs, and NUTs, were also detected with corresponding down-regulation 
of neighboring genes in cells lacking Rrp6 suggesting transcription interference. 
A number of these transcripts have been well-characterized as being extended 
following depletion or genetic inactivation of NNS components but not the 
exonuclease RRP6.  
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An early and well-characterized example of a gene that is regulated by 
NNS-dependent termination is the NRD1 gene [43, 145, 171]. There are a cluster 
of multiple Nrd1 and Nab3 binding sites in the 5’-UTR of the NRD1 mRNA 
leading to early termination of the transcript and autoregulation of NRD1 
expression levels through a mechanism that also requires Sen1 [43, 49, 50, 171]. 
In expression analysis of the RNA-Seq data, we see nearly a 2-fold increase in 
the expression of the NRD1 transcript in rrp6Δ cells, as well as an increase in 
CUT320, a noncoding transcript near the NRD1 promoter on the opposite strand 
(Figure 21A). Since Rrp6 is responsible for the degradation of the short NRD1 
transcript, this increase in expression could be attributed to stabilization of 
terminated transcript. Alternatively, increased expression of NRD1 in rrp6Δ cells 
could suggest that the early termination sites are not being utilized by the NNS 
pathway as often in the rrp6Δ cells, leading to transcription of the full-length 
mRNA. Analysis of RNAPII occupancy at the NRD1 gene in the ChIP-exo 
dataset can distinguish these two possibilities (Figure 21B). In WT cells, there 
are several peaks of RNAPII at the 5’-end of the NRD1 gene that quickly 
decreases to low levels along the NRD1 transcribed region in agreement with 
previous findings in an NRD1 mutant [171]. In fact, comparison of the ChIP-exo 
data with Nrd1 RNA binding sites mapped by PAR-CLIP reveal that the majority 
of RNAPII terminates just downstream of the final Nrd1 binding site in WT cells 
(Figure 21B). In rrp6Δ cells, the intense peaks of RNAPII localization at the 5’-
UTR are shifted 3’ and RNAPII localization is higher along the entire length of the 
gene, including a higher peak at the poly-A dependent termination site of the full-
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length transcript (Figure 21B). This supports the hypothesis that the NNS-
termination pathway is not terminating the short 5’-UTR transcript efficiently in 
rrp6Δ cells and that RNAPII continues down the length of the gene producing the 
full transcript and increasing overall NRD1 expression levels (Figure 21). The 
requirement for multiple Nrd1-Nab3 RNA binding sites at NRD1 when compared 
to RNAPII ChIP-exo data suggest that NNS-dependent termination requires 
multiple Nrd1 and/or Nab3 binding sites to effectively terminate RNAPII as has 
been previously proposed (Figure 21B) [40, 50]. The 3’ shift in RNAPII 
localization observed at NRD1 supports this hypothesis.  
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Figure 21: Early termination of NRD1 transcription requires Rrp6 for efficient 
RNAPII termination. (A) Average normalized read counts ± standard deviations 
for NRD1 and CUT320 transcripts in rrp6Δ cells versus WT (n=3). One star 
indicates a p-value of <0.05 and two stars indicate a p-value of <0.01. (B) Rpb3-
FLAG localization as determined by ChIP-exo sequencing reads mapped to the 
NRD1 region. WT reads are in black, and rrp6Δ are in orange. The location and 
direction of transcription for all analyzed annotations are diagrammed below the 
graphs to scale. Length of mRNAs including untranslated regions are in black, 
CUTs are in gray, and NUTs are in aqua. Nrd1 binding sites as determined by 
PAR-CLIP from [50] are shown in aqua for comparison. The scale for Nrd1 PAR-
CLIP data is shown to the right.  
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Changes in RNAPII occupancy downstream of known NNS-dependent 
early termination (also known as attenuated) targets was also observed at HRP1 
and SRG1-SER3 (Figures 22, 23). The RNAPII occupancy at HRP1 shows 
similar changes as seen at NRD1 with the majority of RNAPII terminating early in 
WT cells while showing a 3’- shift (arrow #1) and persistence through the gene 
(arrow #2) in rrp6Δ cells (Figure 22A).  RNA-Seq analysis also revealed an 
increase in downstream HRP1 RNA levels relative to WT (Figure 22B). Another 
well-characterized example of upstream noncoding RNA regulation occurs at the 
SRG1-SER3 region. SRG1 (SER3 regulatory gene 1) is a known non-coding 
RNA whose transcription down-regulates expression of SER3 [168]. SRG1 RNA 
is bound by both Nrd1 and Nab3 just prior to the SER3 transcribed region, which 
could then terminate SRG1 transcription to prevent interference with SER3 [60, 
147]. SRG1 can also be terminated through a polyA-dependent pathway at a site 
downstream of the NNS termination site(s) [147]. ChIP-exo revealed that RNAPII 
occupancy also shifts 3’- in rrp6Δ cells with increased RNAPII occupancy in the 
SER3 gene (Figure 23A). An increase in specific SRG1 transcripts including a 
SRG1:SER3 chimeric transcript has previously been observed in Nrd1-depletion 
rrp6Δ cells [147]. Our data suggests that defective termination of SRG1 can 
occur in rrp6Δ cells even in the absence of Nrd1 disruption (Figure 23). These 
data clearly show that Rrp6 is required for NNS-dependent termination of 
regulatory non-coding RNAs that participate in gene expression attenuation.  
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Figure 22: Efficient termination of RNAPII at the HRP1 5’-UTR requires Rrp6. (A) 
Rpb3-FLAG localization as determined by ChIP-exo sequencing reads mapped 
to the HRP1 region. WT reads are in black, and rrp6Δ are in orange. The location 
and direction of transcription for all analyzed annotations are diagrammed below 
the graphs to scale. Length of mRNAs including untranslated regions are in 
black, CUTs are in gray, and NUTs are in aqua. (B) Graphical representation of 
strand-specific RNA-Seq reads mapped to HRP1 transcribed region. Reads 
mapped to the positive strand are shown in red. No reads were mapped to the 
reverse strand at HRP1. 
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Figure 23: Rrp6 regulates RNAPII localization at SRG1-SER3 independent of 
other NNS-pathway disruptions. (A) Rpb3-FLAG localization as determined by 
ChIP-exo sequencing reads mapped to the SRG1-SER3 region. WT reads are in 
black, and rrp6Δ are in orange. The location and direction of transcription for all 
analyzed annotations are diagrammed below the graphs to scale. Length of 
mRNAs including untranslated regions are in black, CUTs are in gray, and NUTs 
are in aqua. Note that SRG1 and SER3 annotations are overlapping. (B) 
Graphical representation of strand-specific RNA-Seq reads mapped to SRG1-
SER3 transcribed region. Reads mapped to the positive-strand are shown in red 
while reverse reads are shown in blue.  
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There are multiple published examples of transcription interference by 
CUTs in which an antisense CUT regulates the expression of the sense gene in 
cis through transcript extension across the sense gene promoter [217, 226-229]. 
These lncRNA-type transcripts have also been shown to be required for efficient 
gene activation [230]. Expression of the FMP40 transcript has been previously 
shown by several groups to be regulated by an NNS-terminated antisense 
transcript initiating at the 3’ end of FMP40 [41, 50, 231]. The FMP40 antisense 
transcript (also known as CUT882 and YPL222C-A) is readily detectable in our 
RNA-Seq data from WT cells and it is significantly up-regulated in rrp6Δ cells as 
has been previously reported (Figure 24A, C) [72, 73, 232, 233]. Mapped 
sequencing reads suggest that the antisense transcript was significantly longer in 
rrp6Δ cells than in WT (specifically in the region of CUT882), supporting the 
hypothesis that NNS-dependent termination is not as efficient in rrp6Δ mutants. 
To determine the length of the antisense transcript in rrp6Δ cells and compare to 
an nrd1-ts mutant, we performed northern blot analysis with strand specific 
oligonucleotide probes to FMP40 and its antisense transcript YPL222C-A (Figure 
24D). YPL222C-A transcripts were detected as smears extending into the region 
of the CUT882 annotation suggesting that these transcripts terminate at multiple 
3’-end locations as has previously been shown for other specific CUTs including 
NEL025c [71]. The YPL222C-A antisense transcripts were not detected in WT 
cells by northern blot even after an extended exposure time (Figure 24D). In the 
nrd1-ts mutant, there is an accumulation of a strong band ~4500 nt long in the 
YPL222C-A blot, and the FMP40 transcript is undetectable as a consequence of 
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transcription interference. There is a band of the same size in the rrp6Δ, although 
it is not as abundant as that observed in the Nrd1 mutant. There are also shorter 
transcripts present in YPL222C-A blots derived from the nrd1-ts mutant that are 
also present in the rrp6Δ cells (Figure 24D). RNAPII localization in the FMP40 
region was determined by ChIP-exo and clearly shows that the majority of 
RNAPII was localized at the 5’-end of the antisense YPL222C-A transcript, even 
in WT cells (Figure 24B). The highest peaks of RNAPII localization at YPL222C-
A are of similar intensity in WT and rrp6Δ cells, but RNAPII spreads 3’- in rrp6Δ 
cells and continues to be higher through the CUT882 annotation and past the 
FMP40 promoter. These data indicate that the antisense transcript is terminated 
less efficiently in rrp6Δ cells leading to increased RNAPII occupancy downstream 
of the normal YPL222C-A/CUT882 termination site. The RNAPII occupancy data 
also suggest that CUT882 is an extended transcript of YPL222C-A that occurs as 
a consequence of inefficient RNAPII termination in rrp6Δ cells (Figure 24B, red 
arrows). In nrd1Δ151-214 temperature sensitive mutants, YPL222C-A 
termination rarely occurs, resulting in a 4500 nt antisense transcript that is also 
seen at low levels in rrp6Δ strains (Figure 24D). 
 
3. Rtr1 is a negative regulator of the NNS transcription termination pathway 
3.1. RNA expression Data – Global analysis 
To determine if a specific class of RNAPII transcripts were altered upon 
loss of the RNAPII CTD phosphatase RTR1, we performed RNA-Seq analysis of 
rtr1Δ cell total RNA and performed a Fisher’s Exact Test on the  
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Figure 24: The FMP40 antisense transcript YPL222C-A is extended in rrp6Δ cells 
as a result of inefficient RNAPII termination. (A) Graphical representation of 
strand-specific RNA-Seq reads mapped to FMP40 region. Reads mapped to the 
positive-strand are on the top portion of the panel in red, whereas reads mapped 
to the negative-strand are on the bottom in blue. The location and direction of 
transcription for all analyzed annotations are diagrammed below the graphs to 
scale. Length of mRNAs including untranslated regions are in black, CUTs are in 
gray, dubious ORFs (an antisense transcript named YPL222C-A) are in tan, and 
bent arrows indicate direction of the TSS. The dotted black lines mark the 3’ end 
of the annotations for CUT882 and YPL222C-A. (B) Rpb3-FLAG localization as 
determined by ChIP-exo sequencing reads mapped to the same region and 
aligned to (A). WT reads are in black, and rrp6Δ are in orange. Red arrows note 
areas of interest. (C) Average normalized read counts ± standard deviations for 
significantly altered transcripts in rrp6Δ cells versus WT (n=4). Three stars 
indicate a p-value of <0.001 as determined by an unpaired, two-tailed student’s t-
test. The colors of the bars in each graph correspond to the color representing 
the related annotation. (D) Strand-specific northern blot analysis using a 5’ end 
labeled probes specific to either FMP40 or YPL222C-A directly comparing rrp6Δ 
to mutants known to be defective in NNS termination.  
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differentially expressed transcripts identified by EdgeR analysis (Table 9, Figure 
25). We analyzed transcripts that were both significantly increased and 
decreased in rtr1Δ cells compared to levels the total number of transcripts in 
each class in WT. A highly significant (p<0.001) number of snRNAs and open 
reading frame transcripts (ORF-Ts) are increased in rtr1Δ cells, and a significant 
number of antisense transcripts (ASTs) (p<0.01) and cryptic unannotated 
transcripts (CUTs) (p<0.05) were also up-regulated. More strikingly, multiple 
classes had a significant number of transcripts with decreased expression. ASTs, 
Nrd1 unterminated transcripts (NUTs), Ssu72-restricted transcripts (SRTs), and 
ORF-Ts all have a p-values of <0.001, and snRNAs are down-regulated with a 
significance of p<0.01. Many antisense annotations overlap with NUT 
annotations (example in Figures 29), indicating that they require Nrd1 for proper 
termination. Likewise, RNAPII-transcribed snRNAs are terminated by the NNS 
pathway, and many of the down-regulated ORF-Ts overlap with a NUT to some 
extent. This suggests that Rtr1 may have an important role in proper regulation of 
the Nrd1 termination pathway. SRTs are transcripts that were accumulated after 
loss of Ssu72 activity. Surprisingly, our data clearly show that those transcripts 
that are increased after loss of one Ser5 phosphatase (Ssu72) are often inhibited 
after the loss of the other Ser5 phosphatase (Rtr1), suggesting that the two 
enzymes have unique effects on the transcription cycle. 
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3.2. Immunoprecipitation of DNA sequences by Nrd1-bound RNAPII 
complexes 
To determine the localization of TAP-tagged Nrd1 across an actively 
transcribed gene, we performed chromatin immunoprecipitation followed by 
exonuclease digestion and genome-wide sequencing (ChIP-exo) as described 
previously [211]. As noted earlier, Nrd1 does not bind DNA directly, rather it 
binds nascent RNA in a sequence-specific manner via its RNA RRM domain, and 
it binds RNAPII CTD repeats at Ser5-P via its CID. Therefore, this method 
detects regions of DNA bound by RNAPII that is also in complex with Nrd1 (See 
Figure 26A).  
To confirm that the binding pattern was specific to Nrd1, we compared the 
Nrd1-TAP ChIP-exo reads to that of Rpb3-FLAG (Figure 26B, C). At the well-
characterized protein-coding gene PMA1, RNAPII occupancy is relatively 
consistent across the entire length of the gene (Figure 26B). Nrd1-binding, in 
contrast, peaks in the 5’-end of the gene, approximately 500 nt past the 
transcription start site. Nrd1 has been reported to only function within <1000 nt 
from the transcription start site [44] and these data are consistent with those 
findings. Although there is a peak in the Rpb3-FLAG signal at the 5’-end, levels 
of bound RNAPII stay high across the entire length of the gene, while the amount 
of Nrd1 drops off quickly after the peak associated with the 5’end of the gene. 
Therefore, Nrd1 may play a role in RNAPII promoter-proximal pausing in yeast. 
Nrd1 has previously been reported to interact with the cap-binding complex [70]. 
Perhaps these interactions are required during a capping checkpoint that   
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Figure 25: Characterization of differentially expressed transcripts in rtr1Δ cells. A) 
Expression plot for normalized RNA-Seq data for all transcripts differentially 
expressed in rtr1Δ cells. After sequencing reads were aligned to the yeast 
genome, reads mapped to annotated open reading frame transcripts (ORF-Ts), 
cryptic unstable transcripts (CUTs), stable unannotated transcripts (SUTs), and 
Nrd1 unterminated transcripts (NUTs) were used for differential expression 
analysis using edgeR. Log2 of the fold-change values in rrp6Δ cells are plotted 
versus the log2 of the fold-change values in rtr1Δ cells compared to WT across all 
biological replicates. B) Distribution of transcripts differentially expressed in rtr1Δ 
cells compared to WT across annotation categories. Colors correspond to colors 
used for these categories throughout this manuscript. For both (A) and (B) 
transcripts were included if p ≤ 0.005 and FDR ≤ 0.32. A relaxed FDR was used 
with a stringent p-value cut-off because many of the cryptic transcripts are 
expressed at low levels and therefore have a large variance. The total number of 
transcripts at this cut-off is 194.  
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Category Total 
Increased 
in rtr1Δ 
p-value 
(Fisher's 
Exact) 
Decreased 
in rtr1Δ 
p-value 
(Fisher's 
Exact) 
AST 2576 32 0.0031 267 <0.0001 
CUT 699 11 0.0231 39 0.458 
MANUnit 346 0 0.1755 20 0.5315 
NUT 1271 12 0.5687 104 <0.0001 
snR 159 7 <0.0001 0 0.0069 
SRT 180 3 0.3413 20 0.0002 
SUT 675 3 0.4372 45 0.0384 
ORFs 5742 22 <0.0001 78 <0.0001 
Total 11648 90   573   
 
 
Table 9: Fisher’s Exact Test to determine significance of dis-regulated transcript 
classes in rtr1Δ cells. The first column contains the names of the categories of 
RNAPII transcripts investigated. The total number of annotations included in our 
database for each category is in the second column. The number of transcripts 
significantly increased or decreased in rtr1Δ cells differential expression analysis 
is listed in the third and fifth columns, respectively. Transcripts were included if p 
≤ 0.005 and FDR ≤ 0.32. A relaxed FDR was used with a stringent p-value cut-off 
because many of the cryptic transcripts are expressed at low levels and therefore 
have a large variance. The total number of transcripts at this cut-off is 194. P-
values calculated using the Fisher’s Exact Test indicate the probability that the 
respective category of transcripts is significantly altered by the loss of RTR1.  
 
 
  
 119 
ensures that mRNA is properly capped prior to RNAPII elongation. In the 
absence of proper capping, mRNA transcripts could be terminated during early 
transcription by the NNS pathway. 
The URA8/SOD1 locus illustrates the differences seen in the binding 
patterns of the Rpb3-FLAG and Nrd1-TAP strains when comparing transcripts 
with high (URA8) and low (SOD1) levels of consensus Nrd1-Nab3 RNA binding 
sites (Figure 26C). URA8 encodes a CTP synthetase that carries out the ATP-
dependent conversion of UTP to CTP. URA8 is known to be regulated by 
alternative start site selection that is dependent on nucleotide availability [234]. 
There is a consensus Nrd1 binding site of TTTGTAAAGTT 40 nt upstream of the 
URA8 ATG. The upstream, alternative start site is terminated by the NNS 
pathway in nutrient-rich conditions such as growth in YPD, resulting in low levels 
of full-length URA8 transcription [152]. Our strains were grown in nutrient rich 
YPD media resulting in repression of URA8 expression. Our ChIP-exo analysis of 
Rpb3-FLAG showed that the majority of RNAPII is localized at the 5’-end of the 
URA8 gene (Figure 26C). This corresponds with the peak of Nrd1 binding at 
URA8, indicating that most of its transcription is being terminated by the NNS 
pathway, resulting in low-level transcription of full-length URA8. The SOD1 gene 
is situated at the 3’-end of URA8 and is transcribed in a convergent orientation. 
SOD1 is not known to be regulated by NNS-dependent termination and does not 
contain Nrd1 RNA binding sites. Therefore, levels of Nrd1 association at the 
SOD1 gene are much lower than at URA8 even though total Rpb3-FLAG 
occupancy is higher at SOD1 than at URA8.  
 120 
 
S P S T P S Y S P S T 
P S Y
S P S
 T P
 S Y
 S P S T P S Y
S 
P 
S 
T 
 P
 S Y
S P 
S T
  P
 S
 Y
Nrd1
P
P
P
P
P P
TAP
Sepharose
Bead
0 
1000 
2000 
3000 
0 
1000 
2000 
3000 
478000 479000 480000 481000 482000 483000 
R
pb
3-
FL
AG
C
hI
P-
ex
o
no
rm
al
iz
ed
 re
ad
 c
ou
nt
PMA1
N
rd
1-
TA
P
C
hI
P-
ex
o
no
rm
al
iz
ed
 
re
ad
 c
ou
nt
NUT0422
URA8
NUT1196
SOD1
SUT645
0 
200 
400 
600 
0 
1000 
2000 
620000 621000 622000 623000 624000 
R
pb
3-
FL
AG
C
hI
P-
ex
o
no
rm
al
iz
ed
 re
ad
 c
ou
nt
N
rd
1-
TA
P
C
hI
P-
ex
o
no
rm
al
iz
ed
 
re
ad
 c
ou
nt
A
B
C
 121 
Figure 26: ChIP-exo analysis of the RNAPII- and RNA-binding protein Nrd1. A) 
Simplified schematic of immunoprecipitation of Nrd1-TAP by IgG-sepharose 
beads. Nrd1 binds to sequences in the RNA (red rectangle) via its RNA 
Recognition Motif (RRM domain). The RNA consensus sequences for Nrd1 
binding are UGUAG and UGUAA. Nrd1 binds RNAPII at Ser5-P of the CTD of 
RNAPII via the Nrd1 CID. Therefore, DNA sequences detected by Nrd1-TAP 
ChIP represent regions of DNA bound by RNAPII bound to Nrd1. B and C) 
Graphical representation of Rpb3-FLAG (black) and Nrd1-TAP (green) 
occupancy in the WT strain as determined by ChIP-exo sequencing reads 
mapped to PMA1 (B) and URA8-SOD1 (C). The location and direction of 
transcription for all analyzed annotations are diagrammed below the graphs to 
scale. Protein-coding mRNAs are in black, NUTs are in aqua, SUTs are in blue, 
and bent arrows indicate direction of the TSS. 
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 To determine the locations of highest Nrd1-binding as measured by ChIP-Exo, 
we performed peak-calling analysis using the MACS2 algorithm [212]. 
Unsurprisingly, the top 100 ranking peaks were generally located at snRNAs and 
highly abundant, known Nrd1-regulated transcripts (Table 10). As described 
above, our ChIP-exo data identifies regions in the DNA where Nrd1-bound 
RNAPII complexes are localized. Nrd1 does not bind the DNA directly, but 
instead binds the nascent RNA. Transcriptome-wide binding sites of Nrd1 to RNA 
have previously been described using PAR-CLIP [50]. Again, the majority of the 
Nrd1 RNA binding sites are located near snRNAs and highly abundant, known 
Nrd1-regulated transcripts. We compared our top 100 Nrd1 DNA binding sites as 
measured by ChIP-exo to the published top 100 Nrd1 RNA binding sites as 
measured by PAR-CLIP.  
From these two data sets, 44 binding sites occur in both lists. Of these 44 
transcripts, 31 of them are located near snRNAs. This is not surprising because 
snRNAs are some of the most highly transcribed NNS-targeted transcripts and 
would therefore be expected to have the highest occupancy of RNAPII and Nrd1. 
Other peak locations occurring in both lists include genes with strong NNS 
terminators previously discussed such as NRD1, URA2, URA8, and IMD2. 
Interestingly, the ribosomal protein-coding genes RPS14B and RPS9A occur in 
both lists, as does the non-coding region of the rDNA repeat, NTS2-1 (Table 10). 
NTS2-1 is particularly surprising because the rRNA repeat region is transcribed 
by RNAPI and NTS2-1 contains a known RNAPI termination site [235]. What 
function Nrd1 may be serving in this location is yet to be determined.  
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Of the top 100 Nrd1 DNA binding sites and top 100 RNA binding sites, 66 
sites are reported independently in each list (Table 10). Creamer et al. also 
reported that Nrd1 PAR-CLIP and ChIP sites do not always overlap [50]. 
Specifically, the authors reported that 10 ribosomal protein coding genes were 
detected in their top 100 Nrd1 ChIP binding sites while they were not detected in 
their top 100 PAR-CLIP sites [50]. It is of note that a lower number of genomic 
locations that are present in ChIP-exo peak calling but not in the PAR-CLIP data 
are near snRNAs. Of these sites detected by one technique but not the other, 
27/66 are near snRNAs in the ChIP data, but only 2/66 are near snRNAs in the 
PAR-CLIP data (Table 10).  
One explanation for the relative abundance of snRNAs in the ChIP data 
compared to the PAR-CLIP data is that the ChIP data is dependent on the 
localization of RNAPII, whereas the PAR-CLIP localization is independent of 
RNAPII. It is likely that the Nrd1-binding peaks adjacent to snRNAs are more 
readily detectable, and therefore ranked higher in our list, due to the abundance 
of RNAPII localization and subsequent increased proximity of Nrd1 to the DNA. 
Additionally, Creamer et al. hypothesized that Nrd1 is able to bind to elongating 
RNAPII independent of RNA binding, allowing Nrd1 to bind Nrd1-binding sites in 
the nascent RNA as soon as it is available [50]. Finally, it is possible that these 
additional regions contain Nab3 RNA binding sites and that Nrd1 is recruited 
through its interaction with Nab3 not through direct RNA binding that would be 
detected by PAR-CLIP.  
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Gene Chr. 
Start 
position 
End 
position 
Summit 
relative 
to start 
Fold-
change 
 -log10 p-
value 
In both 
ChIP & 
CLIP? 
snR8 XV 832350 832866 236 62.62 13301.30 yes 
RPL9B XIV 499664 500794 985 60.05 18900.26 
 snR39B VII 366209 366605 64 56.44 13540.35 yes 
snR81 XV 234197 234845 384 48.76 6331.58 
 NTS2-1 XII 459732 460624 786 45.02 20224.90 yes 
snr72 XIII 297092 298824 1613 43.36 11983.66 
 snr85 XIII 67343 67960 366 37.46 3005.84 yes 
snr66 XIV 585650 586686 631 36.62 6909.90 
 snR13 IV 1402990 1403459 144 34.53 10683.54 yes 
snr64 XI 38711 39350 316 34.34 5147.62 
 snr45 XVI 821693 822342 391 33.06 4957.72 yes 
snr51 XVI 718291 719378 229 32.96 4743.62 
 snr47 IV 541132 541864 328 32.78 6507.77 
 snr48 VII 609443 610016 427 32.73 5303.05 
 snr30 XII 198799 199759 729 32.24 7947.24 
 IMD2 VIII 554099 554661 291 31.94 1843.78 
 snR56 II 87983 88565 405 31.15 6096.91 yes 
snR37 X 227697 228563 309 30.53 5580.30 
 snR10 VII 345917 346778 451 30.08 6994.02 yes 
PPS1 II 759668 759898 180 29.24 1609.37 
 snr128 X 139119 140160 370 28.98 9025.75 yes 
snr34 XII 899157 899858 348 28.75 3447.50 yes 
URA2 X 172329 173132 555 28.21 3042.65 yes 
snR83 XIII 626277 627042 523 28.00 3442.29 yes 
IMD3 XII 1002267 1002952 276 27.63 3583.40 yes 
snR161 II 306464 307340 643 27.58 2335.93 
 snR40 XIV 89016 89715 405 27.44 8476.20 yes 
snR71 VIII 411093 411911 350 27.42 3994.06 
 snR11-
CMC4 XIII 652175 653046 581 27.26 5004.97 yes 
snR5 XV 842397 842984 366 26.33 4124.14 yes 
snr17A XV 780014 781013 731 26.18 4738.10 
 snR80 V 51681 52409 399 25.95 3662.38 
 snR79 XII 347918 348681 301 25.81 2773.99 
 snR61 XII 794034 795148 366 24.45 4285.89 
 snr4 V 424637 425457 479 24.19 3513.68 yes 
RPS9A XVI 404935 406116 556 24.15 3734.95 yes 
snr50 XV 259321 260024 477 24.01 2181.64 yes 
snr86 XIII 761640 762471 358 23.76 3336.11 yes 
TYE7 XV 977246 978350 809 23.71 2422.06 
 snR60 X 348662 349402 410 23.67 3159.60 yes 
snR37 X 227697 228563 255 23.51 3857.54 
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Gene Chr. 
Start 
position 
End 
position 
Summit 
relative 
to start 
Fold-
change 
 -log10 p-
value 
In both 
ChIP 
and 
CLIP? 
snR10 VII 345917 346778 451 30.08 6994.02 yes 
PPS1 II 759668 759898 180 29.24 1609.37 
 snr128 X 139119 140160 370 28.98 9025.75 yes 
snr34 XII 899157 899858 348 28.75 3447.50 yes 
URA2 X 172329 173132 555 28.21 3042.65 yes 
snR83 XIII 626277 627042 523 28.00 3442.29 yes 
IMD3 XII 1002267 1002952 276 27.63 3583.40 yes 
snR161 II 306464 307340 643 27.58 2335.93 
 snR40 XIV 89016 89715 405 27.44 8476.20 yes 
snR71 VIII 411093 411911 350 27.42 3994.06 
 snR11-
CMC4 XIII 652175 653046 581 27.26 5004.97 yes 
snR5 XV 842397 842984 366 26.33 4124.14 yes 
snr17A XV 780014 781013 731 26.18 4738.10 
 snR80 V 51681 52409 399 25.95 3662.38 
 snR79 XII 347918 348681 301 25.81 2773.99 
 snR61 XII 794034 795148 366 24.45 4285.89 
 snr4 V 424637 425457 479 24.19 3513.68 yes 
RPS9A XVI 404935 406116 556 24.15 3734.95 yes 
snr50 XV 259321 260024 477 24.01 2181.64 yes 
snr86 XIII 761640 762471 358 23.76 3336.11 yes 
TYE7 XV 977246 978350 809 23.71 2422.06 
 snR60 X 348662 349402 410 23.67 3159.60 yes 
snR37 X 227697 228563 255 23.51 3857.54 
 snR63 IV 322188 323650 904 23.49 2597.43 
 snR32 VIII 381569 382093 269 23.38 4229.31 
 snR35 XV 758851 759507 423 23.29 3688.46 yes 
snr189-
snR65 III 177052 178757 1463 23.25 2731.82 yes 
RPL41A IV 129961 130561 164 23.24 2444.40 
 snR79 XII 347918 348681 386 23.06 2362.00 
 RPL7B-
snR59 XVI 173073 174138 559 22.89 3429.21 yes 
TDH3 VII 882423 883959 195 22.41 3921.99 yes 
snR58 XV 135689 136324 265 21.61 1588.59 
 RPL25 XV 80363 82938 1027 21.59 2961.70 
 snr37 X 227697 228563 195 21.50 3393.44 
 snr4 V 424637 425457 320 21.48 2959.42 yes 
GIT1 III 297067 297226 99 21.40 1032.56 
 MCM21 IV 1103799 1104154 282 20.99 1004.52 
 NRD1 XIV 173699 174663 656 20.89 2507.13 yes 
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Gene Chr. 
Start 
position 
End 
position 
Summit 
relative 
to start 
Fold-
change 
 -log10 p-
value 
In both 
ChIP 
and 
CLIP? 
snR49 XIV 716069 716708 404 20.84 1833.15 yes 
snr3 X 663669 664742 354 20.48 2166.19 yes 
NUP133 XI 594093 594258 108 19.60 1337.37 
 HTZ1 XV 303315 303586 145 19.20 1200.63 
 MTO1 VII 55514 56171 418 18.85 1532.38 yes 
SRG1 V 322136 323577 535 18.84 2429.55 
 URA8 X 620608 621119 181 18.66 1219.66 yes 
snr35 XV 758851 759507 330 18.60 2659.08 yes 
snR18 I 142115 143699 1347 17.85 1268.30 
 snr82 VII 316816 317485 411 17.83 1176.22 yes 
tG(UCC)O XV 110105 111113 757 17.41 1132.50 
 snR7-L VII 938983 939738 331 17.40 781.23 
 snr9 XV 407564 408218 285 17.37 2511.44 
 HOS4 IX 153875 154124 117 17.21 750.58 
 snr43 III 107016 107743 363 17.21 1329.34 
 ydl241w IV 20959 21223 56 17.19 749.34 
 ylr257w XII 657300 658083 479 17.14 745.61 
 YBR074w II 387692 387851 96 17.00 736.92 
 GNP1 IV 1467714 1468578 633 16.76 1039.31 
 snr33 III 142027 142513 170 16.54 1685.55 
 ADE12 XIV 234249 234828 104 16.52 1740.35 
 ADH1 XV 159176 160268 227 16.28 1220.50 
 snr46 VII 545150 546099 459 16.19 1299.50 yes 
snR72-78 XIII 297092 298824 1530 16.17 2957.56 
 SHM2 XII 258774 259511 85 16.12 1713.66 
 tS(CGA)C III 227847 228577 249 15.98 770.66 
 snr42 XI 558566 559361 319 15.98 1560.63 yes 
RPS2 VII 277461 278758 1112 15.92 1440.35 yes 
tA(UGC)A I 166122 166363 119 15.75 657.44 
 RPS14B X 73755 74982 469 15.71 2055.64 yes 
SWI3 X 92270 92421 55 15.52 786.49 
 snr53 V 61061 62026 771 15.14 1414.02 
 intergenic_2 XIV 784009 784333 251 15.01 610.81 
 TOD6 II 117864 118544 477 14.87 602.53 
 GRS1 XVI 701917 702486 207 14.76 614.67 
 intergenic_4 II 9429 9905 48 14.66 589.57 
 intergenic_5 VIII 562435 562643 94 14.55 582.53 
 snr69 XI 364727 365507 267 14.52 804.83 
 IRC2 IV 679625 679962 159 14.39 573.18 
 OGG1 XIII 152850 153067 52 14.31 568.51 
 BG_YJR107 X 628105 628688 86 14.12 556.90 
 
 127 
Gene Chr. 
Start 
position 
End 
position 
Summit 
relative 
to start 
Fold-
change 
 -log10 p-
value 
In both 
ChIP 
and 
CLIP? 
CCW12 XII 369295 370228 646 14.01 1684.52 yes 
PCF11 IV 923095 923923 94 14.01 549.96 
  
 
Table 10: Top 100 peaks in Nrd1 ChIP-Exo data. Chromosomal location of Nrd1 
ChIP-exo peaks are listed with the name of the closest annotation gene, in order 
of descending fold-change values. The highest point in the peak is listed as 
“Summit relative to start.” Peaks were considered included in both ChIP and 
PAR-CLIP top 100 site lists if the chromosomal location overlapped. ChIP peaks 
are much broader than PAR-CLIP peaks, and in some instances, two PAR-CLIP 
peaks were included in one ChIP peak. These double peaks were counted as 
two locations detected in both data sets for Figure 27.  
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Figure 27: Comparison of top Nrd1-binding sites as detected by ChIP-exo versus 
PAR-CLIP. The DNA footprint of Nrd1-bound RNAPII was measured by Nrd1-
TAP ChIP-exo. The direct RNA-binding sites of Nrd1 were measured by Creamer 
et al. [50] by Nrd1-His PAR-CLIP. The top 100 sites identified in each data set 
were compared. A total of 44 binding sites were identified in both lists. 
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3.3. RTR1 deletion increases the recruitment of Nrd1 to the Ser5-P CTD. 
 To understand the effects on NNS-dependent termination in the RTR1 deletion 
strain, we wanted to determine if the ratio of bound Nrd1 to RNAPII was 
increased at genes with known Nrd1 binding sites. Using the normalized number 
of reads mapped per base pair for each ChIP-exo dataset, we divided the reads 
from Nrd1-TAP by Rpb3-FLAG in the corresponding genetic backgrounds. This 
resulted in a ratio of Nrd1-bound RNAPII to Rpb3 per base that is shown at two 
well-characterized Nrd1-regulated transcripts URA2 (Figure 28A) and NEL025C 
(overlapping with the NUT0952 annotation, Figure 28B). Expression of URA2 is 
repressed in the presence of uracil, and previous ChIP experiments have shown 
that RNAPII occupancy correlates with expression in the URA2 ORF, but not at 
the promoter where it is always present [236]. The promoter region contains an 
upstream CUT that is transcribed in the presence of uracil and terminated by the 
NNS pathway [152]. Our data from yeast grown in YPD medium indicate that 
there is a high occupancy of Nrd1 at this upstream CUT in WT cells, in 
agreement with previous findings (CUT680, Figure 28A). Additionally, the ratio of 
Nrd1 to RNAPII bound to genes increases nearly two-fold in the absence of 
RTR1 (Figure 28A, orange), suggesting that Rtr1 activity in WT cells may limit 
the co-occupancy of Nrd1 and RNAPII at this location.  
NEL025C, the first characterized CUT, originates from a divergent 
promoter at the DLD3 gene [71]. NEL025C is expressed as either a long form 
(about 620 nt, corresponding to the annotations for SUT503, CUT541, and 
CUT542 combined) or a series of heterogeneous shorter transcripts, all of which 
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were shown to be terminated by the NNS-dependent termination machinery and 
degraded by Rrp6 [71, 147]. Using ChIP-exo, we identified a large peak in the 
ratio of Nrd1 to RNAPII associated along the length of the NUT0952 annotation 
(Figure 28B). This peak appears to be primarily due to an absence of Rpb3 
localization at this region in WT cells, which could indicate that RNAPII 
termination is more efficient in the absence of Rtr1. This peak also overlaps with 
the NEL025C gene, with the highest peak localized at the 3’-end of the CUT542 
annotation. There is also a high ratio of Nrd1 to RNAPII observed in the WT 
strain in the middle of the TSSs for DLD3 and NUT0952. In the rtr1Δ strain, the 
Nrd1/RNAPII ratio is increased from 4-6 fold in WT to up to 18 in rtr1Δ cells at the 
peak of mapped DNA reads, indicating that deletion of RTR1 increases Nrd1 co-
occupancy with RNAPII. 
 
3.4. Altered Composition of Affinity Purified Transcription Elongation and 
Termination Complexes 
Because we detected an increased ratio of Nrd1:RNAPII co-localization at 
specific NNS-target gene transcripts in rtr1Δ cells as judged by our ChIP-exo 
studies, we used affinity purification mass spectrometry analysis to determine if 
the Nrd1:RNAPII interaction was increased upon deletion of RTR1. Furthermore, 
because it has previously been shown that loss of RTR1 results in 3’-end 
processing defects at some mRNAs [8], we wanted to determine how the 
deletion of RTR1 affected the composition of proteins associated with RNAPII 
termination complexes. We performed affinity purification mass spectrometry  
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Figure 28: Co-occupancy of Nrd1/RNAPII is increased genome-wide with 
deletion of RTR1 as judged by Rpb3-FLAG and Nrd1-TAP ChIP-exo analysis. 
Graphical representation of the ratio of Nrd1 to Rbp3 read counts per base 
mapped to URA2 (A) and DLD3 region (B). Data derived from WT cells is in 
black, and those from the rtr1Δ strain is in orange. The location and direction of 
transcription for all analyzed annotations are diagrammed below the graphs, 
each to scale. Protein-coding mRNAs are in black, NUTs are in aqua, SUTs are 
in blue, CUTs are in gray, and bent arrows indicate direction of the TSS. The 
transcript approximated by the NUT0952 annotation has also been referred to as 
NEL025C in the literature [71]. 
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analysis of subunits of CPF, Rtt103/Rat1/Rai1, CF1a, and Nrd1 from WT and 
rtr1Δ strains as shown in Figure 29. The data was then analyzed by hierarchical 
clustering as previously described [237]. The resulting cluster separates the 
proteins identified by mass spectrometry into their respective termination 
complexes (Figure 29). Subunits that associate more transiently with the 
complexes are also detected but have a lower NSAF value than the core 
complex components.  
Rpb3-TAP isolation from WT cells followed by mass spectrometry 
successfully identified all subunits of RNAPII. Regulators of RNAPII termination 
were not detected in the Rpb3-TAP isolation, likely because of the dynamic 
nature of recruitment of termination factors during the transcription cycle. Cdc73 
is a member of the Paf complex (PAF-C), which is involved in RNAPII 
transcription elongation and has been implicated in transcription termination 
[238-242]. All subunits of PAF-C and RNAPII were detected in Cdc73-TAP 
purifications. Rtr1, an elongation specific interaction partner of RNAPII, was 
found to primarily interact with all of the subunits of RNAPII and PAF-C in WT 
cells. We also looked at the interactions of Ssu72, the other Ser5 phosphatase, 
in WT and rtr1Δ cells. Ssu72 is a member of the CPF complex, and all CPF 
subunits were detectable in WT and rtr1Δ cells with the exception of Yth1. Yth1 
has previously been shown to interact with Ssu72-purified complexes at low 
levels [188]. Subunits of PAF-C were also detected in Ssu72-FLAG samples. Of 
interest, Ssu72-FLAG and presumably the CPF complex interact with Yra2, a 
protein involved in RNA export in WT, but this interaction in lost in the rtr1Δ 
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strain. We did not detect any increased protein-protein interactions in the Ssu72-
FLAG rtr1Δ purification that would suggest a clear compensatory function of 
Ssu72 in the absence of RTR1.  
Our data indicate that loss of RTR1 disrupts the association of a number 
of subunits in the RNAPII transcription termination machinery. Many proteins that 
normally interact with Rpb1 via the CTD were disrupted upon loss of RTR1 
(green box). Rtt103 normally binds RNAPII through the Ser2-P mark on the CTD. 
In WT cells, we detect Rtt103 interaction with many of the RNAPII subunits and 
interactions with known binding partners Rat1 and Rai1. However, we did not 
detect Rat1 or Rai1 (red box) or any subunits of RNAPII in the Rtt103 purification 
in rtr1Δ cells. Likewise, Pcf11 also binds to Ser2-P modified RNAPII. In this 
cluster, we show two replicates of the Pcf11 purifications in both WT and rtr1Δ to 
illustrate the reproducibility of this method. Similar to the data from the Rtt103 
purifications, Pcf11 interacts with Rpb1 (green box) and other subunits of RNAPII 
in the WT cells, but these interactions are not detectable in rtr1Δ cells. In 
addition, we observed decreases in the association of the CFIa subunit Clp1 in 
Pcf11-TAP RTR1 deletion purifications. These findings are consistent with 
previous in vitro studies that found that Pcf11 and Rtt103 binding to Ser2-P 
modified CTD peptides was much stronger than to Ser5-P [32]. 
Interestingly, Nrd1-TAP appears to have increased interactions with both 
Rpb1 and the Cap Binding Complex (Sto1 and Cbc2) in purifications from RTR1 
deletion strains relative to WT (boxed in aqua in Figure 29). These data support 
our ChIP-exo data shown in Figure 28 that show an increased ratio of 
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Nrd1:RNAPII association at specific genes in the rtr1Δ strain. Nrd1 has been well 
documented to interact with the Cap Binding Complex [70], and, although it is not 
detectable in the WT dataset presented here. The interaction is likely to occur 
below the detectable threshold due to the low abundance of Nrd1 in WT cells. Of 
importance, Nrd1 and its interacting partner Nab3 are detected at similar levels in 
both WT and rtr1Δ strains, and the ratio of Sto1 and Cbc2 compared to Nrd1 
bound to Nab3 is dramatically increased in the RTR1 mutant. Interestingly, this 
increase of Sto1/Cbc2 interaction with Nrd1 is even greater than the increase of 
interaction between Rpb1 and Nrd1. The increased interaction between Nrd1 and 
the cap binding proteins may play a role in promoting the Nrd1/Nab3 interaction 
with the nascent RNA. These findings suggest that the loss of RTR1 increases 
the affinity of the Nrd1-Nab3 complex for RNAPII in vivo, likely through increasing 
the number of Ser5-P modified CTD repeats. This suggests that regulation of 
Rtr1 activity and or expression level could be a key regulatory step for 
transcription termination through the NNS pathway. 
 
3.5. Functional consequences of increased Nrd1 interaction with RNAPII in 
RTR1 deletion cells. 
Rtr1 appears to have a role in regulating antisense transcription at poorly 
expressed genes such as YKL151C, a known target of the NNS pathway [50]. 
RNA-Seq analysis revealed that the antisense transcript in the 3’-end of 
YKL151C appears shorter in rtr1Δ cells relative to WT. Annotated as 
“AS_Unit4881” (indicated by the red bar, Figures 30, 31), this antisense transcript   
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Figure 29: Quantitative proteomic analysis of complexes involved in RNAPII 
transcription termination in WT or rtr1Δ strains. The protein used for purification, 
type of C-terminal tag, and genotype are shown at the top of the figure. Two 
independent biological replicates are shown for Pcf11 purifications to show the 
reproducibility of protein identifications. Proteins identified and their respective 
complexes are shown to the right, and their NSAF values are indicated according 
to the scale on the bottom left. The dendogram to the left of the cluster 
represents the abundance relationship between the purified proteins as 
determined by clustering analysis performed as previously described [201, 202]. 
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is detectable at low levels in WT and much more abundant in both strains lacking 
Rrp6. We created an rtr1Δ rrp6Δ double deletion strain to uncover transcripts 
affected by the loss of RTR1 that would be degraded by Rrp6. However, we 
discovered that there is a requirement for Rrp6 for termination of specific NNS-
target transcripts, as mentioned above [243]. Therefore, we were interested to 
determine what effects the interplay between Rrp6 and Rtr1 in the NNS-
dependent termination pathway would have. In the rtr1Δ rrp6Δ double deletion 
strain, reads aligning to the AS_Unit4881 region to the left of the dashed line, 
where the transcript was detectable in the rtr1Δ deletion strain, are much more 
abundant than reads downstream of this site. This region was previously 
annotated as NUT0447, a transcript that requires Nrd1 for termination. Rpb3-
FLAG occupancy is decreased in this region in rtr1Δ cells compared to WT cells, 
but Nrd1-TAP is increased as measured by ChIP-Exo (Figure 31). Therefore, the 
ratio of Nrd1 bound to RNAPII is higher in rtr1Δ cells as we have previously 
observed at other NNS target genes (Figure 30). Interestingly, the highest 
amount of change was observed in the 5’-end of the antisense transcript that 
could facilitate early termination in the absence of RTR1, in agreement with the 
RNA-Seq results (Figure 30).  
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Figure 30: RTR1 deletion shortens the NNS-terminated antisense transcript at 
YKL151C. (A) Graphical representation of strand-specific RNA-Seq reads 
mapped to YKL151C region. Reads mapped to the positive strand are on top in 
red, while reads mapped to the negative strand are on the bottom in blue. The 
location and direction of transcription for all analyzed annotations are 
diagrammed below the graphs to scale. Processed lengths of mRNAs are in 
black, NUTs are in aqua, antisense transcripts are in red, and bent arrows 
indicate direction of the TSS. (B) Graphical representation of the ratio of Nrd1 to 
Rbp3 read counts per base mapped to the same region as in (A) Data from WT 
is in back, rtr1Δ is in orange.  
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Figure 31: RTR1 deletion alters Rpb3 and Nrd1 occupancy at YKL151C. Rpb3-
FLAG (A) and Nrd1-TAP (B) localization as determined by ChIP-exo sequencing 
reads mapped to YKL151C. The location and direction of transcription for all 
analyzed annotations are diagrammed below the graphs to scale. Protein-coding 
mRNAs are in black, antisense transcripts are in red, and bent arrows indicate 
direction of the TSS. The dotted black line marks the estimated TTS of the 
antisense transcript in rtr1Δ cells. WT Rpb3 reads are in black, WT Nrd1 reads 
are in green and rtr1Δ reads from both strains are in orange.  
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It has been well-documented that FMP40 is regulated by an NNS-
terminated antisense transcript also known as CUT882 and YPL222C-A [41, 50, 
231], and we have previously reported that termination of this RNA is Rrp6-
dependent [243]. As determined by RNA sequencing and Rpb3-FLAG ChIP-exo, 
YPL222C-A is both more abundantly expressed and longer in rrp6Δ cells [243]. 
By the same methods, rtr1Δ appears to have the opposite effect (Figure 32). 
RNA expression of YPL222C-A is down regulated, and RNAPII localization is 
shifted 5’- relative to the antisense transcript compared to WT. Not only does 
RNAPII appear to travel a shorter distance during YPL222C-A transcription in 
rtr1Δ cells, but there is also an increased occupancy of RNAPII at the 5’-end of 
YPL222C-A that may be paused. Nrd1 localization is also increased in the rtr1Δ 
strain, and the first peak of Nrd1 binding aligns well with the RNAPII peak (Figure 
32A). This suggests that loss of RTR1 is promoting Nrd1 localization at this gene 
location, resulting in an increase of RNAPII that is paused in this region. In the 
rtr1Δ rrp6Δ strain, YPL222C-A expression is markedly higher than in WT cells 
and is similar to that observed in the rrp6Δ strain, which suggests that Rrp6 is 
required for the decrease in YPL22C-A expression in RTR1 deleted cells. These 
findings support a model in which transcription elongation of YPL222C-A is 
positively regulated by the removal of Ser5-P by Rtr1. In the absence of Rtr1, 
Ser5-P levels remain high facilitating RNAPII termination via the NNS pathway. 
In WT cells, the removal of Ser5-P by Rtr1 decreases Nrd1-Nab3 binding and 
subsequent NNS pathway action at the earliest termination sites, resulting in 
synthesis of transcripts that are able to escape early termination.   
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Figure 32: RTR1 deletion shortens the NNS-terminated antisense transcript at 
FMP40.  (A) Graphical representation of strand-specific RNA-Seq reads mapped 
to FMP40 region. Reads mapped to the positive strand are on top in red, while 
reads mapped to the negative strand are on the bottom in blue. The dotted black 
line indicates the estimated TSS of the YPL222C-A transcript. The location and 
direction of transcription for all analyzed annotations are diagrammed below the 
graphs to scale. Protein-coding mRNAs are in black, dubious ORFs are in tan, 
CUTs are in gray, and bent arrows indicate direction of the TSS. (B) Rpb3-FLAG 
(top) and Nrd1-TAP (bottom) occupancy in WT and rtr1Δ as determined by ChIP-
exo sequencing reads mapped to the same region and aligned to (A). Reads 
from WT are in black, and those from rtr1Δ are in orange. 
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3.6. Disruption of NNS-pathway termination through RRP6 deletion 
prevents AST regulation by RTR1 deletion 
 As discussed earlier (Figure 25), the majority of transcripts differentially 
expressed in rtr1Δ cells are down-regulated compared to WT. To compare the 
effect of RTR1 in the NNS-dependent termination pathway to the effect of RRP6, 
we looked at the most significantly (p-value < 0.005, FDR < 0.25) down-regulated 
transcripts in rtr1Δ cells. In contrast, many of the antisense transcripts that are 
differentially expressed in rtr1Δ cells are up-regulated in rrp6Δ cells. As shown in 
Figure 33A, the majority of these ASTs have nearly identical expression in the 
rtr1Δ rrp6Δ double deletion as they do in rrp6Δ cells, although some transcripts 
appear similar to the WT strain (Figure 33A). These findings support the 
hypothesis that Rtr1 and Rrp6 are acting through the same pathway with 
opposing actions and that deletion of RRP6 masks the effects of the loss of 
RTR1. This model is illustrated in the specific examples of CUT882, which is 
transcribed antisense to FMP40 (Figure 33B), as well as the antisense transcript 
at GAP1 (Figure 33C, D). We have previously reported using northern blot 
analysis that CUT882 is an extended YPL222C-A transcript transcribed near the 
3’-end of FMP40 (see Figure 32 for diagram). As mentioned, the CUT882 
transcript is shorter in rtr1Δ cells and longer in rrp6Δ cells as detected by RNA-
Seq and Rpb3 ChIP-exo. The annotation for CUT882 is similarly increased in the 
rtr1Δ rrp6Δ double mutant as quantified by RNA-Seq suggesting that YPL222C-A 
is also longer in the double mutant. GAP1, encoding a general amino acid 
permease, also appears to be an antisense-responsive gene [214]. Upon the 
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loss of RTR1, expression of GAP1 is increased 2-fold and the levels of the AS 
GAP1 transcript are decreased by 50% (Figure 33C, D). Conversely when RRP6 
is lost, GAP1 is decreased by 50% and the AS transcript is increased 1.5-fold. In 
the rtr1Δ rrp6Δ double deletion strain, expression of both transcripts is 
unchanged from WT cells. These data show that the AS GAP1 non-coding 
transcript is differentially regulated by Rtr1 and Rrp6, such that the double mutant 
effectively rescues the expression of the sense and antisense GAP1 transcripts. 
It has been well documented that IMD2 is regulated by alternative 
selection of transcription start sites and NNS-dependent early termination [146, 
170, 208, 223]. RNA-Seq data indicates that Rtr1 alters the expression of IMD2 
and its upstream regulatory transcript, a known target of the NNS pathway 
(Figures 34, 35). We previously showed that Rrp6 is required for proper NNS-
dependent termination at specific target gene transcripts [243]. In WT cells, RNA-
Seq reads map across IMD2 and the upstream transcript at similar levels during 
growth in YPD (Figure 34A). When RTR1 is knocked out, the expression of both 
transcripts is significantly decreased (p-value ≤ 5.0 x 10-07, Figures 34, 35). This 
is consistent with previous reports that RTR1 deletion mutants are sensitive to 
the IMD2 inhibitor mycophenolic acid [185, 244].  The decrease in IMD2 RNA is 
confirmed by quantitative PCR (Figure 34B). The ratio of upstream transcript to 
IMD2 transcript is similar between WT and rtr1Δ strains (Figure 34C). When 
RRP6 is knocked out, IMD2 expression is similar to WT levels, but the upstream 
transcript is significantly increased (p-value ≤ 1.09 x 10-10, Figure 35A). This is  
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Figure 33: RTR1/RRP6 double deletion strain phenocopies rrp6Δ cells. A) Heat 
map of transcripts differentially expressed in rtr1Δ cells sorted from most 
decreased in rtr1Δ cells compared to WT cells, according to the scale at the right. 
B-D) Average normalized read counts ± standard deviations for CUT882 (B), 
GAP1 (C), and AS GAP1 (D) in indicated strain versus WT (n=4). Two stars 
indicate a p-value of <0.01, one star indicates a p-value of <0.05 as determined 
by an unpaired, two-tailed student’s t-test. The colors of the bars in each graph 
correspond to the color representing the relative annotation. 
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previously been described. Interestingly, in the rtr1Δ rrp6Δ double mutant, the 
IMD2 transcript levels are reduced to the low levels seen in the rtr1Δ single 
mutant, but the upstream transcript now appears at levels similar to WT. The 
amount of upstream transcript is significantly increased in rtr1Δ rrp6Δ double 
mutant strains relative to rtr1Δ cells (p-value = 0.003). These data suggest that 
the upstream transcript is transcribed and then efficiently degraded by the 
nuclear exosome in the presence of Rrp6.  However, the high efficiency of NNS 
termination in the absence of Rtr1 appears to prevent normal levels of 
transcription of the protein coding IMD2 transcript.  
To distinguish between effects of RNA degradation versus transcription 
termination, we also looked at the RNAPII and Nrd1-bound RNAPII by ChIP-exo 
(Figure 35B, C). In all strains, we see the majority of RNAPII at the upstream 
transcript. In Rpb3-FLAG strains, RNAPII occupancy at IMD2 is decreased by 
approximately 75% in rtr1Δ cells. However, in Nrd1-TAP strains, occupancy is 
only decreased by 50% in rtr1Δ cells, indicating that the ratio of Nrd1 to RNAPII 
is relatively increased in rtr1Δ strains as previously shown for other NNS target 
genes in this study. Overall these data suggest that loss of Rtr1 activity increases 
Nrd1 binding to RNAPII, most likely due to the increased Ser5-P on the CTD. 
The increase in Nrd1 recruitment improves the efficiency of termination at the 
upstream transcript and effectively inhibits transcription initiation at the 
downstream IMD2 TSS. When Rrp6 is present, this upstream transcript is 
degraded, but it is stabilized when RRP6 is deleted without a change in the  
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Figure 34: Deletion of RTR1 disrupts expression of IMD2 mRNA through RRP6. 
A) Graphical representation of strand-specific RNA-Seq reads mapped to IMD2 
region. Reads mapped to the positive strand are on top in red, while reads 
mapped to the negative strand are on the bottom in blue. The location and 
direction of transcription for all analyzed annotations are diagrammed below the 
graphs to scale. Protein-coding mRNAs are in black, dubious ORFs are in tan, 
NUTs are in aqua, and bent arrows indicate direction of the TSS. B) Confirmation 
of expression of IMD2 by QPCR are indicated as the average fold-change from 
WT in rtr1Δ, rrp6Δ, and rtr1Δ rrp6Δ strains (n=3). C) The average ratio of RNA-
Seq reads mapped to the IMD2 upstream CUT annotation compared to the 
number of reads mapped to the IMD2 gene annotation in rtr1Δ, rrp6Δ, and rtr1Δ 
rrp6Δ strains relative to WT (n=4). 
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Figure 35: Deletion of RTR1 disrupts the NNS-dependent transcription 
termination at the IMD2 gene through RRP6. (A) Average differential expression 
± standard deviations for IMD2 (left) and the IMD2 upstream CUT in rtr1Δ, rrp6Δ, 
and rtr1Δ rrp6Δ strains relative to the WT strain (n=4). One star indicates a p-
value of <0.05, and two stars indicate a p-value of <0.01 as determined by an 
unpaired, two-tailed student’s t-test. The colors of the bars in each graph 
correspond to the color representing the related annotation. (B and C) Rpb3-
FLAG (B) and Nrd1-TAP (C)) occupancy in WT and rtr1Δ as determined by 
ChIP-exo sequencing reads. The location and direction of transcription for all 
analyzed annotations are diagrammed above the graphs to scale. Protein-coding 
mRNAs are in black, NUTs are aqua, the upstream CUT is tan, and bent arrows 
indicate direction of the TSS. WT reads are in black, and rtr1Δ are in orange. The 
dotted red line indicates the transcription termination site of the IMD2 upstream 
CUT. 
  
IMD2 upstream CUT
NUT0356
IMD2
0 
100 
200 
300 
400 
500 
600 
0 
500 
1000 
1500 
2000 
2500 
3000 
554000 554500 555000 555500 556000 
R
pb
3-
FL
AG
C
hI
P-
ex
o
no
rm
al
iz
ed
 re
ad
 c
ou
nt
N
rd
1-
TA
P
C
hI
P-
ex
o
no
rm
al
iz
ed
 
re
ad
 c
ou
nt
Wild-type
rtr1∆
Overlap
Wild-type
rtr1∆
Overlap
0 
0.5 
1 
1.5 
2 
2.5 
3 
rtr1∆ rrp6∆ rtr1∆ rrp6∆ R
N
A-
Se
q 
ex
pr
es
si
on
 c
ha
ng
e
re
la
tiv
e 
to
 W
T 
(n
=4
)
0 
1 
2 
3 
4 
5 
R
N
A-
Se
q 
ex
pr
es
si
on
 c
ha
ng
e
re
la
tiv
e 
to
 W
T 
(n
=4
)
rtr1∆ rrp6∆ rtr1∆ rrp6∆ 
IMD2 IMD2 upstream CUT
**
*
**
**
Rpb3
Nrd1
A
B
C
 149 
downstream abundance of RNAPII, suggesting that Rrp6 is not required for 
termination at the IMD2 upstream CUT. 
 
3.7. Deletion of RTR1 increases the efficiency of the NNS pathway  
Our data indicate that Rtr1 plays a role in the NNS-dependent termination 
pathway at gene transcripts expressed at low-levels. As mentioned previously, 
Nrd1 is required for termination of the highly expressed and stabilized snRNAs. 
Although we do not detect any snRNAs that are altered in length when RTR1 is 
deleted, a few snRNAs are expressed at higher levels in rtr1Δ cells such as 
snR65 and snR56 (Figure 36A). Both of these snRNAs are expressed 2-fold 
higher in rtr1Δ cells than in WT cells and decreased by 50% in rrp6Δ and rtr1Δ 
rrp6Δ strains. As discussed previously, deletion of RRP6 may result in improperly 
processed 3’-ends at these snRNAs, causing destabilization and decreased 
expression [243]. We hypothesize that deletion of RTR1 increases the efficiency 
of NNS-dependent termination at these genes, but Rrp6 is required for proper 3’-
end processing and stability in agreement with previous findings. We also see an 
interesting effect in both our RNA and ChIP data at the RNAPIII transcribed gene 
snR52. There is a CUT upstream of snR52 previously annotated as CUT567 
[72]. Although there is not much difference in the expression of RNA from this 
CUT in rrp6Δ cells, CUT567 and snR52 are both increased 2-fold or more in the 
rtr1Δ strain (Figure 36B). Rpb3-FLAG ChIP-exo data indicates that RNAPII 
localizes to CUT567 with low, but detectable levels at snR52 in WT, but RNAPII 
occupancy is increased at snR52 in rtr1Δ cells (Figure 36C). This is a rare 
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example where we see an increase in Rpb3 localization in the rtr1Δ strain. Nrd1-
TAP also localized to both CUT567 and snR52 in WT and is increased in rtr1Δ 
cells (Figure 36D). One possible explanation is that the loss of Rtr1 leads to 
increased Nrd1 interaction with RNAPII, and in some instances, this association 
inhibits release of RNAPII from the DNA. Alternatively, this could indicate that 
deletion of RTR1 could alter transcription initiation of RNAPII allowing it to initiate 
at RNAPIII target genes. 
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Figure 36: Deletion of RTR1 increases the efficiency of the NNS-dependent 
termination pathway at some snRNAs. (A and B) Average differential expression 
± standard deviations for snR65, snR56, snR52, and CUT567 in rtr1Δ, rrp6Δ, and 
rtr1Δ rrp6Δ cells relative to WT (n=4). One star indicates a p-value of <0.05, and 
two stars indicate a p-value of <0.01 as determined by an unpaired, two-tailed 
student’s t-test. The colors of the bars in each graph correspond to the color 
representing the related annotation. (C and D) Rpb3-FLAG (C) and Nrd1-TAP 
(D) occupancy in WT and rtr1Δ as determined by ChIP-exo sequencing reads. 
The location and direction of transcription for all analyzed annotations are 
diagrammed above the graphs to scale. Protein-coding mRNAs are in black, 
CUTs are gray, and bent arrows indicate direction of the TSS. WT reads are in 
black, and rtr1Δ reads are in orange.  
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DISCUSSION 
 
1. Homologous mechanisms in mammals 
1.1. Structure of the Human Exosome 
Although the structure of the human exosome has not been solved, the 
organization of the core complexes are well conserved with its yeast counterpart 
(reviewed in [245]). The human RNA exosome is more complex regarding the 
catalytic subunits and associated cofactors. While there is only one form of the 
Dis3 nuclease in yeast, there are three in humans, DIS3, DIS3L1, and DIS3L2, 
each with distinct subcellular localization patterns [94, 95]. By contrast, Rrp6 only 
has one human ortholog, hRRP6 (also known as PM/Scl100). In the yeast 
exosome, most of the highly structured RNA substrates are degraded by Dis3 
and cannot be processed by Rrp6. In humans, hRRP6 is able to processed more 
structured RNAs, probably do to the more open conformation assumed by 
hRRP6 [118]. hRRP6 also differs from its yeast counterpart in that it is most 
highly concentrated in the nucleolus, but is also present in the nucleoplasm and 
cytoplasm [69]. Human homologs of subunits of the TRAMP complex have also 
been identified, including Mtr4 and the Trf and Air proteins [155, 246, 247]. 
Interestingly, a second distinct complex has been identified to have TRAMP-like 
functionality but is restricted to the nucleolus. This complex, called the Nuclear 
Exosome Targeting Complex (NEXT), is made up of hMTR4 and two other 
proteins, ZCCHC8 and RBM7 [247]. NEXT has been found to play an important 
role in targeting pre-snRNA transcripts to the exosome for processing [248]. 
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1.2. Human Exosome Interacts with Capping Complex 
A number of studies report links between the nuclear exosome and the 
Cap Binding Complex (CBC) (Figure 5). The 5’ mRNA cap is involved in 
coordinating a number of mRNA processing events such as splicing [249], 3’ end 
formation [250], and RNA turnover [251], but specifically how cap formation 
fulfills these roles is unclear. Regarding RNA turnover by the nuclear exosome, it 
appears that proteins associated with the exosome may form a physical link 
between the exosome and CBC. In yeast, it has been shown that Rrp6 directly 
interacts with Nrd1, which in turn interacts with CBC proteins [70]. In humans, the 
exosome cofactor the Nuclear Exosome Targeting complex (NEXT) has been 
shown to interact with the CBC [252, 253]. Furthermore, it has been shown in 
yeast that aberrant mRNAs that cannot be exported from the nucleus are 
subjected to degradation by a process requiring both Cbc1, a nuclear cap-
binding protein, and Rrp6 [254, 255]. The fact that the nuclear exosome and 
Nrd1 may both interact with the CBC [70] is interesting. It is possible that the 
CBC plays an important, unknown role in NNS-dependent termination at specific 
genes, and this role may require Rrp6 leading to the effects detected in our 
studies. 
 
2. Implications of Transcription Events in Human Health and Disease 
2.1. Transcription Regulation by Termination 
 Altered termination of RNAPII transcription termination can affect gene regulation 
and protein expression in at least four ways, described at length below: 1) 
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alternative polyadenylation site usage, 3) defective 3’ end processing, 3) early 
transcription termination of protein-coding mRNAs,and 4) regulation of cryptic 
and antisense transcription. 
 
Alternative Polyadenylation Site Usage 
It has been reported that upwards of 70% of human pre-mRNAs and 
lncRNAs have more than one polyadenylation signal sequence [256]. 
Orchestration of specific cleavage and polyadenylation factors at cis-elements 
play major roles in the subsequent choice for the site of polyadenylation of the 
mRNA [257]. Alternative polyadenylation (APA) changes the length of the 3’-UTR 
and can quantitatively effect the expression of the gene by altering the availability 
of protein-binding sites and/or the composition of regulatory sequences [258, 
259]. To illustrate this idea, it was reported that alternate 3’-ends of RNA may 
regulate localization of the membrane proteins CD44, CD47, ITGA1, and 
TNFRSF13C [260]. In the case of CD47, the extended 3’ UTR serves as a co-
translational scaffold for RNA-binding proteins that facilitate recruitment of 
proteins required for translocation to the plasma membrane. CD47 proteins 
translated from an mRNA with a short 3’ UTR localized instead to the 
endoplasmic reticulum.  
APA can also play a role in cell differentiation, and APA patterns may be 
tissue specific [261]. During development of the central nervous system, the 
expression of two isoforms of GFAP (glial fibrillary acidic protein) is time-
dependent and regulated by APA. The exact mechanism of regulation is not 
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known, but splicing factors may be involved [262]. In another example, one 
aspect of maturation of B cells may be regulated by APA in a related mechanism. 
Young B cells express immunoglobulins bound to the cell surface, while mature 
cells secrete them. This isoform shift is regulated by splicing-dependent APA in 
which the splicing and 3’ end processing machinery compete [263-265]. APA 
may regulate developmental processes on a more global scale in a tissue-
specific fashion during spermatogenesis and brain development [266-270]. 
Generally, more distal polyadenylation sites are used increasingly as 
differentiation progresses, resulting in the inclusion of more miRNA and protein 
binding sites [271-273]. Additionally, proliferating cells, including gastric cancer 
cells [274], tend to use earlier polyadenylation sites and, therefore, have shorter 
3’-UTRs [275, 276]. 
 
Processing of 3’ ends of RNA 
Proper 3’-end processing is important for regulation of gene expression 
and function. As highlighted above, it has become clear that sequences in 3’-
UTRs and their recognition by polyA binding proteins play an important role in the 
majority of cellular processes studied [277]. Improper mRNA 3’-end processing 
has been associated with a number of diseases (reviewed in [278]. Proper 
protein expression may be dependent on sequences in the 3’-UTR of the 
mRNAs, such as sequences containing recognition sites of microRNAs [279]. A 
few human mRNAs have non-canonical 3’-end processing signals called 
upstream sequence elements (USE sites) [280-283]. Regulated utilization of 
 157 
these sites enhance 3’-end processing at otherwise weak signals [284]. One 
such protein, the serine protease thrombin, is an important regulator of blood 
coagulation and clotting. Its expression is regulated in response to inflammation 
and stress by recognition of specific sequences in the 3’-UTR of mRNAs [285, 
286]. Improper utilization of the USE site leads to abnormal coagulation and 
blood clots [285, 287]. Additionally, a mutation in the polyadenylation signal of 
the tumor suppressor gene TP53 present in 0.5-2% of European populations has 
been linked to a predisposition to a number of cancers [288, 289]. Mutations in 
the FOXP3 (forkhead box P3) polyadenylation signal can cause IPEX syndrome, 
a complex syndrome characterized by immune dysfunction, polyendocrinopathy 
and enteropathy [290]. FOXP3 is a transcription factor in T cells, and the 3’-UTR 
resulting from the mutation is very long making the protein unstable and 
decreasing its expression. 
 
Early Termination of Protein Coding RNA and Regulation of Cryptic Transcription 
 The NNS-dependent termination pathway is an important regulator of gene 
transcription. In examples such as NRD1, HRP1, and URA2, transcription can be 
terminated prematurely by the Nrd1 termination pathway [43, 145, 152, 170, 
223]. Only transcripts that escape this early termination can produce functional 
mRNAs, and alterations that increase the effectiveness of the NNS pathway lead 
to a decrease in mRNA expression. At some genes, noncoding RNAs terminated 
by Nrd1 overlap with the promoter of, or are antisense to, an adjacent protein-
coding gene [153, 170, 214]. For instance, IMD2 gene expression is regulated by 
 158 
upstream transcription start sites used when guanine levels are high. These start 
sites encode short, unstable transcripts that are terminated by the NNS pathway 
[146, 170, 208]. In other instances, protein-coding genes are regulated by NNS-
dependent termination of an antisense non-coding RNA, such as FMP40 and 
PHO84 [41, 50, 217, 231]. At these noncoding genes, antisense transcription is 
initiated at the 3’-end of the protein-coding gene and terminated by the NNS 
pathway after a short distance. If NNS-dependent termination does not occur, 
transcription of the antisense strand will continue through the entire gene and 
over the transcription start site of the protein-coding gene, inhibiting proper 
initiation at the mRNA [217, 243]. 
 
2.2. Transcription Addiction in Tumor Cells 
 Many human cancers depend on deregulated transcription of oncogenes and 
tumor suppressors. In some cases, cancer cells may be “addicted” to the 
overexpression of a single oncogene [291]. For instance, it has been well 
documented that the Bcr-Abl fusion protein drives proliferation in chronic 
myelogenous leukemia (CML). Flavopiridol, a drug that inhibits transcription by 
targeting the RNAPII CTD kinase P-TEFb (CTK9) [292] may be used in 
conjunction with the Bcr-Abl inhibitors to decrease imatinib resistance in CML 
[293]. In other cases, the cancer cells may contain a mutation in an oncogene 
that activates a number of downstream targets. Over- expression of the MYC 
gene family aids in aggressive proliferation and poor patient outcomes [294, 295] 
by causing a cascade of global transcription amplification and up-regulation of 
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genes involved in multiple processes [296-299]. It has recently been reported 
that the proliferative effect of up-regulation of the MYCN oncogene can be 
suppressed in neuroblastoma cells by inhibition of the cyclin-dependent kinase 
and general transcription factor CDK7 with limited toxicity to normal cells [300]. 
CDK7 is the human homolog of Kin28, the catalytic subunit of TFIIH that adds 
the Ser5-P mark later removed by Rtr1, and is the major protein kinase that 
modifies Ser5 and Ser7 in the RNAPII CTD in human cells [301]. These findings 
support a working model in which some cancer cells become “addicted” to the 
amplified transcription of proliferative genes. A better understanding of general 
transcription factors and mechanisms is needed to determine if it is possible to 
target transcription addiction in cancer cells with limited effects in normal cells.  
 
2.3. Senataxin, the Human Homolog of Sen1 
 The RNA:DNA helicase Sen1 and its homolog in humans Senataxin contain a 
conserved helicase domain [302, 303]. Mutations in Senataxin are associated 
with the juvenile neuromuscular disorders ataxia oculomotor apraxia type 2 
(AOA2) and amyotrophic lateral sclerosis type 4 (ALS4) [304-306]. The function 
of Senataxin mutations in these disorders is unknown, but many are located 
within the helicase domain [302]. This suggests that the helicase function may 
play a role in neurogenerative diseases.  
Studies of Sen1 have revealed that its helicase function is important for 
protecting against genomic instability and damage [307-309]. As RNAPII 
transcribes a gene, the nascent RNA can bind to the complementary template 
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DNA strand forming an RNA:DNA hybrid with the single stranded non-template 
DNA strand left exposed in a structure called an R-loop. Without removal of the 
R-loop by Sen1, the single stranded DNA is more susceptible to mutation and 
recombination [310-315]. The R-loop structure can lead to RNAPII stalling which 
inhibits transcription elongation and can lead to transcription fork collapse when a 
replicating DNA Polymerase encounters a stalled RNA Polymerase [316-320]. 
Furthermore, Sen1 may play a role in regulating the expression of the DNA repair 
gene RNR1 [309] and an inactivating mutation in the Sen1 helicase domain has 
been shown to alter RNAPII localization genome-wide [53]. Sen1 has also been 
shown to play a direct role in DNA damage response [86, 307, 308, 321, 322], 
and Senataxin forms stress-induced foci that may localize at chromosome fragile 
sites or repetitive sequences, either of which may be susceptible to R-loop 
formation [321, 323, 324]. It is also possible that brain-specific Senataxin protein-
protein interactions are disrupted by the disease-associated mutations. Richard 
and Manley have reported that Senataxin is normally sumoylated and interacts 
with the core exosome subunit Rrp45 via the sumoylation [325]. AOA2-linked 
mutations inhibit Senataxin sumoylation, but ALS4-linked mutations do not [86, 
325]. 
 
2.4. Rrp6 and the Nuclear RNA Exosome 
Autoimmune Disease 
Antibodies against many of the subunits of the human exosome have 
been characterized in autoimmune disorders affecting the connective tissue, 
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specifically: PM (polymyositis), Scl (scleroderma) and PM/Scl overlap syndrome 
[83, 326-328]. Patients’ sera were found to contain antibodies against hRrp6 
(called PM/Scl-100 at the time), and some patients also had antibodies against 
hRrp45, one of the RNase PH-like core proteins (called PM/Scl75) [98-100]. The 
role of the exosome in these disorders remains unclear. 
 
Neurological Disorders 
Two of the core subunits of the human exosome, EXOSC3 (homolog to 
the yeast cap protein Rrp40) and EXOSC8 (homolog to the yeast barrel protein 
Rrp43), have been implicated in pontocerebellar hypoplasia type 1 (PCH1) and 
spinal motor neuron degeneration in several families [84, 102]. PCH is a group of 
autosomal recessive disorders characterized by progressive deteriorations of 
various parts of the brain. Patients with PCH1 also have diffuse muscle wasting. 
Mutations in EXOSC8 have also been linked to cerebellar hypoplasia and spinal 
muscular atrophy [85]. The reporting study determined that down-regulation of 
EXOSC8 in human cells and zebrafish resulted in down-regulation of myelin 
encoding genes and an imbalance of myelin protein. These and other studies 
involving mRNA processing factors indicate that proper regulation of mRNA 
processing is critical in neuromuscular development and maintenance [86, 321, 
329-331]. Furthermore, non-coding RNAs appear to play important roles in 
neurological development, and disregulation of non-coding RNAs has been found 
to lead to neurodegeneration [331-333]. Proper processing, quality control, and 
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degradation by Rrp6 and the nuclear exosome may serve important functions 
keeping non-coding RNAs in check in neuromuscular tissue. 
 
Cancer 
It is not clear if Rrp6, the nuclear exosome, and their cofactors play a 
direct role in cancer formation and progression, but they have been linked to 
DNA repair and chromatin restructuring mechanisms that are important for 
maintaining genomic integrity. The TRAMP complex may play a role in chromatin 
remodeling and DNA repair, important for maintaining properly regulated gene 
expression and inhibiting cancer growth [227]. TRAMP may be functionally linked 
to RNAi machinery in S. pombe and aid in post-transcriptional gene silencing and 
RNA induced transcriptional silencing which result in heterochromatin formation 
over the target gene [334]. One early study suggested that the core exosome 
subunit Rrp46 may be up-regulated in 10–33% of patients with lung cancer, 
melanoma, and prostate cancer [101]. Furthermore, in a genome-wide drug-
target screen, Rrp6 was found to be a potential target of the cell growth inhibitor 
5-fluorouracil used in chemotherapy for the treatment of solid tumors. The role of 
Rrp6 in rRNA processing is proposed as a pathway by which 5-fluorouracil 
inhibits growth [335]. Rrp6 may play a role in repair of DNA double strand breaks 
through the homologous recombination pathway in Drosophila and humans 
[336]. Marin-Vicente et al. recently reported that Rrp6 is recruited to double 
strand breaks in Drosophila S2 cells and human HeLa cells and co-
immunoprecipates with Rad51, a protein involved in recombination. Both deletion 
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of RRP6 and overexpression of a catalytically inactive Rrp6 mutant disrupt 
recruitment of RAD51 to the damage sites but does not decrease Rad51 protein 
levels. Furthermore, depletion of Rrp6 makes both cell lines sensitive to 
radiation, indicating Rrp6 may be involved in DNA damage repair [336]. 
 
3. Transcription termination effects gene regulation 
3.1. Exosome aids in backtracking RNAPII 
 Although most studies have implied that Rrp6 and the exosome targets RNA 
substrates after they are released from RNAPII, the core exosome can associate 
with RNAPII on the DNA. It is known that the exosome associates with RNAPII 
on target genes in Drosophilia [337]. As mentioned above, both catalytic subunits 
of the nuclear exosome are 3’ – 5’ exonucleases. As such, the nascent RNA 
being actively elongated by RNAPII would not be accessible to the exosome. 
However, recent work has shown that the core exosome can aid in terminating 
backtracked RNAPII at protein coding genes in S. pombe [338]. RNAPII has 
been shown to backtrack, or reverse directions while still on the transcribed DNA 
sequence to aid in RNAPII release from the DNA when stalled [339]. By 
backtracking, RNAPII could expose the 3’ end of the RNA, allowing access and 
degradation by the exosome (model shown in Figure 37) [340]. It was determined 
that termination of backtracked RNAPII was carried out by Dis3, with no 
detectable effect from an RRP6 knockout. However, this study focused on 
protein coding mRNAs. Rrp6 may play a greater role in rescuing backtracked 
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RNAPII transcribing noncoding RNAs, as Rrp6 has been shown to play a greater 
role in termination of cryptic transcripts originating from within genes [172]. 
 
3.2. Regulation of PolyA Tail Length 
The length of the polyA tail added to pre-mRNAs after transcription affects 
the stability and translation efficiency of the mRNA (Reviewed in [341]). The 
normal polyA tail length (about 70 – 80 nt in S. cerevisiae) is carefully regulated 
by interactions between PolyA Binding Proteins (PABPs) and polyA 
polymerases. Two PABPs have been identified in yeast: Pab1 which is primarily 
in the cytoplasm but can be shuttled into the nucleus [342-344], and Nab2 which 
is primarily in the nucleus but is exported with the mRNP into the cytoplasm 
where it is thought to be exchanged for Pab1 [345-348]. Expression of Nab2 is 
subject to post-transcriptional auto-regulation in a model in which Nab2 binding 
to the 3’ UTR of a NAB2 mRNA results in recruitment of Rrp6 and subsequent 
mRNA degradation [349]. It has been reported that Rrp6 can physically interact 
with Nab2, displacing Nab2 from polyA tails, leaving the unprotected 3’-ends 
available for subsequent degradation [77]. 
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Figure 37: Model for how the nuclear exosome may facilitate rescue of 
backtracked RNAPII. Dis3 and the core exosome have been found to facilitate 
termination of backtracked RNA, but Rrp6 is suggested not to play a significant 
role in terminating backtracked mRNA transcripts in S. pombe. Rrp6 is suggested 
to function in termination of cryptic antisense transcripts originating within genes 
[172] and certain snRNAs [243], so it is possible that Rrp6 assists backtracking 
RNAPII for these gene transcripts by a model similar to that suggested for Dis3. 
When RNAPII is transcribing, the 3’ end of the RNA is in the active site, protected 
by RNAPII, and inaccessible to Rrp6. When RNAPII backtracks in response to an 
obstacle in the DNA or improperly incorporated nucleotide, the 3’ end of the RNA 
emerges through a ‘backtrack site’ in RNAPII and can be accessed by Rrp6 
[340].  
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4. Additional Roles of the RNA Exosome in Nuclear RNA processing and 
Surveillance  
4.1. RNA Turnover 
With transcription occurring across so much of the genome, the cell must 
recover ribonucleotides tied up in these transcripts. Although many transcripts 
must be stabilized to perform their functions, such as mRNAs, rRNAs, and 
tRNAs, errors in transcription and processing may result in aberrant transcripts 
that need to be recycled. Furthermore, certain transcripts appear to be 
transcribed with no known purpose, other than possibly to regulate the 
transcription of nearby regions in cis. The nuclear exosome appears to recognize 
these unstable transcripts and targets them for degradation, recycling the 
ribonucleotides contained within [141-143, 156, 157, 159, 350, 351]. 
 
4.2. pre-mRNA 
Rrp6 and the exosome are involved in quality control and turnover of 
mRNAs at several steps including splicing and 3’-end processing. The splicing 
machinery recognizes intron-containing mRNAs co-transcriptionally. Once these 
transcripts are bound by the spliceosome, they are restricted to the nucleus until 
they are released [352, 353] (Figure 6C, left panel). This finding suggests that 
any pre-mRNAs bound to the spliceosome that cannot be properly spliced must 
be degraded in the nucleus. Bousquet-Antonelli et al. discovered that these pre-
mRNAs are degraded primarily by Rrp6 and the exosome, and to a lesser extent 
by the 5’ – 3’ exonuclease Rat1 [354]. Interestingly, they also found that inhibition 
 167 
of the degradation pathways could increase the levels of certain spliced mRNAs, 
indicating that pre-mRNAs may compete for splicing and degrading machineries, 
with some transcripts being favored. This competition and resulting pre-mRNA 
preference appears to be regulated by metabolic events such as available 
carbon source and therefore may be an important step in controlling gene 
expression levels [354]. 
The exosome appears to play a role in a type of checkpoint for proper 3’ 
end formation (Figure 6C, right panel). Cells with defective Pap1, the poly(A) 
polymerase that adds the poly(A) tail to stabilize mRNAs, accumulate nascent 
unpolyadenylated pre-mRNA transcripts at the site of transcription [355]. Of 
interest, defects in nuclear export machinery also leads to accumulation of 
nascent RNAs in proximity to the site of gene transcription. In this case, nascent 
RNAs become hyperadenylated with poly(A) tails approximately 30 nt longer than 
expected [356, 357]. Surprisingly, Rrp6 was found to be important in the retention 
of both the hypo- and hyperadenylated transcripts at the site of transcription 
resulting from these polyadenylation and export defects [355]. Furthermore, it 
has been shown that mRNAs with 3’ extensions due to improper termination can 
be processed by Rrp6 to a functional length [358]. Deletion of RRP6 is sufficient 
to see accumulation of aberrant transcripts caused by a variety of transcription 
elongation and termination defects [76, 221]. Because of this accumulation of 
defective transcripts, RRP6 knockouts have become an important tool in the 
study of RNAPII transcription elongation and termination. 
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4.3. Exosome activities in the cytoplasm 
 As mentioned above, the RNA exosome is also present in the cytoplasm, minus 
Rrp6. In the cytoplasm, Dis3 is the only exonuclease in the complex. The 
cytoplasmic exosome interacts with the SKI complex of helicases that targets 
RNA substrates to the exosome in a manor similar to the TRAMP complex in the 
nucleus [359]. The SKI complex is only in the cytoplasm in yeast and is required 
for mRNA turnover and mRNA surveillance by the exosome [360-363]. The 
cytoplasmic exosome and SKI complex are required for proper mRNA 
surveillance via the non-stop decay (NSD) pathway [362, 364, 365]. NSD targets 
mRNAs that do not contain a translation stop codon [364, 366]. Generally, the 
nuclear exosome specializes in RNA 3’-end processing, rapid degradation of 
cryptic transcripts, and surveillance of improper RNA processing, while the 
cytoplasmic exosome specializes in surveillance of mRNAs and RNA turnover. It 
has been reported that a yeast cell can transcribe upwards of 2,000 rRNA 
molecules a minute [367] in addition to other noncoding RNAs and mRNAs. 
Therefore, dual localization of exonucleases such as the exosome is important 
for efficient surveillance and degradation in the nucleus to conserve energy 
required for the nuclear export and potential translation of RNAs in the 
cytoplasm.  
 
4.4. Exosome activity is important for cellular differentiation 
Regulation of transcription termination and degradation of transcription 
products have been shown repeatedly to be required for proper expression at 
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specific genes. Importantly, studies are beginning to emerge that reveal the 
importance of RNA exosome processing at the cellular level. In yeast, the 
nuclear exosome is involved in facilitating meiosis. Budding yeast have been 
shown to degrade Rrp6 as they enter meiosis, leading to the accumulation of 
noncoding transcripts termed meiotic unstable transcripts (MUTs) [81]. 
Degradation of Rrp6 occurs in the first hours of meiosis and corresponds to the 
timing of RNA replication and induced double strand breaks [81]. However, cells 
lacking Rrp6 rarely entire meiosis. In what may be a related process, fission 
yeast express meiotic genes that are degraded by the exosome to inhibit meiosis 
[368]. Furthermore, it has recently been found that Rrp6 and the nuclear 
exosome facilitate proper meiotic recombination [82]. The mechanisms regulating 
the expression of Rrp6 during early meiosis is not clear. 
The exosome is also involved in regulating blood cell maturation [369]. 
Expression of EXOSC8, the human homolog of the exosome core protein Rrp43, 
is repressed by erythropoiesis regulator proteins GATA-1 and Foxo3. Loss of 
EXOSC8 or other exosome components can induce erythroid cell maturation. 
Alternatively, increased exosome activity can repress the expression of genes 
activated by GATA-1 and Foxo3 [369]. The mechanisms by which the exosome 
represses expression of GATA-1/Foxo3-regulated genes has not yet been 
addressed, and it is unclear what specific roles Rrp6 may play. It is possible that 
the RNA exosome plays an important negative regulatory role in many 
maturation and developmental processes. 
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5. Rrp6 is required for proper NNS-dependent termination at specific 
transcripts  
Through comparison of RNA-Seq and RNAPII ChIP-exo datasets, these 
data show that NNS-terminator read-through occurs at a significant number of 
NNS-target genes in the absence of the 3-5’ exonuclease Rrp6. These findings 
support the hypothesis that the NNS pathway requires Rrp6 function for both 3’-
end processing and regulation of NNS-dependent termination of specific 
transcripts. Overall, there is a striking similarity between the annotations for Nrd1 
unterminated transcripts (NUTs) at many locations and the transcripts observed 
following deletion of the nuclear specific 3’-5’ exonuclease subunit Rrp6 genome-
wide. The tight coupling of the NNS pathway with exosome function has been 
previously characterized [4, 47, 56, 58, 70], however our findings are the first to 
demonstrate that Rrp6 function is required to regulate termination through the 
NNS pathway at specific gene transcripts and to show changes in RNAPII 
localization that are caused by rrp6Δ. This finding is in contrast to recent studies 
that determined that NUT transcripts were significantly longer than Rrp6-
dependent transcripts (previously named as CUTs) [214]. However, there are 
specific instances in which NUTs have been shown to be longer than Rrp6-
dependent transcripts including our findings at FMP40 / YPL22C-A [214]. 
Previous studies have found other extended CUT transcripts (eCUTs; 
specifically CUT060 and CUT095) to be significantly longer in Nrd1 mutants than 
in rrp6Δ cells as well [221]. This was also true for snR13 in agreement with 
previous results obtained by northern blotting and other approaches [20, 43, 193, 
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218, 220]. The mechanisms that underlie the specific requirement for Rrp6 at 
some transcripts for Nrd1 termination are unknown, but we speculate that Rrp6 
regulates NNS-termination efficiency through its interaction with Nrd1 [45, 70]. 
Our analysis also suggests that the increased dynamic range and resolution 
provided by RNA-Seq and ChIP-exo gives a distinct advantage in precise 
mapping of the transcripts that accumulate following deletion of RRP6. We 
propose that it is this difference that led to the findings that NUTs were 
significantly longer than CUTs, since all previous CUT studies were performed 
using tiling array based platforms, whereas the NUT studies were performed by 
deep sequencing [72, 73, 214]. Additionally, comparison of the changes in RNA 
transcript signals to actual changes in RNAPII occupancy allowed us to 
distinguish between effects of RNAPII termination events versus exonuclease-
dependent RNA processing, which was of particular importance for this study. 
In this study, we performed multiple biological replicates (n=4) to provide 
highly accurate differential expression analysis for all classes of annotated 
transcripts. In addition, we included differential expression analysis of 1215 
antisense transcripts that were significantly changed in rrp6Δ cells, the majority 
of which (76%) were up-regulated. These data will serve as a valuable resource 
to determine the diverse roles of the NNS pathway and Rrp6 in transcriptome-
wide gene expression regulation. Using RNA-Seq, we have determined that loss 
of Rrp6 leads to decreased expression of the majority of sn/snoRNA transcripts. 
Additionally, we have found that the mRNA transcripts from ribosomal protein 
coding genes show a strong dependence on Rrp6 for control of their steady state 
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transcript levels. Previous ChIP studies on Nrd1 have shown that although Nrd1 
localizes to many ribosomal protein-coding genes, it does not directly bind to the 
mRNA transcripts from those genes [50]. This class of mRNA transcripts may be 
regulated by Nrd1 and Rrp6 due to their short length and hence high levels of 
Ser5-phosphorylated RNAPII at their 3’-ends, which could facilitate interaction 
with Nrd1 and regulation of termination [3, 4, 6, 45]. By comparing our data to 
recent 4tU-Seq datasets involving Nrd1-depletion from the nucleus, we found 
that multiple ribosomal subunit mRNAs display transcript extension following loss 
of Nrd1 activity. These data strongly suggest that ribosomal protein coding 
mRNAs may require Rrp6 and the NNS pathway for proper 3’ processing and 
transcript stability.  
High-resolution RNAPII occupancy maps generated by ChIP-exo provide 
unique insights into the mechanisms of NNS-dependent termination. At NRD1, 
HRP1, and YPL222C-A, deletion of RRP6 lead to a 3’ shift in RNAPII localization 
indicating that NNS-dependent termination was delayed or less efficient (Figures 
21, 22, 23). This phenomenon was also observed to a lesser extent at SRG1-
SER3 (Figure 23). Interestingly, we observed distinct accumulation of RNAPII at 
these regions that occurred just 3’ to Nrd1 and/or Nab3 binding sites that have 
previously been mapped by RNA-protein crosslinking approaches (Figure 21) 
[50, 60]. These findings suggest that termination through the NNS-pathway may 
be an inefficient process requiring clusters of Nrd1/Nab3 binding sites to for 
facilitate higher order recruitment of multiple Nrd1-Nab3 heterodimers to carry 
out transcription termination, an idea that is also supported by other studies [40, 
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222]. This hypothesis is further supported by a report that showed that NNS-
termination occurs in a ‘termination zone’ rather than a specific termination site 
as proposed for polyA-dependent termination pathways [51]. Through this 
mechanism, gene expression attenuation at genes such as NRD1 and SRG1-
SER3 would remain leaky, allowing for transcription of a small percentage of full-
length transcripts even in the presence of high Nrd1-Nab3 protein levels, which is 
what we observe in WT cells at these genes (Figures 21, 22, 23). The 
requirement for the nuclear exosome and Rrp6 for efficient NNS-regulated 
attenuation adds a layer of complexity to this process and another path for 
regulation for these tightly controlled genes. 
It is unclear at this time what role Rrp6 has in regulating RNA expression 
at this specific class of protein-coding genes. Rrp6 may play a greater role in 
rescuing backtracked RNAPII at noncoding RNAs, as Rrp6 has been shown to 
play a role in termination of specific snRNAs [43] and cryptic transcripts 
originating from within gene bodies [147]. The evidence presented here and by 
others points toward a mechanism in which Rrp6 is directly involved in NNS-
dependent termination, but it is possible that there is another explanation for 
these findings. For instance, there could be some as-of-yet unknown lncRNA that 
is normally degraded by Rrp6 but, when stabilized, acts to interfere with the 
activity of one or more proteins required for proper NNS-dependent termination 
(Figure 38, bottom panel). This mechanism could be similar to that of NEAT1, a 
long non-coding RNA that is thought to sequester RNA-binding proteins in 
subnuclear bodies called paraspeckles (reviewed in [370]). In this theoretical 
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indirect model for Rrp6 function in RNAPII termination, the lncRNA could bind to 
the RNA Recognition Motifs (RRM domains) of Nrd1 or Nab3, or an unidentified 
protein. This would not result in decreased transcription, but would nonetheless 
inhibit termination activity through the NNS pathway. 
 
6. Insights from transcriptome-wide sequencing 
6.1. Annotation boundaries vs. transcription boundaries 
 Transcriptome-wide RNA analysis such as RNA-Seq has recently revealed that 
most of the eukaryotic genome is transcribed. Previous attempts to annotate the 
yeast genome have relied on determining the sequences of stable, easily 
detectable proteins and therefore only report coding regions in the genome. Even 
updated sequencing-based approaches to annotating the entire yeast genome 
have difficulty determining the exact TSS and TTS of every transcript [219]. Our 
findings support the notion that transcriptional boundaries may not be precise for 
every gene. As mentioned above, many genes like IMD2 are regulated by 
alternative TSSs [208]. Additionally, regulation of transcription elongation and 
termination may alter the location of the TTS, such as we have shown here. It is 
important to keep in mind that many groups report new annotations that have 
been estimated by methods that do not accurately and specifically measure the 
5’- and 3’- ends of RNAs [72, 214]. Genomic annotations are necessary and 
important tools that provide points of reference and methods of expression 
analysis, but they are difficult if not impossible to perfect.  
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Figure 38: Two models describing how Rrp6-activity possibly modulates NNS-
dependent transcription termination. Rrp6 may have a direct role in NNS-
dependent termination through protein-protein interactions or an indirect role 
through an unidentified RNA intermediary. (Top) Nrd1 binds Ser5-P on the 
RNAPII CTD, and Nrd1 and Nab3 bind the nascent RNA. The mechanism by 
which Nrd1 causes termination is not known, but may involve an interaction with 
Rrp6. Sen1 unwinds RNA:DNA hybrids in a 3’-5’ direction relative to the nascent 
RNA facilitating RNAPII termination. The TRAMP subunit Trf4 binds Nrd1, 
releasing it from the CTD (indicated as a red ‘X’). TRAMP adds a short polyA tail 
to the RNA, targeting it for degradation by the exosome. Rrp6 interacts with 
Nrd1, likely still bound to the RNA to inhibit complete degradation of stable 
transcripts such as snRNA. RNAPII must then be removed from the DNA and 
proteins bound to both the RNA and RNA must be released through unresolved 
mechanisms. (Bottom) In the RNA-dependent model, a theoretical cryptic 
lncRNA that is usually degraded by Rrp6 may be stabilized in its absence. This 
trans-acting RNA may then sequester one or more proteins required for NNS-
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dependent termination. This subnuclear trapping may be similar to the 
mechanism by which NEAT1 sequesters RNA-binding proteins in paraspeckles, 
effectively inhibiting their activity without decreasing their overall abundance. 
Nrd1 and Nab3 would be reasonable candidates for such a mechanism 
considering their RRM domains, or another currently unidentified protein could 
also be affected. 
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6.2. Pros and cons of a compact genome 
 As we have illustrated in our RNA-Seq results, it is critical that RNAPII 
transcription termination occurs in a limited region. We clearly show that 
extended transcription resulting from improper termination can effect the 
expression of neighboring genes (Figures 16, 17, 20). Proper regulation of 
termination is therefore not only required for the expression of the specific target 
gene but also has implications for global RNA expression levels. As discussed 
above, the genome of S. cerevisiae is extremely compact. Almost all of the 
genome is transcribed in some capacity, and even highly transcribed regions 
including snRNA genes and mRNA genes converge and overlap (examples in 
Figures 16-20, 22, 23, and 26). A compact genome has less room for error when 
regulating the location of transcription termination, but it also required less 
energy to replicate during cell division. It is our current understanding that genes 
are not as tightly packed in the more complex mammalian genomes. These 
genomes are much larger and require more energy to duplicate, but they also 
contain various cis and trans regulatory elements in non-coding genomic regions 
that fine tune gene expression. Altered RNAPII transcription caused by events 
like termination defects could potentially have a more detrimental effect on 
genomic expression in such a complicated system. Therefore, the additional 
energy required to replicate and maintain a larger, less compact genome may be 
a required cost of maintaining a complex, multicellular organism. However, this 
does not negate the requirement for proper regulation of transcription termination 
in mammalian genomes. Data from S. cerevisiae has shown that transcription 
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can be extended several kilobases when termination is disrupted, such as at the 
antisense transcript of FMP40 when Nrd1 is depleted from the nucleus [214]. 
Transcription extending to such lengths would still interfere with protein coding 
genes in a mammalian system. 
 
7. Role of Rtr1 in the NNS-dependent termination pathway 
7.1. Rtr1 limits the co-occupancy of Nrd1/RNAPII 
 By comparison of RNA-Seq, ChIP-exo, and affinity purification mass 
spectrometry, our data clearly show that Nrd1/RNAPII co-localization is 
increased and NNS-dependent termination is enhanced in the absence of the 
atypical phosphatase Rtr1. Additionally, loss of RTR1 is shown to have the 
opposite phenotype as the RRP6 deletion at many NNS-target transcripts, and 
the rtr1Δ rrp6Δ phenocopies the rrp6Δ strain. These findings support the 
hypothesis that Rtr1 helps to fine-tune NNS-dependent termination of 
transcription, particularly of non-coding gene transcripts that can regulate 
adjacent or overlapping protein-coding genes. Furthermore, our data indicate that 
this role of Rtr1 is carried out directly through the NNS-dependent termination 
pathway and is epistatic to the effects of the rrp6Δ.  
Our group and others have previously shown that Rtr1 is capable of 
removing both Tyr1-P and Ser5-P on the RNAPII CTD [8, 17], but the 
mechanism of Rtr1 phosphatase activity and the scope of the effects of Rtr1 on 
transcription are not well understood. Our findings are the first to indicate that 
Rtr1 plays a role in the termination of short, noncoding RNAs and to show 
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changes in Nrd1 occupancy that are caused by rtr1Δ. We note that loss of RTR1 
results in a 5’-shift of Nrd1 occupancy. Conversely, disruption of Ssu72, another 
Ser5 phosphatase, results in NNS-dependent terminator read-through and longer 
Ssu72-responsive transcripts [218, 223]. These data suggest that Rtr1 and 
Ssu72 play opposite roles in the regulation of NNS termination perhaps through 
regulation of context specific Ser5 CTD phosphorylation.  
 Our data further supports the hypothesis that the NNS-dependent terminator 
mechanism is an inefficient process requiring multiple Nrd1/Nab3-binding sites at 
some target genes such as NRD1 [40, 222], and that Rtr1 plays a role in 
regulating its efficiency. As mentioned previously, leaky transcription attenuation 
at genes such as NRD1, IMD2, and SRG1-SER3 adds a layer of regulation at 
these tightly controlled genes. It could be presumed that such attenuation 
mechanisms, which could have the ability to completely abolish gene expression 
by an abundance of Nrd1/Nab3, would have multiple avenues for regulation. Our 
findings suggest that Rrp6 and Rtr1 play opposing, yet complementary roles in 
fine-tuning NNS-dependent termination. These data support a model (illustrated 
in Figure 39) in which Rtr1 activity in WT cells limits the interaction of Nrd1 and 
RNAPII, likely by decreasing the number of potential Nrd1-docking sites (Ser5-P) 
along the CTD (Figure 39A). More Rtr1 activity therefore decreases the efficiency 
of NNS-dependent termination resulting in a leakier system. Without Rtr1, or in 
conditions in which Rtr1 protein levels are decreased, Nrd1 can bind more 
efficiently to RNAPII (Figure 39B). Once Nrd1 is bound to RNAPII in the ratio 
determined, at least in part, by Rtr1 and Kin28 (the Ser5 kinase) activity, the 
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interaction between Nrd1 and Rrp6 is required for proper termination (Figure 
39C). Without Rrp6, the 3’-end of the transcript may be improperly processed, 
destabilizing the RNA, which may then be degraded by other RNases such as 
Dis3, resulting in decreased expression regardless of the upstream affects of 
Rtr1 (Figure 39D). Therefore, these two proteins, and likely others, work in 
concert to regulate NNS-dependent gene expression attenuation. 
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Figure 39: Representation of the effects of Rtr1 and Rrp6 on NNS-dependent 
transcription termination. A) Rtr1 activity in WT cells limits the interaction of Nrd1 
and RNAPII, likely by decreasing the number of potential Nrd1-docking sites. B) 
Without Rtr1 Nrd1 can bind more efficiently to RNAPII. C) The interaction 
between Nrd1 and Rrp6 is required for proper termination. D) NNS-dependent 
termination is inefficient at certain transcripts without Rrp6, resulting in terminator 
read-through and improperly processed RNAs. 
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7.2. Comparison of Rtr1 and Ssu72 in NNS-dependent termination 
 These studies are the first to uncover the differences in the molecular roles of the 
two Ser5 phosphates Rtr1 and Ssu72. An earlier transcriptome-wide study 
measured the global effects on RNA of inactivation of Ssu72 using tiling 
microarrays [218]. The loss of Ssu72 activity in the temperature sensitive strain 
SSU72-2 resulted in increased detection of noncoding RNAs transcribed from 
bidirectional promoters, a class of transcripts the authors termed Ssu72-
restricted transcripts (SRTs).  The promoters associated with these SRTs were 
also found to have a more relaxed chromatin structure in the absence of Ssu72 
activity. Ssu72 has also been implicated in gene-looping, a model in which 
promoter and terminator regions of a gene are brought together through protein-
protein interactions in a termination-dependent mechanism. This loop formation 
facilitates RNAPII transcription re-initiation and requires CTD dephosphorylation 
by Ssu72 and TFIIB binding of RNAPII at the terminator that then associates with 
the promoter [371, 372]. These findings fit well with data showing that Ssu72 
occupancy at mRNA genes peaks primarily at the transcription termination site 
but also associates to a lesser extent at the transcription start site, independent 
on transcription rate and gene length [188]. Conversely, Rtr1 occupancy peaks 
during mid-to-late elongation during the Ser5-P to Ser2-P transition [8]. Taken 
together, these data support a working model in which Ssu72-mediated gene-
looping promotes RNAPII transcription directionality [218].  
 Conversely, our data shows that loss of Rtr1 has a much larger effect on 
antisense noncoding transcripts that occur within the gene body of a protein-
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coding gene. It is evident that noncoding transcripts originating from within a 
gene body or from a bidirectional promoter are regulated by different 
mechanisms. As mentioned previously, degradation of many noncoding 
transcripts from within a gene require Rrp6 activity whereas transcripts 
originating from a bidirectional promoter can be degraded by the core exosome 
and do not require Rrp6 [243]. The work described here does not address 
whether or not regulation of antisense transcripts is dependent on the 
phosphatase activity of Rtr1, but the discovery that the loss of Rtr1 enhances 
Nrd1 and RNAPII interaction suggests that it may be.  
 Furthermore, we showed that loss of RTR1 has the opposite effect of Ssu72-
inactivation at previously studied transcripts such as IMD2 ([223] and Figure 34, 
35) and FMP40 [218]. As mentioned, IMD2 is regulated in part by an upstream 
noncoding RNA that is terminated by the NNS pathway. Our data indicate that 
NNS-dependent termination is more efficient at this non-coding transcript in the 
absence of RTR1 resulting in decreased expression of this upstream transcript 
and the IMD2 gene. However, Loya et al. found that an SSU72 mutant they 
termed Ssu72 TOV (Terminator Override) inhibited proper NNS-dependent 
termination at the IMD2 upstream transcript upon loss of Ssu72 activity [223]. 
Likewise, our data clearly show that NNS-dependent termination of the non-
coding transcript YPL222C-A is more efficient upon loss of RTR1, but tiling 
microarray data interrogating the effects of the Ssu72 temperature sensitive 
mutant ssu72-2 shows that this transcript is extended without proper Ssu72 
activity, indicating that RNAPII termination is inhibited [218]. At both of these 
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transcripts, NNS-dependent termination is found to require Ssu72 activity but be 
limited by the presence of Rtr1. 
A central question remains: how do these two Ser5 phosphatases confer 
their distinct effects on RNAPII CTD phosphorylation and gene transcription? 
There are at least three possibilities. First, Rtr1- and Ssu72-specific protein-
protein interactions may cause these distinct downstream effects. Second, Rtr1 
and Ssu72 may not target the exact same substrate. The combinatorial nature of 
post-translational modifications along the CTD may result in populations of Ser5 
repeats that are preferentially dephosphorylated by one or the other. For 
instance, it is known that Ssu72 prefers to dephosphorylate Ser5 that is in a cis-
Ser5-P-Pro6 confirmation, isomerized by the CTD factor Ess1 [63, 373, 374]. It is 
still unclear what form Rtr1 prefers. The third possibility is that both Rtr1 and 
Ssu72 have been found to have other targets along the CTD. Rtr1 can 
dephosphorylate Tyr1 [17], and Ssu72 can dephosphorylate Ser7 [188, 190]. 
Future structural and phosphatase activity studies focused on Rtr1 may elucidate 
how the targeting mechanisms of these enzymes differ and what, if any, effect 
they may have on the regulation of RNAPII transcription. 
 
8. Potential significance of Rbp3 ChIP-exo and Nrd1 PAR-CLIP overlap 
8.1. Implications for RNA binding proteins in transcription. 
 This study is the first to perform high-resolution ChIP-exo analysis on RNAPII. 
One benefit of the ChIP-exo technique is that we can detect peaks of RNAPII 
occupancy adjacent to Nrd1 RNA-binding sites previously reported using PAR-
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CLIP [50] (examples in Figures 16 and 21). We hypothesize that the RNAPII 
peaks are the result of paused polymerase in the undergoing NNS-dependent 
termination. The NRD1 gene is a particularly striking example (Figure 21). At 
NRD1, there are three distinguishable Nrd1 RNA-binding sites, and each RNA-
binding site is accompanied by a slightly offset peak of RNAPII. As discussed 
above, Nrd1 binds both the nascent RNA (via its RRM) and the RNAPII CTD (via 
its CID) [19, 45, 375]. Furthermore, Sen1 has been proposed to follow RNAPII 
along the transcribed region until Sen1 reached RNAPII triggering termination 
[51]. We propose that Nrd1 functions in NNS-dependent termination to anchor 
RNAPII to the nascent RNA near the termination site. The binding of Nrd1 to both 
the RNA and RNAPII may act to slow the transcribing polymerase at the required 
point of termination, allowing Sen1 to reach RNAPII, resulting in termination. 
 
8.2. Future Directions  
 Many questions remain regarding the mechanism of NNS-dependent termination. 
The model proposed above in which Nrd1 slows the transcribing polymerase to 
allow for transcription termination would be a major step forward in our 
understanding of NNS-dependent termination if shown to be true. In this model, 
we propose that S5-P and Nrd1-binding sites within the nascent RNA are 
sufficient to recruit Nrd1 and slow RNAPII. This hypothesis could be tested in 
vivo by adding Nrd1-binding sites to the yeast genome in a location where 
transcribing RNAPII would be phosphorylated at S5. We propose that embedding 
Nrd1-binding sites within a 5’-UTR of a highly transcribed gene would result in 
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recruitment of Nrd1 and pausing of RNAPII. These outcomes could be detected 
using ChIP-exo to measure the localization of Nrd1-TAP and Rpb3-FLAG as 
described in this thesis. 
 
8.3. Implications for strict NNS regulation by changing the expression 
level/nuclear localization of Rtr1 and the exosome 
 Many NNS-target transcripts, such as NRD1 contain multiple Nrd1-binding sites. 
Our data indicate that varying the abundance of proteins such as Rtr1 and Rrp6 
alters the efficiency with which NNS-dependent termination occurs. We could 
speculate that, by varying the rate at which Nrd1 slows RNAPII transcription at 
these redundant Nrd1-binding sites, the NNS-dependent termination pathway 
provides, not an on/off switch, but a rheostat serving to dial the efficiency of 
transcription termination up or down. This model may also help to describe some 
of the gene-specific effects we see regarding the role of Rtr1 and Rrp6 in NNS-
dependent termination. Perhaps, the NNS-dependent “rheostat” is more sensitive 
to perturbation at some genes than others, allowing for a wider range of genome-
wide effects from the regulation of NNS-dependent termination. 
  
 187 
REFERENCES 
 
1. Buratowski S: Progression through the RNA polymerase II CTD cycle. 
Mol Cell 2009, 36(4):541-546. 
2. Bataille AR, Jeronimo C, Jacques PE, Laramee L, Fortin ME, Forest A, 
Bergeron M, Hanes SD, Robert F: A universal RNA polymerase II CTD 
cycle is orchestrated by complex interplays between kinase, 
phosphatase, and isomerase enzymes along genes. Mol Cell 2012, 
45(2):158-170. 
3. Mayer A, Lidschreiber M, Siebert M, Leike K, Soding J, Cramer P: 
Uniform transitions of the general RNA polymerase II transcription 
complex. Nat Struct Mol Biol 2010, 17(10):1272-1278. 
4. Gudipati RK, Villa T, Boulay J, Libri D: Phosphorylation of the RNA 
polymerase II C-terminal domain dictates transcription termination 
choice. Nat Struct Mol Biol 2008, 15(8):786-794. 
5. Wong KH, Jin Y, Struhl K: TFIIH phosphorylation of the Pol II CTD 
stimulates mediator dissociation from the preinitiation complex and 
promoter escape. Mol Cell 2014, 54(4):601-612. 
6. Akhtar MS, Heidemann M, Tietjen JR, Zhang DW, Chapman RD, Eick D, 
Ansari AZ: TFIIH kinase places bivalent marks on the carboxy-
terminal domain of RNA polymerase II. Mol Cell 2009, 34(3):387-393. 
7. Valay JG, Simon M, Dubois MF, Bensaude O, Facca C, Faye G: The 
KIN28 gene is required both for RNA polymerase II mediated 
 188 
transcription and phosphorylation of the Rpb1p CTD. J Mol Biol 1995, 
249(3):535-544. 
8. Mosley AL, Pattenden SG, Carey M, Venkatesh S, Gilmore JM, Florens L, 
Workman JL, Washburn MP: Rtr1 is a CTD phosphatase that regulates 
RNA polymerase II during the transition from serine 5 to serine 2 
phosphorylation. Mol Cell 2009, 34(2):168-178. 
9. Smith-Kinnaman WR, Berna MJ, Hunter GO, True JD, Hsu P, Cabello GI, 
Fox MJ, Varani G, Mosley AL: The interactome of the atypical 
phosphatase Rtr1 in Saccharomyces cerevisiae. Mol Biosyst 2014, 
10(7):1730-1741. 
10. Patturajan M, Conrad NK, Bregman DB, Corden JL: Yeast carboxyl-
terminal domain kinase I positively and negatively regulates RNA 
polymerase II carboxyl-terminal domain phosphorylation. J Biol Chem 
1999, 274(39):27823-27828. 
11. Tietjen JR, Zhang DW, Rodriguez-Molina JB, White BE, Akhtar MS, 
Heidemann M, Li X, Chapman RD, Shokat K, Keles S et al: Chemical-
genomic dissection of the CTD code. Nat Struct Mol Biol 2010, 
17(9):1154-1161. 
12. Xiang K, Nagaike T, Xiang S, Kilic T, Beh MM, Manley JL, Tong L: Crystal 
structure of the human symplekin-Ssu72-CTD phosphopeptide 
complex. Nature 2010, 467(7316):729-733. 
13. Mayer A, Heidemann M, Lidschreiber M, Schreieck A, Sun M, Hintermair 
C, Kremmer E, Eick D, Cramer P: CTD tyrosine phosphorylation 
 189 
impairs termination factor recruitment to RNA polymerase II. Science 
2012, 336(6089):1723-1725. 
14. Schreieck A, Easter AD, Etzold S, Wiederhold K, Lidschreiber M, Cramer 
P, Passmore LA: RNA polymerase II termination involves C-terminal-
domain tyrosine dephosphorylation by CPF subunit Glc7. Nat Struct 
Mol Biol 2014, 21(2):175-179. 
15. Nedea E, He X, Kim M, Pootoolal J, Zhong G, Canadien V, Hughes T, 
Buratowski S, Moore CL, Greenblatt J: Organization and function of 
APT, a subcomplex of the yeast cleavage and polyadenylation factor 
involved in the formation of mRNA and small nucleolar RNA 3'-ends. 
J Biol Chem 2003, 278(35):33000-33010. 
16. Nedea E, Nalbant D, Xia D, Theoharis NT, Suter B, Richardson CJ, 
Tatchell K, Kislinger T, Greenblatt JF, Nagy PL: The Glc7 phosphatase 
subunit of the cleavage and polyadenylation factor is essential for 
transcription termination on snoRNA genes. Mol Cell 2008, 29(5):577-
587. 
17. Hsu PL, Yang F, Smith-Kinnaman W, Yang W, Song JE, Mosley AL, 
Varani G: Rtr1 is a dual specificity phosphatase that 
dephosphorylates Tyr1 and Ser5 on the RNA polymerase II CTD. J 
Mol Biol 2014, 426(16):2970-2981. 
18. Rondon AGM, Hannah E.; Proudfoot, Nick J.: Terminating Transcription 
in Yeast: whether to be a 'nerd' or a 'rat'. Nat Struct Mol Biol 2008, 
15(8):775-776. 
 190 
19. Vasiljeva L, Kim M, Mutschler H, Buratowski S, Meinhart A: The Nrd1-
Nab3-Sen1 termination complex interacts with the Ser5-
phosphorylated RNA polymerase II C-terminal domain. Nat Struct Mol 
Biol 2008, 15(8):795-804. 
20. Kim M, Vasiljeva L, Rando OJ, Zhelkovsky A, Moore C, Buratowski S: 
Distinct pathways for snoRNA and mRNA termination. Mol Cell 2006, 
24(5):723-734. 
21. Kuehner JN, Pearson EL, Moore C: Unravelling the means to an end: 
RNA polymerase II transcription termination. Nat Rev Mol Cell Biol 
2011, 12(5):283-294. 
22. Kyburz A, Sadowski M, Dichtl B, Keller W: The role of the yeast 
cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-
mRNA 3'-end formation. Nucleic Acids Res 2003, 31(14):3936-3945. 
23. Ezeokonkwo C, Zhelkovsky A, Lee R, Bohm A, Moore CL: A flexible 
linker region in Fip1 is needed for efficient mRNA polyadenylation. 
Rna 2011, 17(4):652-664. 
24. Vo LT, Minet M, Schmitter JM, Lacroute F, Wyers F: Mpe1, a zinc 
knuckle protein, is an essential component of yeast cleavage and 
polyadenylation factor required for the cleavage and polyadenylation 
of mRNA. Mol Cell Biol 2001, 21(24):8346-8356. 
25. Danckwardt SH, Matthias W.; Kulozik, Andreas: 3' end mRNA 
processing; molecular mechanisms and implications for health and 
disease. Embo J 2008, 27:482-498. 
 191 
26. Ohnacker M BS, Preker PJ, Keller W.: The WD-repeat protein pfs2p 
bridges two essential factors within the yeast pre-mRNA 3'-end-
processing complex. Embo J 2000, 19(1):37-47. 
27. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, 
Pelegrin A, Bourgaux JF, Pannequin J, Joubert D et al: Symplekin 
promotes tumorigenicity by up-regulating claudin-2 expression. Proc 
Natl Acad Sci U S A 2010, 107(6):2628-2633. 
28. Das BG, Zijian; Russo, Patrick; Chartrand, Pascal; Sherman, Fred: The 
role of nuclear cap binding protein Cdc1p of yeast in mRNA 
termination and degradation. Mol Cell Biol 2000, 20(8):2827-2838. 
29. Holbein S, Scola S, Loll B, Dichtl BS, Hubner W, Meinhart A, Dichtl B: The 
P-loop domain of yeast Clp1 mediates interactions between CF IA 
and CPF factors in pre-mRNA 3' end formation. PLoS One 2011, 
6(12):e29139. 
30. Kim M, Krogan NJ, Vasiljeva L, Rando OJ, Nedea E, Greenblatt JF, 
Buratowski S: The yeast Rat1 exonuclease promotes transcription 
termination by RNA polymerase II. Nature 2004, 432(7016):517-522. 
31. Zhao J, Kessler M, Helmling S, O'Connor JP, Moore C: Pta1, a 
component of yeast CF II, is required for both cleavage and poly(A) 
addition of mRNA precursor. Mol Cell Biol 1999, 19(11):7733-7740. 
32. Lunde BM, Reichow SL, Kim M, Suh H, Leeper TC, Yang F, Mutschler H, 
Buratowski S, Meinhart A, Varani G: Cooperative interaction of 
 192 
transcription termination factors with the RNA polymerase II C-
terminal domain. Nat Struct Mol Biol 2010, 17(10):1195-1201. 
33. Xiang K, Tong L, Manley JL: Delineating the structural blueprint of the 
pre-mRNA 3'-end processing machinery. Mol Cell Biol 2014, 
34(11):1894-1910. 
34. Gromak N, West S, Proudfoot NJ: Pause sites promote transcriptional 
termination of mammalian RNA polymerase II. Mol Cell Biol 2006, 
26(10):3986-3996. 
35. Glover-Cutter K, Kim S, Espinosa J, Bentley DL: RNA polymerase II 
pauses and associates with pre-mRNA processing factors at both 
ends of genes. Nat Struct Mol Biol 2008, 15(1):71-78. 
36. Anderson JT: RNA turnover: unexpected consequences of being 
tailed. Curr Biol 2005, 15(16):R635-638. 
37. Nag A, Narsinh K, Martinson HG: The poly(A)-dependent 
transcriptional pause is mediated by CPSF acting on the body of the 
polymerase. Nat Struct Mol Biol 2007, 14(7):662-669. 
38. Proudfoot N: New perspectives on connecting messenger RNA 3' end 
formation to transcription. Current opinion in cell biology 2004, 
16(3):272-278. 
39. Buratowski S: Connections between mRNA 3' end processing and 
transcription termination. Current opinion in cell biology 2005, 
17(3):257-261. 
 193 
40. Carroll KL, Ghirlando R, Ames JM, Corden JL: Interaction of yeast RNA-
binding proteins Nrd1 and Nab3 with RNA polymerase II terminator 
elements. Rna 2007, 13(3):361-373. 
41. Arigo JT, Eyler DE, Carroll KL, Corden JL: Termination of cryptic 
unstable transcripts is directed by yeast RNA-binding proteins Nrd1 
and Nab3. Mol Cell 2006, 23(6):841-851. 
42. Carroll KL, Pradhan DA, Granek JA, Clarke ND, Corden JL: Identification 
of cis elements directing termination of yeast nonpolyadenylated 
snoRNA transcripts. Mol Cell Biol 2004, 24(14):6241-6252. 
43. Steinmetz EJ, Conrad NK, Brow DA, Corden JL: RNA-binding protein 
Nrd1 directs poly(A)-independent 3'-end formation of RNA 
polymerase II transcripts. Nature 2001, 413(6853):327-331. 
44. Webb S, Hector, R.D., Kudla, G., Granneman, S.: PAR-CLIP data 
indicate that Nrd1-Nab3-dependent transcription termination 
regulates expression of hundreds of protein coding genes in yeast. 
Genome Biol 2014, 15(1):R8. 
45. Heo DH, Yoo I, Kong J, Lidschreiber M, Mayer A, Choi BY, Hahn Y, 
Cramer P, Buratowski S, Kim M: The RNA polymerase II C-terminal 
domain-interacting domain of yeast Nrd1 contributes to the choice of 
termination pathway and couples to RNA processing by the nuclear 
exosome. J Biol Chem 2013, 288(51):36676-36690. 
 194 
46. Meinhart A, Cramer P: Recognition of RNA polymerase II carboxy-
terminal domain by 3'-RNA-processing factors. Nature 2004, 
430(6996):223-226. 
47. Vasiljeva L, Kim M, Terzi N, Soares LM, Buratowski S: Transcription 
termination and RNA degradation contribute to silencing of RNA 
polymerase II transcription within heterochromatin. Mol Cell 2008, 
29(3):313-323. 
48. Conrad NK, Wilson SM, Steinmetz EJ, Patturajan M, Brow DA, Swanson 
MS, Corden JL: A yeast heterogeneous nuclear ribonucleoprotein 
complex associated with RNA polymerase II. Genetics 2000, 
154(2):557-571. 
49. Jamonnak N, Creamer TJ, Darby MM, Schaughency P, Wheelan SJ, 
Corden JL: Yeast Nrd1, Nab3, and Sen1 transcriptome-wide binding 
maps suggest multiple roles in post-transcriptional RNA processing. 
Rna 2011, 17(11):2011-2025. 
50. Creamer TJ, Darby MM, Jamonnak N, Schaughency P, Hao H, Wheelan 
SJ, Corden JL: Transcriptome-wide binding sites for components of 
the Saccharomyces cerevisiae non-poly(A) termination pathway: 
Nrd1, Nab3, and Sen1. PLoS Genet 2011, 7(10):e1002329. 
51. Hazelbaker DZ, Marquardt S, Wlotzka W, Buratowski S: Kinetic 
competition between RNA Polymerase II and Sen1-dependent 
transcription termination. Mol Cell 2013, 49(1):55-66. 
52. Brow DA: Sen-sing RNA terminators. Mol Cell 2011, 42(6):717-718. 
 195 
53. Steinmetz EJ, Warren CL, Kuehner JN, Panbehi B, Ansari AZ, Brow DA: 
Genome-wide distribution of yeast RNA polymerase II and its control 
by Sen1 helicase. Mol Cell 2006, 24(5):735-746. 
54. Skourti-Stathaki K, Proudfoot NJ, Gromak N: Human senataxin resolves 
RNA/DNA hybrids formed at transcriptional pause sites to promote 
Xrn2-dependent termination. Mol Cell 2011, 42(6):794-805. 
55. Porrua O, Libri D: A bacterial-like mechanism for transcription 
termination by the Sen1p helicase in budding yeast. Nat Struct Mol 
Biol 2013, 20(7):884-891. 
56. Honorine R, Mosrin-Huaman C, Hervouet-Coste N, Libri D, Rahmouni AR: 
Nuclear mRNA quality control in yeast is mediated by Nrd1 co-
transcriptional recruitment, as revealed by the targeting of Rho-
induced aberrant transcripts. Nucleic Acids Res 2011, 39(7):2809-2820. 
57. Lykke-Andersen S, Jensen TH: Overlapping pathways dictate 
termination of RNA polymerase II transcription. Biochimie 2007, 
89(10):1177-1182. 
58. Grzechnik P, Kufel J: Polyadenylation linked to transcription 
termination directs the processing of snoRNA precursors in yeast. 
Mol Cell 2008, 32(2):247-258. 
59. Stuparevic I, Mosrin-Huaman C, Hervouet-Coste N, Remenaric M, 
Rahmouni AR: Cotranscriptional recruitment of RNA exosome 
cofactors Rrp47p and Mpp6p and two distinct Trf-Air-Mtr4 
polyadenylation (TRAMP) complexes assists the exonuclease Rrp6p 
 196 
in the targeting and degradation of an aberrant messenger 
ribonucleoprotein particle (mRNP) in yeast. J Biol Chem 2013, 
288(44):31816-31829. 
60. Wlotzka W, Kudla G, Granneman S, Tollervey D: The nuclear RNA 
polymerase II surveillance system targets polymerase III transcripts. 
Embo J 2011, 30(9):1790-1803. 
61. Tudek A, Porrua O, Kabzinski T, Lidschreiber M, Kubicek K, Fortova A, 
Lacroute F, Vanacova S, Cramer P, Stefl R et al: Molecular basis for 
coordinating transcription termination with noncoding RNA 
degradation. Mol Cell 2014, 55(3):467-481. 
62. Grzechnik P, Gdula MR, Proudfoot NJ: Pcf11 orchestrates transcription 
termination pathways in yeast. Genes Dev 2015, 29(8):849-861. 
63. Singh N, Ma Z, Gemmill T, Wu X, Defiglio H, Rossettini A, Rabeler C, 
Beane O, Morse RH, Palumbo MJ et al: The Ess1 prolyl isomerase is 
required for transcription termination of small noncoding RNAs via 
the Nrd1 pathway. Mol Cell 2009, 36(2):255-266. 
64. Mitchell P, Petfalski E, Shevchenko A, Mann M, Tollervey D: The 
exosome: a conserved eukaryotic RNA processing complex 
containing multiple 3'-->5' exoribonucleases. Cell 1997, 91(4):457-466. 
65. Bonneau F, Basquin J, Ebert J, Lorentzen E, Conti E: The yeast 
exosome functions as a macromolecular cage to channel RNA 
substrates for degradation. Cell 2009, 139(3):547-559. 
 197 
66. Schneider C, Tollervey D: Threading the barrel of the RNA exosome. 
Trends Biochem Sci 2013, 38(10):485-493. 
67. Makino DL, Baumgartner M, Conti E: Crystal structure of an RNA-
bound 11-subunit eukaryotic exosome complex. Nature 2013, 
495(7439):70-75. 
68. Makino DL, Halbach F, Conti E: The RNA exosome and proteasome: 
common principles of degradation control. Nat Rev Mol Cell Biol 2013, 
14(10):654-660. 
69. van Dijk EL, Schilders G, Pruijn GJ: Human cell growth requires a 
functional cytoplasmic exosome, which is involved in various mRNA 
decay pathways. Rna 2007, 13(7):1027-1035. 
70. Vasiljeva L, Buratowski S: Nrd1 interacts with the nuclear exosome for 
3' processing of RNA polymerase II transcripts. Mol Cell 2006, 
21(2):239-248. 
71. Wyers F, Rougemaille M, Badis G, Rousselle JC, Dufour ME, Boulay J, 
Regnault B, Devaux F, Namane A, Seraphin B et al: Cryptic pol II 
transcripts are degraded by a nuclear quality control pathway 
involving a new poly(A) polymerase. Cell 2005, 121(5):725-737. 
72. Neil H, Malabat C, d'Aubenton-Carafa Y, Xu Z, Steinmetz LM, Jacquier A: 
Widespread bidirectional promoters are the major source of cryptic 
transcripts in yeast. Nature 2009, 457(7232):1038-1042. 
73. Xu Z, Wei W, Gagneur J, Perocchi F, Clauder-Munster S, Camblong J, 
Guffanti E, Stutz F, Huber W, Steinmetz LM: Bidirectional promoters 
 198 
generate pervasive transcription in yeast. Nature 2009, 
457(7232):1033-1037. 
74. Porrua O, Hobor F, Boulay J, Kubicek K, D'Aubenton-Carafa Y, Gudipati 
RK, Stefl R, Libri D: In vivo SELEX reveals novel sequence and 
structural determinants of Nrd1-Nab3-Sen1-dependent transcription 
termination. Embo J 2012, 31(19):3935-3948. 
75. Davis CA, Ares M, Jr.: Accumulation of unstable promoter-associated 
transcripts upon loss of the nuclear exosome subunit Rrp6p in 
Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 2006, 
103(9):3262-3267. 
76. Dichtl B, Blank D, Ohnacker M, Friedlein A, Roeder D, Langen H, Keller 
W: A role for SSU72 in balancing RNA polymerase II transcription 
elongation and termination. Mol Cell 2002, 10(5):1139-1150. 
77. Schmid M, Poulsen MB, Olszewski P, Pelechano V, Saguez C, Gupta I, 
Steinmetz LM, Moore C, Jensen TH: Rrp6p controls mRNA poly(A) tail 
length and its decoration with poly(A) binding proteins. Mol Cell 2012, 
47(2):267-280. 
78. Grenier St-Sauveur V, Soucek S, Corbett AH, Bachand F: Poly(A) tail-
mediated gene regulation by opposing roles of Nab2 and Pab2 
nuclear poly(A)-binding proteins in pre-mRNA decay. Mol Cell Biol 
2013, 33(23):4718-4731. 
 199 
79. Gudipati RK, Xu Z, Lebreton A, Seraphin B, Steinmetz LM, Jacquier A, 
Libri D: Extensive degradation of RNA precursors by the exosome in 
wild-type cells. Mol Cell 2012, 48(3):409-421. 
80. Schneider C, Kudla G, Wlotzka W, Tuck A, Tollervey D: Transcriptome-
wide analysis of exosome targets. Mol Cell 2012, 48(3):422-433. 
81. Lardenois A, Liu Y, Walther T, Chalmel F, Evrard B, Granovskaia M, Chu 
A, Davis RW, Steinmetz LM, Primig M: Execution of the meiotic 
noncoding RNA expression program and the onset of 
gametogenesis in yeast require the conserved exosome subunit 
Rrp6. Proc Natl Acad Sci U S A 2011, 108(3):1058-1063. 
82. Frenk S, Oxley D, Houseley J: The nuclear exosome is active and 
important during budding yeast meiosis. PLoS One 2014, 
9(9):e107648. 
83. Brouwer R, Pruijn GJ, van Venrooij WJ: The human exosome: an 
autoantigenic complex of exoribonucleases in myositis and 
scleroderma. Arthritis Res 2001, 3(2):102-106. 
84. Wan J, Yourshaw M, Mamsa H, Rudnik-Schoneborn S, Menezes MP, 
Hong JE, Leong DW, Senderek J, Salman MS, Chitayat D et al: 
Mutations in the RNA exosome component gene EXOSC3 cause 
pontocerebellar hypoplasia and spinal motor neuron degeneration. 
Nat Genet 2012, 44(6):704-708. 
85. Boczonadi V, Muller JS, Pyle A, Munkley J, Dor T, Quartararo J, Ferrero I, 
Karcagi V, Giunta M, Polvikoski T et al: EXOSC8 mutations alter mRNA 
 200 
metabolism and cause hypomyelination with spinal muscular 
atrophy and cerebellar hypoplasia. Nat Commun 2014, 5:4287. 
86. Richard P, Feng S, Manley JL: A SUMO-dependent interaction between 
Senataxin and the exosome, disrupted in the neurodegenerative 
disease AOA2, targets the exosome to sites of transcription-induced 
DNA damage. Genes Dev 2013, 27(20):2227-2232. 
87. Dziembowski A, Lorentzen E, Conti E, Seraphin B: A single subunit, 
Dis3, is essentially responsible for yeast exosome core activity. Nat 
Struct Mol Biol 2007, 14(1):15-22. 
88. Lorentzen E, Walter P, Fribourg S, Evguenieva-Hackenberg E, Klug G, 
Conti E: The archaeal exosome core is a hexameric ring structure 
with three catalytic subunits. Nat Struct Mol Biol 2005, 12(7):575-581. 
89. Buttner K, Wenig K, Hopfner KP: Structural framework for the 
mechanism of archaeal exosomes in RNA processing. Mol Cell 2005, 
20(3):461-471. 
90. Liu Q, Greimann JC, Lima CD: Reconstitution, activities, and structure 
of the eukaryotic RNA exosome. Cell 2006, 127(6):1223-1237. 
91. Schaeffer D, Tsanova B, Barbas A, Reis FP, Dastidar EG, Sanchez-
Rotunno M, Arraiano CM, van Hoof A: The exosome contains domains 
with specific endoribonuclease, exoribonuclease and cytoplasmic 
mRNA decay activities. Nat Struct Mol Biol 2009, 16(1):56-62. 
92. Wang HW, Wang J, Ding F, Callahan K, Bratkowski MA, Butler JS, 
Nogales E, Ke A: Architecture of the yeast Rrp44 exosome complex 
 201 
suggests routes of RNA recruitment for 3' end processing. Proc Natl 
Acad Sci U S A 2007, 104(43):16844-16849. 
93. Malet H, Topf M, Clare DK, Ebert J, Bonneau F, Basquin J, Drazkowska 
K, Tomecki R, Dziembowski A, Conti E et al: RNA channelling by the 
eukaryotic exosome. EMBO Rep 2010, 11(12):936-942. 
94. Staals RH, Bronkhorst AW, Schilders G, Slomovic S, Schuster G, Heck 
AJ, Raijmakers R, Pruijn GJ: Dis3-like 1: a novel exoribonuclease 
associated with the human exosome. Embo J 2010, 29(14):2358-2367. 
95. Tomecki R, Kristiansen MS, Lykke-Andersen S, Chlebowski A, Larsen 
KM, Szczesny RJ, Drazkowska K, Pastula A, Andersen JS, Stepien PP et 
al: The human core exosome interacts with differentially localized 
processive RNases: hDIS3 and hDIS3L. Embo J 2010, 29(14):2342-
2357. 
96. Briggs MW, Burkard KT, Butler JS: Rrp6p, the yeast homologue of the 
human PM-Scl 100-kDa autoantigen, is essential for efficient 5.8 S 
rRNA 3' end formation. J Biol Chem 1998, 273(21):13255-13263. 
97. Mitchell P, Petfalski E, Houalla R, Podtelejnikov A, Mann M, Tollervey D: 
Rrp47p is an exosome-associated protein required for the 3' 
processing of stable RNAs. Mol Cell Biol 2003, 23(19):6982-6992. 
98. Alderuccio F, Chan EK, Tan EM: Molecular characterization of an 
autoantigen of PM-Scl in the polymyositis/scleroderma overlap 
syndrome: a unique and complete human cDNA encoding an 
 202 
apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 
1991, 173(4):941-952. 
99. Bluthner M, Bautz FA: Cloning and characterization of the cDNA 
coding for a polymyositis-scleroderma overlap syndrome-related 
nucleolar 100-kD protein. J Exp Med 1992, 176(4):973-980. 
100. Ge Q, Frank MB, O'Brien C, Targoff IN: Cloning of a complementary 
DNA coding for the 100-kD antigenic protein of the PM-Scl 
autoantigen. J Clin Invest 1992, 90(2):559-570. 
101. Yang XF, Wu CJ, Chen L, Alyea EP, Canning C, Kantoff P, Soiffer RJ, 
Dranoff G, Ritz J: CML28 is a broadly immunogenic antigen, which is 
overexpressed in tumor cells. Cancer Res 2002, 62(19):5517-5522. 
102. Eggens VR, Barth PG, Niermeijer JM, Berg JN, Darin N, Dixit A, Fluss J, 
Foulds N, Fowler D, Hortobagyi T et al: EXOSC3 mutations in 
pontocerebellar hypoplasia type 1: novel mutations and genotype-
phenotype correlations. Orphanet J Rare Dis 2014, 9:23. 
103. Weissbach S, Langer C, Puppe B, Nedeva T, Bach E, Kull M, Bargou R, 
Einsele H, Rosenwald A, Knop S et al: The molecular spectrum and 
clinical impact of DIS3 mutations in multiple myeloma. Br J Haematol 
2015, 169(1):57-70. 
104. Tomecki R, Drazkowska K, Kucinski I, Stodus K, Szczesny RJ, Gruchota 
J, Owczarek EP, Kalisiak K, Dziembowski A: Multiple myeloma-
associated hDIS3 mutations cause perturbations in cellular RNA 
 203 
metabolism and suggest hDIS3 PIN domain as a potential drug 
target. Nucleic Acids Res 2014, 42(2):1270-1290. 
105. Morris MR, Astuti D, Maher ER: Perlman syndrome: overgrowth, Wilms 
tumor predisposition and DIS3L2. Am J Med Genet C Semin Med 
Genet 2013, 163C(2):106-113. 
106. Schilders G, Egberts WV, Raijmakers R, Pruijn GJ: C1D is a major 
autoantibody target in patients with the polymyositis-scleroderma 
overlap syndrome. Arthritis Rheum 2007, 56(7):2449-2454. 
107. Noguchi E, Hayashi N, Azuma Y, Seki T, Nakamura M, Nakashima N, 
Yanagida M, He X, Mueller U, Sazer S et al: Dis3, implicated in mitotic 
control, binds directly to Ran and enhances the GEF activity of 
RCC1. Embo J 1996, 15(20):5595-5605. 
108. Allmang C, Petfalski E, Podtelejnikov A, Mann M, Tollervey D, Mitchell P: 
The yeast exosome and human PM-Scl are related complexes of 3' --
> 5' exonucleases. Genes Dev 1999, 13(16):2148-2158. 
109. Wasmuth EV, Lima CD: Exo- and endoribonucleolytic activities of 
yeast cytoplasmic and nuclear RNA exosomes are dependent on the 
noncatalytic core and central channel. Mol Cell 2012, 48(1):133-144. 
110. Schneider C, Leung E, Brown J, Tollervey D: The N-terminal PIN domain 
of the exosome subunit Rrp44 harbors endonuclease activity and 
tethers Rrp44 to the yeast core exosome. Nucleic Acids Res 2009, 
37(4):1127-1140. 
 204 
111. Drazkowska K, Tomecki R, Stodus K, Kowalska K, Czarnocki-Cieciura M, 
Dziembowski A: The RNA exosome complex central channel controls 
both exonuclease and endonuclease Dis3 activities in vivo and in 
vitro. Nucleic Acids Res 2013, 41(6):3845-3858. 
112. Lebreton A, Tomecki R, Dziembowski A, Seraphin B: Endonucleolytic 
RNA cleavage by a eukaryotic exosome. Nature 2008, 456(7224):993-
996. 
113. Lorentzen E, Basquin J, Tomecki R, Dziembowski A, Conti E: Structure 
of the active subunit of the yeast exosome core, Rrp44: diverse 
modes of substrate recruitment in the RNase II nuclease family. Mol 
Cell 2008, 29(6):717-728. 
114. Liu JJ, Bratkowski MA, Liu X, Niu CY, Ke A, Wang HW: Visualization of 
distinct substrate-recruitment pathways in the yeast exosome by EM. 
Nat Struct Mol Biol 2014, 21(1):95-102. 
115. Yang W, Lee JY, Nowotny M: Making and breaking nucleic acids: two-
Mg2+-ion catalysis and substrate specificity. Mol Cell 2006, 22(1):5-
13. 
116. Callahan KP, Butler JS: Evidence for core exosome independent 
function of the nuclear exoribonuclease Rrp6p. Nucleic Acids Res 
2008, 36(21):6645-6655. 
117. Midtgaard SF, Assenholt J, Jonstrup AT, Van LB, Jensen TH, Brodersen 
DE: Structure of the nuclear exosome component Rrp6p reveals an 
 205 
interplay between the active site and the HRDC domain. Proc Natl 
Acad Sci U S A 2006, 103(32):11898-11903. 
118. Januszyk K, Liu Q, Lima CD: Activities of human RRP6 and structure 
of the human RRP6 catalytic domain. Rna 2011, 17(8):1566-1577. 
119. Wasmuth EV, Januszyk K, Lima CD: Structure of an Rrp6-RNA 
exosome complex bound to poly(A) RNA. Nature 2014, 511(7510):435-
439. 
120. Halbach F, Reichelt P, Rode M, Conti E: The yeast ski complex: crystal 
structure and RNA channeling to the exosome complex. Cell 2013, 
154(4):814-826. 
121. Schmidt K, Butler JS: Nuclear RNA surveillance: role of TRAMP in 
controlling exosome specificity. Wiley Interdiscip Rev RNA 2013, 
4(2):217-231. 
122. LaCava J, Houseley J, Saveanu C, Petfalski E, Thompson E, Jacquier A, 
Tollervey D: RNA degradation by the exosome is promoted by a 
nuclear polyadenylation complex. Cell 2005, 121(5):713-724. 
123. Callahan KP, Butler JS: TRAMP complex enhances RNA degradation 
by the nuclear exosome component Rrp6. J Biol Chem 2010, 
285(6):3540-3547. 
124. Kish-Trier E, Hill CP: Structural biology of the proteasome. Annu Rev 
Biophys 2013, 42:29-49. 
 206 
125. Burkard KT, Butler JS: A nuclear 3'-5' exonuclease involved in mRNA 
degradation interacts with Poly(A) polymerase and the hnRNA 
protein Npl3p. Mol Cell Biol 2000, 20(2):604-616. 
126. Stead JA, Costello JL, Livingstone MJ, Mitchell P: The PMC2NT domain 
of the catalytic exosome subunit Rrp6p provides the interface for 
binding with its cofactor Rrp47p, a nucleic acid-binding protein. 
Nucleic Acids Res 2007, 35(16):5556-5567. 
127. Feigenbutz M, Garland W, Turner M, Mitchell P: The exosome cofactor 
Rrp47 is critical for the stability and normal expression of its 
associated exoribonuclease Rrp6 in Saccharomyces cerevisiae. 
PLoS One 2013, 8(11):e80752. 
128. Garland W, Feigenbutz M, Turner M, Mitchell P: Rrp47 functions in RNA 
surveillance and stable RNA processing when divorced from the 
exoribonuclease and exosome-binding domains of Rrp6. Rna 2013, 
19(12):1659-1668. 
129. Feigenbutz M, Jones R, Besong TM, Harding SE, Mitchell P: Assembly 
of the yeast exoribonuclease Rrp6 with its associated cofactor Rrp47 
occurs in the nucleus and is critical for the controlled expression of 
Rrp47. J Biol Chem 2013, 288(22):15959-15970. 
130. Schuch B, Feigenbutz M, Makino DL, Falk S, Basquin C, Mitchell P, Conti 
E: The exosome-binding factors Rrp6 and Rrp47 form a composite 
surface for recruiting the Mtr4 helicase. Embo J 2014, 33(23):2829-
2846. 
 207 
131. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin 
G, Moroni C, Mann M, Karin M: AU binding proteins recruit the 
exosome to degrade ARE-containing mRNAs. Cell 2001, 107(4):451-
464. 
132. Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L, Westendorf JM: 
Identification of novel M phase phosphoproteins by expression 
cloning. Mol Biol Cell 1996, 7(9):1455-1469. 
133. Schilders G, Raijmakers R, Raats JM, Pruijn GJ: MPP6 is an exosome-
associated RNA-binding protein involved in 5.8S rRNA maturation. 
Nucleic Acids Res 2005, 33(21):6795-6804. 
134. Milligan L, Decourty L, Saveanu C, Rappsilber J, Ceulemans H, Jacquier 
A, Tollervey D: A yeast exosome cofactor, Mpp6, functions in RNA 
surveillance and in the degradation of noncoding RNA transcripts. 
Mol Cell Biol 2008, 28(17):5446-5457. 
135. de la Cruz J, Kressler D, Tollervey D, Linder P: Dob1p (Mtr4p) is a 
putative ATP-dependent RNA helicase required for the 3' end 
formation of 5.8S rRNA in Saccharomyces cerevisiae. Embo J 1998, 
17(4):1128-1140. 
136. Bernstein J, Patterson DN, Wilson GM, Toth EA: Characterization of the 
essential activities of Saccharomyces cerevisiae Mtr4p, a 3'->5' 
helicase partner of the nuclear exosome. J Biol Chem 2008, 
283(8):4930-4942. 
 208 
137. Jackson RN, Klauer AA, Hintze BJ, Robinson H, van Hoof A, Johnson SJ: 
The crystal structure of Mtr4 reveals a novel arch domain required 
for rRNA processing. Embo J 2010, 29(13):2205-2216. 
138. Weir JR, Bonneau F, Hentschel J, Conti E: Structural analysis reveals 
the characteristic features of Mtr4, a DExH helicase involved in 
nuclear RNA processing and surveillance. Proc Natl Acad Sci U S A 
2010, 107(27):12139-12144. 
139. Taylor LL, Jackson RN, Rexhepaj M, King AK, Lott LK, van Hoof A, 
Johnson SJ: The Mtr4 ratchet helix and arch domain both function to 
promote RNA unwinding. Nucleic Acids Res 2014, 42(22):13861-13872. 
140. Bernstein J, Ballin JD, Patterson DN, Wilson GM, Toth EA: Unique 
properties of the Mtr4p-poly(A) complex suggest a role in substrate 
targeting. Biochemistry 2010, 49(49):10357-10370. 
141. Vanacova S, Wolf J, Martin G, Blank D, Dettwiler S, Friedlein A, Langen 
H, Keith G, Keller W: A new yeast poly(A) polymerase complex 
involved in RNA quality control. PLoS Biol 2005, 3(6):e189. 
142. Kadaba S, Krueger A, Trice T, Krecic AM, Hinnebusch AG, Anderson J: 
Nuclear surveillance and degradation of hypomodified initiator 
tRNAMet in S. cerevisiae. Genes Dev 2004, 18(11):1227-1240. 
143. Wang X, Jia H, Jankowsky E, Anderson JT: Degradation of 
hypomodified tRNA(iMet) in vivo involves RNA-dependent ATPase 
activity of the DExH helicase Mtr4p. Rna 2008, 14(1):107-116. 
 209 
144. Jenks MH, Reines D: Dissection of the molecular basis of 
mycophenolate resistance in Saccharomyces cerevisiae. Yeast 2005, 
22(15):1181-1190. 
145. Steinmetz EJ, Ng SB, Cloute JP, Brow DA: cis- and trans-Acting 
determinants of transcription termination by yeast RNA polymerase 
II. Mol Cell Biol 2006, 26(7):2688-2696. 
146. Kopcewicz KA, O'Rourke TW, Reines D: Metabolic regulation of IMD2 
transcription and an unusual DNA element that generates short 
transcripts. Mol Cell Biol 2007, 27(8):2821-2829. 
147. Thiebaut M, Kisseleva-Romanova E, Rougemaille M, Boulay J, Libri D: 
Transcription termination and nuclear degradation of cryptic 
unstable transcripts: a role for the nrd1-nab3 pathway in genome 
surveillance. Mol Cell 2006, 23(6):853-864. 
148. Mosrin-Huaman C, Honorine R, Rahmouni AR: Expression of bacterial 
Rho factor in yeast identifies new factors involved in the functional 
interplay between transcription and mRNP biogenesis. Mol Cell Biol 
2009, 29(15):4033-4044. 
149. Fasken MB, Laribee RN, Corbett AH: Nab3 facilitates the function of 
the TRAMP complex in RNA processing via recruitment of Rrp6 
independent of Nrd1. PLoS Genet 2015, 11(3):e1005044. 
150. Wagschal A, Rousset E, Basavarajaiah P, Contreras X, Harwig A, 
Laurent-Chabalier S, Nakamura M, Chen X, Zhang K, Meziane O et al: 
Microprocessor, Setx, Xrn2, and Rrp6 co-operate to induce 
 210 
premature termination of transcription by RNAPII. Cell 2012, 
150(6):1147-1157. 
151. Macias S, Cordiner RA, Caceres JF: Cellular functions of the 
microprocessor. Biochem Soc Trans 2013, 41(4):838-843. 
152. Thiebaut M, Colin J, Neil H, Jacquier A, Seraphin B, Lacroute F, Libri D: 
Futile cycle of transcription initiation and termination modulates the 
response to nucleotide shortage in S. cerevisiae. Mol Cell 2008, 
31(5):671-682. 
153. Colin J, Libri D, Porrua O: Cryptic transcription and early termination 
in the control of gene expression. Genet Res Int 2011, 2011:653494. 
154. Mitchell P, Petfalski E, Tollervey D: The 3' end of yeast 5.8S rRNA is 
generated by an exonuclease processing mechanism. Genes Dev 
1996, 10(4):502-513. 
155. Schilders G, van Dijk E, Pruijn GJ: C1D and hMtr4p associate with the 
human exosome subunit PM/Scl-100 and are involved in pre-rRNA 
processing. Nucleic Acids Res 2007, 35(8):2564-2572. 
156. Allmang C, Mitchell P, Petfalski E, Tollervey D: Degradation of 
ribosomal RNA precursors by the exosome. Nucleic Acids Res 2000, 
28(8):1684-1691. 
157. Kadaba S, Wang X, Anderson JT: Nuclear RNA surveillance in 
Saccharomyces cerevisiae: Trf4p-dependent polyadenylation of 
nascent hypomethylated tRNA and an aberrant form of 5S rRNA. Rna 
2006, 12(3):508-521. 
 211 
158. Huang Y, Bayfield MA, Intine RV, Maraia RJ: Separate RNA-binding 
surfaces on the multifunctional La protein mediate distinguishable 
activities in tRNA maturation. Nat Struct Mol Biol 2006, 13(7):611-618. 
159. Schneider C, Anderson JT, Tollervey D: The exosome subunit Rrp44 
plays a direct role in RNA substrate recognition. Mol Cell 2007, 
27(2):324-331. 
160. Caffarelli E, Arese M, Santoro B, Fragapane P, Bozzoni I: In vitro study 
of processing of the intron-encoded U16 small nucleolar RNA in 
Xenopus laevis. Mol Cell Biol 1994, 14(5):2966-2974. 
161. Cecconi F, Mariottini P, Amaldi F: The Xenopus intron-encoded U17 
snoRNA is produced by exonucleolytic processing of its precursor in 
oocytes. Nucleic Acids Res 1995, 23(22):4670-4676. 
162. Cavaille J, Bachellerie JP: Processing of fibrillarin-associated 
snoRNAs from pre-mRNA introns: an exonucleolytic process 
exclusively directed by the common stem-box terminal structure. 
Biochimie 1996, 78(6):443-456. 
163. Larimer FW, Hsu CL, Maupin MK, Stevens A: Characterization of the 
XRN1 gene encoding a 5'-->3' exoribonuclease: sequence data and 
analysis of disparate protein and mRNA levels of gene-disrupted 
yeast cells. Gene 1992, 120(1):51-57. 
164. Petfalski E, Dandekar T, Henry Y, Tollervey D: Processing of the 
precursors to small nucleolar RNAs and rRNAs requires common 
components. Mol Cell Biol 1998, 18(3):1181-1189. 
 212 
165. Allmang C, Kufel J, Chanfreau G, Mitchell P, Petfalski E, Tollervey D: 
Functions of the exosome in rRNA, snoRNA and snRNA synthesis. 
Embo J 1999, 18(19):5399-5410. 
166. van Hoof A, Lennertz P, Parker R: Yeast exosome mutants accumulate 
3'-extended polyadenylated forms of U4 small nuclear RNA and small 
nucleolar RNAs. Mol Cell Biol 2000, 20(2):441-452. 
167. Lemay JF, D'Amours A, Lemieux C, Lackner DH, St-Sauveur VG, Bahler 
J, Bachand F: The nuclear poly(A)-binding protein interacts with the 
exosome to promote synthesis of noncoding small nucleolar RNAs. 
Mol Cell 2010, 37(1):34-45. 
168. Martens JA, Laprade L, Winston F: Intergenic transcription is required 
to repress the Saccharomyces cerevisiae SER3 gene. Nature 2004, 
429(6991):571-574. 
169. Martens JA, Wu PY, Winston F: Regulation of an intergenic transcript 
controls adjacent gene transcription in Saccharomyces cerevisiae. 
Genes Dev 2005, 19(22):2695-2704. 
170. Kuehner JN, Brow DA: Regulation of a eukaryotic gene by GTP-
dependent start site selection and transcription attenuation. Mol Cell 
2008, 31(2):201-211. 
171. Arigo JT, Carroll KL, Ames JM, Corden JL: Regulation of yeast NRD1 
expression by premature transcription termination. Mol Cell 2006, 
21(5):641-651. 
 213 
172. Pefanis E, Wang J, Rothschild G, Lim J, Kazadi D, Sun J, Federation A, 
Chao J, Elliott O, Liu ZP et al: RNA exosome-regulated long non-
coding RNA transcription controls super-enhancer activity. Cell 2015, 
161(4):774-789. 
173. Wang KC, Chang HY: Molecular mechanisms of long noncoding 
RNAs. Mol Cell 2011, 43(6):904-914. 
174. Wilusz JE, Sunwoo H, Spector DL: Long noncoding RNAs: functional 
surprises from the RNA world. Genes Dev 2009, 23(13):1494-1504. 
175. Nagano T, Fraser P: No-nonsense functions for long noncoding 
RNAs. Cell 2011, 145(2):178-181. 
176. Berretta J, Morillon A: Pervasive transcription constitutes a new level 
of eukaryotic genome regulation. EMBO Rep 2009, 10(9):973-982. 
177. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk 
O, Carey BW, Cassady JP et al: Chromatin signature reveals over a 
thousand highly conserved large non-coding RNAs in mammals. 
Nature 2009, 458(7235):223-227. 
178. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, 
Thomas K, Presser A, Bernstein BE, van Oudenaarden A et al: Many 
human large intergenic noncoding RNAs associate with chromatin-
modifying complexes and affect gene expression. Proc Natl Acad Sci 
U S A 2009, 106(28):11667-11672. 
 214 
179. Galipon J, Miki A, Oda A, Inada T, Ohta K: Stress-induced lncRNAs 
evade nuclear degradation and enter the translational machinery. 
Genes Cells 2013, 18(5):353-368. 
180. Geisler S, Lojek L, Khalil AM, Baker KE, Coller J: Decapping of long 
noncoding RNAs regulates inducible genes. Mol Cell 2012, 45(3):279-
291. 
181. Kim M, Suh H, Cho EJ, Buratowski S: Phosphorylation of the yeast 
Rpb1 C-terminal domain at serines 2, 5, and 7. J Biol Chem 2009, 
284(39):26421-26426. 
182. Rosado-Lugo JD, Hampsey M: The Ssu72 phosphatase mediates the 
RNA polymerase II initiation-elongation transition. J Biol Chem 2014, 
289(49):33916-33926. 
183. Egloff S, Zaborowska J, Laitem C, Kiss T, Murphy S: Ser7 
phosphorylation of the CTD recruits the RPAP2 Ser5 phosphatase to 
snRNA genes. Mol Cell 2012, 45(1):111-122. 
184. Ni Z, Xu C, Guo X, Hunter GO, Kuznetsova OV, Tempel W, Marcon E, 
Zhong G, Guo H, Kuo WH et al: RPRD1A and RPRD1B are human RNA 
polymerase II C-terminal domain scaffolds for Ser5 
dephosphorylation. Nat Struct Mol Biol 2014, 21(8):686-695. 
185. Gibney PA, Fries T, Bailer SM, Morano KA: Rtr1 is the Saccharomyces 
cerevisiae homolog of a novel family of RNA polymerase II-binding 
proteins. Eukaryot Cell 2008, 7(6):938-948. 
 215 
186. Ni Z, Olsen JB, Guo X, Zhong G, Ruan ED, Marcon E, Young P, Guo H, Li 
J, Moffat J et al: Control of the RNA polymerase II phosphorylation 
state in promoter regions by CTD interaction domain-containing 
proteins RPRD1A and RPRD1B. Transcription 2011, 2(5):237-242. 
187. Xiang K, Manley JL, Tong L: The yeast regulator of transcription 
protein Rtr1 lacks an active site and phosphatase activity. Nat 
Commun 2012, 3:946. 
188. Zhang DW, Mosley AL, Ramisetty SR, Rodriguez-Molina JB, Washburn 
MP, Ansari AZ: Ssu72 phosphatase-dependent erasure of phospho-
Ser7 marks on the RNA polymerase II C-terminal domain is essential 
for viability and transcription termination. J Biol Chem 2012, 
287(11):8541-8551. 
189. Krishnamurthy S, He X, Reyes-Reyes M, Moore C, Hampsey M: Ssu72 Is 
an RNA polymerase II CTD phosphatase. Mol Cell 2004, 14(3):387-394. 
190. Xiang K, Manley JL, Tong L: An unexpected binding mode for a Pol II 
CTD peptide phosphorylated at Ser7 in the active site of the CTD 
phosphatase Ssu72. Genes Dev 2012, 26(20):2265-2270. 
191. Wani S, Yuda M, Fujiwara Y, Yamamoto M, Harada F, Ohkuma Y, Hirose 
Y: Vertebrate Ssu72 regulates and coordinates 3'-end formation of 
RNAs transcribed by RNA polymerase II. PLoS One 2014, 
9(8):e106040. 
 216 
192. Schwer B, Sanchez AM, Shuman S: Punctuation and syntax of the 
RNA polymerase II CTD code in fission yeast. Proc Natl Acad Sci U S 
A 2012, 109(44):18024-18029. 
193. Steinmetz EJ, Brow DA: Ssu72 protein mediates both poly(A)-coupled 
and poly(A)-independent termination of RNA polymerase II 
transcription. Mol Cell Biol 2003, 23(18):6339-6349. 
194. Ghazy MA, He X, Singh BN, Hampsey M, Moore C: The essential N 
terminus of the Pta1 scaffold protein is required for snoRNA 
transcription termination and Ssu72 function but is dispensable for 
pre-mRNA 3'-end processing. Mol Cell Biol 2009, 29(8):2296-2307. 
195. Luo Y, Yogesha SD, Cannon JR, Yan W, Ellington AD, Brodbelt JS, 
Zhang Y: Novel Modifications on C-terminal Domain of RNA 
Polymerase II Can Fine-tune the Phosphatase Activity of Ssu72. ACS 
Chem Biol 2013, 8(9):2042-2052. 
196. Allepuz-Fuster P, Martinez-Fernandez V, Garrido-Godino AI, Alonso-
Aguado S, Hanes SD, Navarro F, Calvo O: Rpb4/7 facilitates RNA 
polymerase II CTD dephosphorylation. Nucleic Acids Res 2014, 
42(22):13674-13688. 
197. Mosley AL HG, Sardiu ME, Smolle M, Workman JL, Florens L, Washburn 
MP.: Quantitative Proteomics Demonstrates that the RNA 
Polymerase II Subunits Rpb4 and Rpb7 Dissociate During 
Transcription Elongation. Mol Cell Proteomics 2013, 12(6). 
 217 
198. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, 
Bangham R, Benito R, Boeke JD, Bussey H et al: Functional 
characterization of the S. cerevisiae genome by gene deletion and 
parallel analysis. Science 1999, 285(5429):901-906. 
199. Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E, 
Wilm M, Seraphin B: The tandem affinity purification (TAP) method: a 
general procedure of protein complex purification. Methods 2001, 
24(3):218-229. 
200. Funakoshi M, Hochstrasser M: Small epitope-linker modules for PCR-
based C-terminal tagging in Saccharomyces cerevisiae. Yeast 2009, 
26(3):185-192. 
201. Mosley AL, Florens L, Wen Z, Washburn MP: A label free quantitative 
proteomic analysis of the Saccharomyces cerevisiae nucleus. J 
Proteomics 2009, 72(1):110-120. 
202. Mosley ALS, Mihaela E.; Pattenden, Samantha G.; Workman, Jerry L.; 
Florens, Laurence; Washburn, Michael P.: Highly reproducible label 
free quantitative proteomic analysis of RNA polymerase coplexes. 
Molecular and cellular proteomics 2011, 10(2). 
203. Homer NM, Barry; Nelson, Stanley F.: BFAST: an alignment tool for 
large scale genome resequencing. PLoS One 2009, 4(11):e7767. 
204. Breese MR, Liu Y: NGSUtils: a software suite for analyzing and 
manipulating next-generation sequencing datasets. Bioinformatics 
2013, 29(4):494-496. 
 218 
205. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor 
package for differential expression analysis of digital gene 
expression data. Bioinformatics 2010, 26(1):139-140. 
206. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz 
G, Mesirov JP: Integrative genomics viewer. Nat Biotechnol 2011, 
29(1):24-26. 
207. Thorvaldsdottir H, Robinson JT, Mesirov JP: Integrative Genomics 
Viewer (IGV): high-performance genomics data visualization and 
exploration. Brief Bioinform 2013, 14(2):178-192. 
208. Jenks MH, O'Rourke TW, Reines D: Properties of an intergenic 
terminator and start site switch that regulate IMD2 transcription in 
yeast. Mol Cell Biol 2008, 28(12):3883-3893. 
209. Beissbarth T, Speed TP: GOstat: find statistically overrepresented 
Gene Ontologies within a group of genes. Bioinformatics 2004, 
20(9):1464-1465. 
210. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources. 
Nat Protoc 2009, 4(1):44-57. 
211. Rhee HS, Pugh BF: ChIP-exo method for identifying genomic location 
of DNA-binding proteins with near-single-nucleotide accuracy. Curr 
Protoc Mol Biol 2012, Chapter 21:Unit 21 24. 
 219 
212. Trinh QM, Jen FY, Zhou Z, Chu KM, Perry MD, Kephart ET, Contrino S, 
Ruzanov P, Stein LD: Cloud-based uniform ChIP-Seq processing tools 
for modENCODE and ENCODE. BMC Genomics 2013, 14:494. 
213. Feng J, Liu T, Qin B, Zhang Y, Liu XS: Identifying ChIP-seq enrichment 
using MACS. Nat Protoc 2012, 7(9):1728-1740. 
214. Schulz D, Schwalb B, Kiesel A, Baejen C, Torkler P, Gagneur J, Soeding 
J, Cramer P: Transcriptome surveillance by selective termination of 
noncoding RNA synthesis. Cell 2013, 155(5):1075-1087. 
215. Park D, Morris AR, Battenhouse A, Iyer VR: Simultaneous mapping of 
transcript ends at single-nucleotide resolution and identification of 
widespread promoter-associated non-coding RNA governed by 
TATA elements. Nucleic Acids Res 2014. 
216. van Dijk EL, Chen CL, d'Aubenton-Carafa Y, Gourvennec S, Kwapisz M, 
Roche V, Bertrand C, Silvain M, Legoix-Ne P, Loeillet S et al: XUTs are a 
class of Xrn1-sensitive antisense regulatory non-coding RNA in 
yeast. Nature 2011, 475(7354):114-117. 
217. Castelnuovo M, Rahman S, Guffanti E, Infantino V, Stutz F, Zenklusen D: 
Bimodal expression of PHO84 is modulated by early termination of 
antisense transcription. Nat Struct Mol Biol 2013, 20(7):851-858. 
218. Tan-Wong SM, Zaugg JB, Camblong J, Xu Z, Zhang DW, Mischo HE, 
Ansari AZ, Luscombe NM, Steinmetz LM, Proudfoot NJ: Gene loops 
enhance transcriptional directionality. Science 2012, 338(6107):671-
675. 
 220 
219. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder 
M: The transcriptional landscape of the yeast genome defined by 
RNA sequencing. Science 2008, 320(5881):1344-1349. 
220. Ganem C, Devaux F, Torchet C, Jacq C, Quevillon-Cheruel S, Labesse G, 
Facca C, Faye G: Ssu72 is a phosphatase essential for transcription 
termination of snoRNAs and specific mRNAs in yeast. Embo J 2003, 
22(7):1588-1598. 
221. Marquardt S, Hazelbaker DZ, Buratowski S: Distinct RNA degradation 
pathways and 3' extensions of yeast non-coding RNA species. 
Transcription 2011, 2(3):145-154. 
222. Loya TJ, O'Rourke TW, Degtyareva N, Reines D: A network of 
interdependent molecular interactions describes a higher order 
Nrd1-Nab3 complex involved in yeast transcription termination. J Biol 
Chem 2013. 
223. Loya TJ, O'Rourke TW, Reines D: A genetic screen for terminator 
function in yeast identifies a role for a new functional domain in 
termination factor Nab3. Nucleic Acids Res 2012. 
224. Lowe TM, Eddy SR: A computational screen for methylation guide 
snoRNAs in yeast. Science 1999, 283(5405):1168-1171. 
225. Samarsky DA, Fournier MJ: A comprehensive database for the small 
nucleolar RNAs from Saccharomyces cerevisiae. Nucleic Acids Res 
1999, 27(1):161-164. 
 221 
226. Camblong J, Beyrouthy N, Guffanti E, Schlaepfer G, Steinmetz LM, Stutz 
F: Trans-acting antisense RNAs mediate transcriptional gene 
cosuppression in S. cerevisiae. Genes Dev 2009, 23(13):1534-1545. 
227. Houseley J, Tollervey D: The nuclear RNA surveillance machinery: the 
link between ncRNAs and genome structure in budding yeast? 
Biochim Biophys Acta 2008, 1779(4):239-246. 
228. Uhler JP, Hertel C, Svejstrup JQ: A role for noncoding transcription in 
activation of the yeast PHO5 gene. Proc Natl Acad Sci U S A 2007, 
104(19):8011-8016. 
229. Pelechano V, Steinmetz LM: Gene regulation by antisense 
transcription. Nat Rev Genet 2013, 14(12):880-893. 
230. Cloutier SC, Wang S, Ma WK, Petell CJ, Tran EJ: Long noncoding 
RNAs promote transcriptional poising of inducible genes. PLoS Biol 
2013, 11(11):e1001715. 
231. Terzi N, Churchman LS, Vasiljeva L, Weissman J, Buratowski S: H3K4 
trimethylation by Set1 promotes efficient termination by the Nrd1-
Nab3-Sen1 pathway. Mol Cell Biol 2011, 31(17):3569-3583. 
232. Yassour M, Pfiffner J, Levin JZ, Adiconis X, Gnirke A, Nusbaum C, 
Thompson DA, Friedman N, Regev A: Strand-specific RNA sequencing 
reveals extensive regulated long antisense transcripts that are 
conserved across yeast species. Genome Biol 2010, 11(8):R87. 
233. Lenstra TL, Tudek A, Clauder S, Xu Z, Pachis ST, van Leenen D, 
Kemmeren P, Steinmetz LM, Libri D, Holstege FC: The Role of Ctk1 
 222 
Kinase in Termination of Small Non-Coding RNAs. PLoS One 2013, 
8(12):e80495. 
234. Nadkarni AK, McDonough VM, Yang WL, Stukey JE, Ozier-
Kalogeropoulos O, Carman GM: Differential biochemical regulation of 
the URA7- and URA8-encoded CTP synthetases from 
Saccharomyces cerevisiae. J Biol Chem 1995, 270(42):24982-24988. 
235. Venema J, Tollervey D: Ribosome synthesis in Saccharomyces 
cerevisiae. Annu Rev Genet 1999, 33:261-311. 
236. Kwapisz M, Wery M, Despres D, Ghavi-Helm Y, Soutourina J, Thuriaux P, 
Lacroute F: Mutations of RNA polymerase II activate key genes of the 
nucleoside triphosphate biosynthetic pathways. Embo J 2008, 
27(18):2411-2421. 
237. Sardiu MEF, Laurence; Washburn, Michael P.: Evaluation of clustering 
algorithms for protein complex and protein interaction network 
assembly. JOurnal of proteome research 2009, 8:2944-2952. 
238. Nordick K, Hoffman MG, Betz JL, Jaehning JA: Direct interactions 
between the Paf1 complex and a cleavage and polyadenylation factor 
are revealed by dissociation of Paf1 from RNA polymerase II. 
Eukaryot Cell 2008, 7(7):1158-1167. 
239. Mueller CL, Porter SE, Hoffman MG, Jaehning JA: The Paf1 complex 
has functions independent of actively transcribing RNA polymerase 
II. Mol Cell 2004, 14(4):447-456. 
 223 
240. Penheiter KL, Washburn TM, Porter SE, Hoffman MG, Jaehning JA: A 
posttranscriptional role for the yeast Paf1-RNA polymerase II 
complex is revealed by identification of primary targets. Mol Cell 
2005, 20(2):213-223. 
241. Sheldon KE, Mauger DM, Arndt KM: A Requirement for the 
Saccharomyces cerevisiae Paf1 complex in snoRNA 3' end 
formation. Mol Cell 2005, 20(2):225-236. 
242. Tomson BN, Davis CP, Warner MH, Arndt KM: Identification of a role for 
histone H2B ubiquitylation in noncoding RNA 3'-end formation 
through mutational analysis of Rtf1 in Saccharomyces cerevisiae. 
Genetics 2011, 188(2):273-289. 
243. Fox MJ, Gao H, Smith-Kinnaman WR, Liu Y, Mosley AL: The exosome 
component Rrp6 is required for RNA polymerase II termination at 
specific targets of the Nrd1-Nab3 pathway. PLoS Genet 2015, 
10(2):e1004999. 
244. Shaw RJ, Wilson JL, Smith KT, Reines D: Regulation of an IMP 
dehydrogenase gene and its overexpression in drug-sensitive 
transcription elongation mutants of yeast. J Biol Chem 2001, 
276(35):32905-32916. 
245. Sloan KE, Schneider C, Watkins NJ: Comparison of the yeast and 
human nuclear exosome complexes. Biochem Soc Trans 2012, 
40(4):850-855. 
 224 
246. Fasken MB, Leung SW, Banerjee A, Kodani MO, Chavez R, Bowman EA, 
Purohit MK, Rubinson ME, Rubinson EH, Corbett AH: Air1 zinc knuckles 
4 and 5 and a conserved IWRXY motif are critical for the function and 
integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA 
quality control complex. J Biol Chem 2011, 286(43):37429-37445. 
247. Lubas M, Christensen MS, Kristiansen MS, Domanski M, Falkenby LG, 
Lykke-Andersen S, Andersen JS, Dziembowski A, Jensen TH: Interaction 
profiling identifies the human nuclear exosome targeting complex. 
Mol Cell 2011, 43(4):624-637. 
248. Hrossova D, Sikorsky T, Potesil D, Bartosovic M, Pasulka J, Zdrahal Z, 
Stefl R, Vanacova S: RBM7 subunit of the NEXT complex binds U-rich 
sequences and targets 3'-end extended forms of snRNAs. Nucleic 
Acids Res 2015. 
249. Gornemann J, Kotovic KM, Hujer K, Neugebauer KM: Cotranscriptional 
spliceosome assembly occurs in a stepwise fashion and requires the 
cap binding complex. Mol Cell 2005, 19(1):53-63. 
250. Flaherty SM, Fortes P, Izaurralde E, Mattaj IW, Gilmartin GM: 
Participation of the nuclear cap binding complex in pre-mRNA 3' 
processing. Proc Natl Acad Sci U S A 1997, 94(22):11893-11898. 
251. Hosoda N, Kim YK, Lejeune F, Maquat LE: CBP80 promotes interaction 
of Upf1 with Upf2 during nonsense-mediated mRNA decay in 
mammalian cells. Nat Struct Mol Biol 2005, 12(10):893-901. 
 225 
252. Andersen PR, Domanski M, Kristiansen MS, Storvall H, Ntini E, 
Verheggen C, Schein A, Bunkenborg J, Poser I, Hallais M et al: The 
human cap-binding complex is functionally connected to the nuclear 
RNA exosome. Nat Struct Mol Biol 2013, 20(12):1367-1376. 
253. Hallais M, Pontvianne F, Andersen PR, Clerici M, Lener D, Benbahouche 
Nel H, Gostan T, Vandermoere F, Robert MC, Cusack S et al: CBC-ARS2 
stimulates 3'-end maturation of multiple RNA families and favors 
cap-proximal processing. Nat Struct Mol Biol 2013, 20(12):1358-1366. 
254. Kuai L, Das B, Sherman F: A nuclear degradation pathway controls 
the abundance of normal mRNAs in Saccharomyces cerevisiae. Proc 
Natl Acad Sci U S A 2005, 102(39):13962-13967. 
255. Das B, Butler JS, Sherman F: Degradation of normal mRNA in the 
nucleus of Saccharomyces cerevisiae. Mol Cell Biol 2003, 23(16):5502-
5515. 
256. Tian B, Manley JL: Alternative cleavage and polyadenylation: the long 
and short of it. Trends Biochem Sci 2013, 38(6):312-320. 
257. Li W, You B, Hoque M, Zheng D, Luo W, Ji Z, Park JY, Gunderson SI, 
Kalsotra A, Manley JL et al: Systematic profiling of poly(A)+ transcripts 
modulated by core 3' end processing and splicing factors reveals 
regulatory rules of alternative cleavage and polyadenylation. PLoS 
Genet 2015, 11(4):e1005166. 
258. Akman HB, Erson-Bensan AE: Alternative polyadenylation and its 
impact on cellular processes. Microrna 2014, 3(1):2-9. 
 226 
259. Curinha A, Oliveira Braz S, Pereira-Castro I, Cruz A, Moreira A: 
Implications of polyadenylation in health and disease. Nucleus 2014, 
5(6):508-519. 
260. Berkovits BD, Mayr C: Alternative 3' UTRs act as scaffolds to regulate 
membrane protein localization. Nature 2015, 522(7556):363-367. 
261. Ni T, Yang Y, Hafez D, Yang W, Kiesewetter K, Wakabayashi Y, Ohler U, 
Peng W, Zhu J: Distinct polyadenylation landscapes of diverse 
human tissues revealed by a modified PA-seq strategy. BMC 
Genomics 2013, 14:615. 
262. Blechingberg J, Lykke-Andersen S, Jensen TH, Jorgensen AL, Nielsen 
AL: Regulatory mechanisms for 3'-end alternative splicing and 
polyadenylation of the Glial Fibrillary Acidic Protein, GFAP, 
transcript. Nucleic Acids Res 2007, 35(22):7636-7650. 
263. Brown SL, Morrison SL: Developmental regulation of membrane and 
secretory Ig gamma 2b mRNA. J Immunol 1989, 142(6):2072-2080. 
264. Peterson ML: Mechanisms controlling production of membrane and 
secreted immunoglobulin during B cell development. Immunol Res 
2007, 37(1):33-46. 
265. Peterson ML: Immunoglobulin heavy chain gene regulation through 
polyadenylation and splicing competition. Wiley Interdiscip Rev RNA 
2011, 2(1):92-105. 
266. Dass B, Tardif S, Park JY, Tian B, Weitlauf HM, Hess RA, Carnes K, 
Griswold MD, Small CL, Macdonald CC: Loss of polyadenylation 
 227 
protein tauCstF-64 causes spermatogenic defects and male 
infertility. Proc Natl Acad Sci U S A 2007, 104(51):20374-20379. 
267. Hockert KJ, Martincic K, Mendis-Handagama SM, Borghesi LA, Milcarek 
C, Dass B, MacDonald CC: Spermatogenetic but not immunological 
defects in mice lacking the tauCstF-64 polyadenylation protein. J 
Reprod Immunol 2011, 89(1):26-37. 
268. Li W, Yeh HJ, Shankarling GS, Ji Z, Tian B, MacDonald CC: The 
tauCstF-64 polyadenylation protein controls genome expression in 
testis. PLoS One 2012, 7(10):e48373. 
269. Liu D, Brockman JM, Dass B, Hutchins LN, Singh P, McCarrey JR, 
MacDonald CC, Graber JH: Systematic variation in mRNA 3'-
processing signals during mouse spermatogenesis. Nucleic Acids 
Res 2007, 35(1):234-246. 
270. Miura P, Shenker S, Andreu-Agullo C, Westholm JO, Lai EC: Widespread 
and extensive lengthening of 3' UTRs in the mammalian brain. 
Genome Res 2013, 23(5):812-825. 
271. Hoque M, Ji Z, Zheng D, Luo W, Li W, You B, Park JY, Yehia G, Tian B: 
Analysis of alternative cleavage and polyadenylation by 3' region 
extraction and deep sequencing. Nat Methods 2013, 10(2):133-139. 
272. Shepard PJ, Choi EA, Lu J, Flanagan LA, Hertel KJ, Shi Y: Complex and 
dynamic landscape of RNA polyadenylation revealed by PAS-Seq. 
Rna 2011, 17(4):761-772. 
 228 
273. Hinske LC, Galante PA, Limbeck E, Mohnle P, Parmigiani RB, Ohno-
Machado L, Camargo AA, Kreth S: Alternative polyadenylation allows 
differential negative feedback of human miRNA miR-579 on its host 
gene ZFR. PLoS One 2015, 10(3):e0121507. 
274. Lai DP, Tan S, Kang YN, Wu J, Ooi HS, Chen J, Shen TT, Qi Y, Zhang X, 
Guo Y et al: Genome-wide profiling of polyadenylation sites reveals a 
link between selective polyadenylation and cancer metastasis. Hum 
Mol Genet 2015, 24(12):3410-3417. 
275. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB: Proliferating 
cells express mRNAs with shortened 3' untranslated regions and 
fewer microRNA target sites. Science 2008, 320(5883):1643-1647. 
276. Elkon R, Drost J, van Haaften G, Jenal M, Schrier M, Oude Vrielink JA, 
Agami R: E2F mediates enhanced alternative polyadenylation in 
proliferation. Genome Biol 2012, 13(7):R59. 
277. Vindry C, Vo Ngoc L, Kruys V, Gueydan C: RNA-binding protein-
mediated post-transcriptional controls of gene expression: 
integration of molecular mechanisms at the 3' end of mRNAs? 
Biochem Pharmacol 2014, 89(4):431-440. 
278. Hollerer I, Grund K, Hentze MW, Kulozik AE: mRNA 3'end processing: A 
tale of the tail reaches the clinic. EMBO Mol Med 2014, 6(1):16-26. 
279. Boutet SC, Cheung TH, Quach NL, Liu L, Prescott SL, Edalati A, Iori K, 
Rando TA: Alternative polyadenylation mediates microRNA 
 229 
regulation of muscle stem cell function. Cell Stem Cell 2012, 
10(3):327-336. 
280. Natalizio BJ, Muniz LC, Arhin GK, Wilusz J, Lutz CS: Upstream elements 
present in the 3'-untranslated region of collagen genes influence the 
processing efficiency of overlapping polyadenylation signals. J Biol 
Chem 2002, 277(45):42733-42740. 
281. Hall-Pogar T, Liang S, Hague LK, Lutz CS: Specific trans-acting 
proteins interact with auxiliary RNA polyadenylation elements in the 
COX-2 3'-UTR. Rna 2007, 13(7):1103-1115. 
282. Brackenridge S, Proudfoot NJ: Recruitment of a basal polyadenylation 
factor by the upstream sequence element of the human lamin B2 
polyadenylation signal. Mol Cell Biol 2000, 20(8):2660-2669. 
283. Moreira A, Takagaki Y, Brackenridge S, Wollerton M, Manley JL, 
Proudfoot NJ: The upstream sequence element of the C2 complement 
poly(A) signal activates mRNA 3' end formation by two distinct 
mechanisms. Genes Dev 1998, 12(16):2522-2534. 
284. Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert AS, 
Gehring NH, Neu-Yilik G, Bork P, Keller W, Wilm M et al: Splicing factors 
stimulate polyadenylation via USEs at non-canonical 3' end 
formation signals. Embo J 2007, 26(11):2658-2669. 
285. Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel 
M, Wilm M, Grone HJ, Schirmacher P, Hentze MW, Kulozik AE: p38 
 230 
MAPK controls prothrombin expression by regulated RNA 3' end 
processing. Mol Cell 2011, 41(3):298-310. 
286. Danckwardt S, Gehring NH, Neu-Yilik G, Hundsdoerfer P, Pforsich M, 
Frede U, Hentze MW, Kulozik AE: The prothrombin 3'end formation 
signal reveals a unique architecture that is sensitive to thrombophilic 
gain-of-function mutations. Blood 2004, 104(2):428-435. 
287. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, 
Kulozik AE: Increased efficiency of mRNA 3' end formation: a new 
genetic mechanism contributing to hereditary thrombophilia. Nat 
Genet 2001, 28(4):389-392. 
288. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, 
Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, 
Thorisdottir K et al: A germline variant in the TP53 polyadenylation 
signal confers cancer susceptibility. Nat Genet 2011, 43(11):1098-
1103. 
289. Enciso-Mora V, Hosking FJ, Di Stefano AL, Zelenika D, Shete S, 
Broderick P, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y et al: Low 
penetrance susceptibility to glioma is caused by the TP53 variant 
rs78378222. Br J Cancer 2013, 108(10):2178-2185. 
290. Bennett CL, Ochs HD: IPEX is a unique X-linked syndrome 
characterized by immune dysfunction, polyendocrinopathy, 
enteropathy, and a variety of autoimmune phenomena. Curr Opin 
Pediatr 2001, 13(6):533-538. 
 231 
291. Weinstein IB: Cancer. Addiction to oncogenes--the Achilles heal of 
cancer. Science 2002, 297(5578):63-64. 
292. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz 
AM, Peterlin BM, Price DH: Flavopiridol inhibits P-TEFb and blocks 
HIV-1 replication. J Biol Chem 2000, 275(37):28345-28348. 
293. Chen R, Gandhi V, Plunkett W: A sequential blockade strategy for the 
design of combination therapies to overcome oncogene addiction in 
chronic myelogenous leukemia. Cancer Res 2006, 66(22):10959-
10966. 
294. Wasylishen AR, Penn LZ: Myc: the beauty and the beast. Genes Cancer 
2010, 1(6):532-541. 
295. Eilers M, Eisenman RN: Myc's broad reach. Genes Dev 2008, 
22(20):2755-2766. 
296. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, 
Tessarollo L, Casellas R et al: c-Myc is a universal amplifier of 
expressed genes in lymphocytes and embryonic stem cells. Cell 
2012, 151(1):68-79. 
297. Schuhmacher M, Eick D: Dose-dependent regulation of target gene 
expression and cell proliferation by c-Myc levels. Transcription 2013, 
4(4):192-197. 
298. Loven J, Orlando DA, Sigova AA, Lin CY, Rahl PB, Burge CB, Levens DL, 
Lee TI, Young RA: Revisiting global gene expression analysis. Cell 
2012, 151(3):476-482. 
 232 
299. Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, 
Young RA: Transcriptional amplification in tumor cells with elevated 
c-Myc. Cell 2012, 151(1):56-67. 
300. Chipumuro E, Marco E, Christensen CL, Kwiatkowski N, Zhang T, 
Hatheway CM, Abraham BJ, Sharma B, Yeung C, Altabef A et al: CDK7 
inhibition suppresses super-enhancer-linked oncogenic 
transcription in MYCN-driven cancer. Cell 2014, 159(5):1126-1139. 
301. Glover-Cutter K, Larochelle S, Erickson B, Zhang C, Shokat K, Fisher RP, 
Bentley DL: TFIIH-associated Cdk7 kinase functions in 
phosphorylation of C-terminal domain Ser7 residues, promoter-
proximal pausing, and termination by RNA polymerase II. Mol Cell 
Biol 2009, 29(20):5455-5464. 
302. Chen X, Muller U, Sundling KE, Brow DA: Saccharomyces cerevisiae 
Sen1 as a model for the study of mutations in human Senataxin that 
elicit cerebellar ataxia. Genetics 2014, 198(2):577-590. 
303. Bennett CL, La Spada AR: Unwinding the role of senataxin in 
neurodegeneration. Discov Med 2015, 19(103):127-136. 
304. Lemmens R, Moore MJ, Al-Chalabi A, Brown RH, Jr., Robberecht W: RNA 
metabolism and the pathogenesis of motor neuron diseases. Trends 
Neurosci 2010, 33(5):249-258. 
305. Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, 
Kennerson ML, Rabin BA et al: DNA/RNA helicase gene mutations in a 
 233 
form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum 
Genet 2004, 74(6):1128-1135. 
306. Moreira MC, Klur S, Watanabe M, Nemeth AH, Le Ber I, Moniz JC, 
Tranchant C, Aubourg P, Tazir M, Schols L et al: Senataxin, the ortholog 
of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat 
Genet 2004, 36(3):225-227. 
307. Mischo HE, Gomez-Gonzalez B, Grzechnik P, Rondon AG, Wei W, 
Steinmetz L, Aguilera A, Proudfoot NJ: Yeast Sen1 helicase protects the 
genome from transcription-associated instability. Mol Cell 2011, 
41(1):21-32. 
308. Alzu A, Bermejo R, Begnis M, Lucca C, Piccini D, Carotenuto W, 
Saponaro M, Brambati A, Cocito A, Foiani M et al: Senataxin associates 
with replication forks to protect fork integrity across RNA-
polymerase-II-transcribed genes. Cell 2012, 151(4):835-846. 
309. Golla U, Singh V, Azad GK, Singh P, Verma N, Mandal P, Chauhan S, 
Tomar RS: Sen1p contributes to genomic integrity by regulating 
expression of ribonucleotide reductase 1 (RNR1) in Saccharomyces 
cerevisiae. PLoS One 2013, 8(5):e64798. 
310. Chavez S, Beilharz T, Rondon AG, Erdjument-Bromage H, Tempst P, 
Svejstrup JQ, Lithgow T, Aguilera A: A protein complex containing 
Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription 
elongation with mitotic recombination in Saccharomyces cerevisiae. 
Embo J 2000, 19(21):5824-5834. 
 234 
311. Gallardo M, Aguilera A: A new hyperrecombination mutation identifies 
a novel yeast gene, THP1, connecting transcription elongation with 
mitotic recombination. Genetics 2001, 157(1):79-89. 
312. Fischer T, Strasser K, Racz A, Rodriguez-Navarro S, Oppizzi M, Ihrig P, 
Lechner J, Hurt E: The mRNA export machinery requires the novel 
Sac3p-Thp1p complex to dock at the nucleoplasmic entrance of the 
nuclear pores. Embo J 2002, 21(21):5843-5852. 
313. Huertas P, Aguilera A: Cotranscriptionally formed DNA:RNA hybrids 
mediate transcription elongation impairment and transcription-
associated recombination. Mol Cell 2003, 12(3):711-721. 
314. Li X, Manley JL: Inactivation of the SR protein splicing factor ASF/SF2 
results in genomic instability. Cell 2005, 122(3):365-378. 
315. Gonzalez-Aguilera C, Tous C, Gomez-Gonzalez B, Huertas P, Luna R, 
Aguilera A: The THP1-SAC3-SUS1-CDC31 complex works in 
transcription elongation-mRNA export preventing RNA-mediated 
genome instability. Mol Biol Cell 2008, 19(10):4310-4318. 
316. Libri D, Dower K, Boulay J, Thomsen R, Rosbash M, Jensen TH: 
Interactions between mRNA export commitment, 3'-end quality 
control, and nuclear degradation. Mol Cell Biol 2002, 22(23):8254-8266. 
317. Rondon AG, Jimeno S, Garcia-Rubio M, Aguilera A: Molecular evidence 
that the eukaryotic THO/TREX complex is required for efficient 
transcription elongation. J Biol Chem 2003, 278(40):39037-39043. 
 235 
318. Mason PB, Struhl K: Distinction and relationship between elongation 
rate and processivity of RNA polymerase II in vivo. Mol Cell 2005, 
17(6):831-840. 
319. Wellinger RE, Prado F, Aguilera A: Replication fork progression is 
impaired by transcription in hyperrecombinant yeast cells lacking a 
functional THO complex. Mol Cell Biol 2006, 26(8):3327-3334. 
320. Rougemaille M, Dieppois G, Kisseleva-Romanova E, Gudipati RK, 
Lemoine S, Blugeon C, Boulay J, Jensen TH, Stutz F, Devaux F et al: 
THO/Sub2p functions to coordinate 3'-end processing with gene-
nuclear pore association. Cell 2008, 135(2):308-321. 
321. Yuce O, West SC: Senataxin, defective in the neurodegenerative 
disorder ataxia with oculomotor apraxia 2, lies at the interface of 
transcription and the DNA damage response. Mol Cell Biol 2013, 
33(2):406-417. 
322. Becherel OJ, Yeo AJ, Stellati A, Heng EY, Luff J, Suraweera AM, Woods 
R, Fleming J, Carrie D, McKinney K et al: Senataxin plays an essential 
role with DNA damage response proteins in meiotic recombination 
and gene silencing. PLoS Genet 2013, 9(4):e1003435. 
323. Franchitto A: Genome instability at common fragile sites: searching 
for the cause of their instability. Biomed Res Int 2013, 2013:730714. 
324. Durkin SG, Glover TW: Chromosome fragile sites. Annu Rev Genet 
2007, 41:169-192. 
 236 
325. Richard P, Manley JL: SETX sumoylation: A link between DNA damage 
and RNA surveillance disrupted in AOA2. Rare Dis 2014, 2:e27744. 
326. Gelpi C, Alguero A, Angeles Martinez M, Vidal S, Juarez C, Rodriguez-
Sanchez JL: Identification of protein components reactive with anti-
PM/Scl autoantibodies. Clin Exp Immunol 1990, 81(1):59-64. 
327. Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, Treadwell 
E, Tan EM: Antibodies to a nuclear/nucleolar antigen in patients with 
polymyositis overlap syndromes. J Clin Immunol 1984, 4(1):40-44. 
328. Mahler M, Raijmakers R: Novel aspects of autoantibodies to the 
PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun 
Rev 2007, 6(7):432-437. 
329. Airoldi G, Guidarelli A, Cantoni O, Panzeri C, Vantaggiato C, Bonato S, 
Grazia D'Angelo M, Falcone S, De Palma C, Tonelli A et al: 
Characterization of two novel SETX mutations in AOA2 patients 
reveals aspects of the pathophysiological role of senataxin. 
Neurogenetics 2010, 11(1):91-100. 
330. Suraweera A, Lim Y, Woods R, Birrell GW, Nasim T, Becherel OJ, Lavin 
MF: Functional role for senataxin, defective in ataxia oculomotor 
apraxia type 2, in transcriptional regulation. Hum Mol Genet 2009, 
18(18):3384-3396. 
331. Roberts TC, Morris KV, Wood MJ: The role of long non-coding RNAs in 
neurodevelopment, brain function and neurological disease. Philos 
Trans R Soc Lond B Biol Sci 2014, 369(1652). 
 237 
332. van de V, II, Gordebeke PM, Khoshab N, Tiesinga PH, Buitelaar JK, 
Kozicz T, Aschrafi A, Glennon JC: Long non-coding RNAs in 
neurodevelopmental disorders. Front Mol Neurosci 2013, 6:53. 
333. Shi X, Sun M, Liu H, Yao Y, Song Y: Long non-coding RNAs: a new 
frontier in the study of human diseases. Cancer Lett 2013, 339(2):159-
166. 
334. Verdel A, Moazed D: RNAi-directed assembly of heterochromatin in 
fission yeast. FEBS Lett 2005, 579(26):5872-5878. 
335. Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, 
Hinshaw JC, Garnier P, Prestwich GD, Leonardson A et al: Discovering 
modes of action for therapeutic compounds using a genome-wide 
screen of yeast heterozygotes. Cell 2004, 116(1):121-137. 
336. Marin-Vicente C, Domingo-Prim J, Eberle AB, Visa N: RRP6/EXOSC10 is 
required for the repair of DNA double-strand breaks by homologous 
recombination. J Cell Sci 2015, 128(6):1097-1107. 
337. Andrulis ED, Werner J, Nazarian A, Erdjument-Bromage H, Tempst P, Lis 
JT: The RNA processing exosome is linked to elongating RNA 
polymerase II in Drosophila. Nature 2002, 420(6917):837-841. 
338. Lemay JF, Larochelle M, Marguerat S, Atkinson S, Bahler J, Bachand F: 
The RNA exosome promotes transcription termination of 
backtracked RNA polymerase II. Nat Struct Mol Biol 2014, 21(10):919-
926. 
 238 
339. Gomez-Herreros F, de Miguel-Jimenez L, Millan-Zambrano G, Penate X, 
Delgado-Ramos L, Munoz-Centeno MC, Chavez S: One step back 
before moving forward: regulation of transcription elongation by 
arrest and backtracking. FEBS Lett 2012, 586(18):2820-2825. 
340. Cheung AC, Cramer P: Structural basis of RNA polymerase II 
backtracking, arrest and reactivation. Nature 2011, 471(7337):249-253. 
341. Eckmann CR, Rammelt C, Wahle E: Control of poly(A) tail length. Wiley 
Interdiscip Rev RNA 2011, 2(3):348-361. 
342. Amrani N, Minet M, Le Gouar M, Lacroute F, Wyers F: Yeast Pab1 
interacts with Rna15 and participates in the control of the poly(A) tail 
length in vitro. Mol Cell Biol 1997, 17(7):3694-3701. 
343. Brune C, Munchel SE, Fischer N, Podtelejnikov AV, Weis K: Yeast 
poly(A)-binding protein Pab1 shuttles between the nucleus and the 
cytoplasm and functions in mRNA export. Rna 2005, 11(4):517-531. 
344. Minvielle-Sebastia L, Preker PJ, Wiederkehr T, Strahm Y, Keller W: The 
major yeast poly(A)-binding protein is associated with cleavage 
factor IA and functions in premessenger RNA 3'-end formation. Proc 
Natl Acad Sci U S A 1997, 94(15):7897-7902. 
345. Fasken MB, Stewart M, Corbett AH: Functional significance of the 
interaction between the mRNA-binding protein, Nab2, and the 
nuclear pore-associated protein, Mlp1, in mRNA export. J Biol Chem 
2008, 283(40):27130-27143. 
 239 
346. Hector RE, Nykamp KR, Dheur S, Anderson JT, Non PJ, Urbinati CR, 
Wilson SM, Minvielle-Sebastia L, Swanson MS: Dual requirement for 
yeast hnRNP Nab2p in mRNA poly(A) tail length control and nuclear 
export. Embo J 2002, 21(7):1800-1810. 
347. Iglesias N, Tutucci E, Gwizdek C, Vinciguerra P, Von Dach E, Corbett AH, 
Dargemont C, Stutz F: Ubiquitin-mediated mRNP dynamics and 
surveillance prior to budding yeast mRNA export. Genes Dev 2010, 
24(17):1927-1938. 
348. Lemay JF, Lemieux C, St-Andre O, Bachand F: Crossing the borders: 
poly(A)-binding proteins working on both sides of the fence. RNA 
Biol 2010, 7(3):291-295. 
349. Roth KM, Wolf MK, Rossi M, Butler JS: The nuclear exosome 
contributes to autogenous control of NAB2 mRNA levels. Mol Cell 
Biol 2005, 25(5):1577-1585. 
350. Dez C, Houseley J, Tollervey D: Surveillance of nuclear-restricted pre-
ribosomes within a subnucleolar region of Saccharomyces 
cerevisiae. Embo J 2006, 25(7):1534-1546. 
351. Wery M, Ruidant S, Schillewaert S, Lepore N, Lafontaine DL: The nuclear 
poly(A) polymerase and Exosome cofactor Trf5 is recruited 
cotranscriptionally to nucleolar surveillance. Rna 2009, 15(3):406-419. 
352. Legrain P, Rosbash M: Some cis- and trans-acting mutants for 
splicing target pre-mRNA to the cytoplasm. Cell 1989, 57(4):573-583. 
 240 
353. Shiomi T, Fukushima K, Suzuki N, Nakashima N, Noguchi E, Nishimoto T: 
Human dis3p, which binds to either GTP- or GDP-Ran, complements 
Saccharomyces cerevisiae dis3. J Biochem 1998, 123(5):883-890. 
354. Bousquet-Antonelli C, Presutti C, Tollervey D: Identification of a 
regulated pathway for nuclear pre-mRNA turnover. Cell 2000, 
102(6):765-775. 
355. Hilleren P, McCarthy T, Rosbash M, Parker R, Jensen TH: Quality 
control of mRNA 3'-end processing is linked to the nuclear exosome. 
Nature 2001, 413(6855):538-542. 
356. Hilleren P, Parker R: Defects in the mRNA export factors Rat7p, Gle1p, 
Mex67p, and Rat8p cause hyperadenylation during 3'-end formation 
of nascent transcripts. Rna 2001, 7(5):753-764. 
357. Jensen TH, Patricio K, McCarthy T, Rosbash M: A block to mRNA 
nuclear export in S. cerevisiae leads to hyperadenylation of 
transcripts that accumulate at the site of transcription. Mol Cell 2001, 
7(4):887-898. 
358. Torchet C, Bousquet-Antonelli C, Milligan L, Thompson E, Kufel J, 
Tollervey D: Processing of 3'-extended read-through transcripts by 
the exosome can generate functional mRNAs. Mol Cell 2002, 
9(6):1285-1296. 
359. Synowsky SA, Heck AJ: The yeast Ski complex is a hetero-tetramer. 
Protein Sci 2008, 17(1):119-125. 
 241 
360. Anderson JS, Parker RP: The 3' to 5' degradation of yeast mRNAs is a 
general mechanism for mRNA turnover that requires the SKI2 DEVH 
box protein and 3' to 5' exonucleases of the exosome complex. Embo 
J 1998, 17(5):1497-1506. 
361. Houseley J, Tollervey D: The many pathways of RNA degradation. Cell 
2009, 136(4):763-776. 
362. Parker R: RNA degradation in Saccharomyces cerevisae. Genetics 
2012, 191(3):671-702. 
363. Schmid M, Jensen TH: The exosome: a multipurpose RNA-decay 
machine. Trends Biochem Sci 2008, 33(10):501-510. 
364. van Hoof A, Frischmeyer PA, Dietz HC, Parker R: Exosome-mediated 
recognition and degradation of mRNAs lacking a termination codon. 
Science 2002, 295(5563):2262-2264. 
365. Schaeffer D, Clark A, Klauer AA, Tsanova B, van Hoof A: Functions of 
the cytoplasmic exosome. Adv Exp Med Biol 2011, 702:79-90. 
366. Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz 
HC: An mRNA surveillance mechanism that eliminates transcripts 
lacking termination codons. Science 2002, 295(5563):2258-2261. 
367. Warner JR: The economics of ribosome biosynthesis in yeast. Trends 
Biochem Sci 1999, 24(11):437-440. 
368. Harigaya Y, Tanaka H, Yamanaka S, Tanaka K, Watanabe Y, Tsutsumi C, 
Chikashige Y, Hiraoka Y, Yamashita A, Yamamoto M: Selective 
 242 
elimination of messenger RNA prevents an incidence of untimely 
meiosis. Nature 2006, 442(7098):45-50. 
369. McIver SC, Kang YA, DeVilbiss AW, O'Driscoll CA, Ouellette JN, Pope NJ, 
Camprecios G, Chang CJ, Yang D, Bouhassira EE et al: The exosome 
complex establishes a barricade to erythroid maturation. Blood 2014, 
124(14):2285-2297. 
370. Yamazaki T, Hirose T: The building process of the functional 
paraspeckle with long non-coding RNAs. Front Biosci (Elite Ed) 2015, 
7:1-41. 
371. Singh BN, Hampsey M: A transcription-independent role for TFIIB in 
gene looping. Mol Cell 2007, 27(5):806-816. 
372. Ansari A, Hampsey M: A role for the CPF 3'-end processing machinery 
in RNAP II-dependent gene looping. Genes Dev 2005, 19(24):2969-
2978. 
373. Krishnamurthy S, Ghazy MA, Moore C, Hampsey M: Functional 
interaction of the Ess1 prolyl isomerase with components of the RNA 
polymerase II initiation and termination machineries. Mol Cell Biol 
2009, 29(11):2925-2934. 
374. Werner-Allen JW, Lee CJ, Liu P, Nicely NI, Wang S, Greenleaf AL, Zhou 
P: cis-Proline-mediated Ser(P)5 dephosphorylation by the RNA 
polymerase II C-terminal domain phosphatase Ssu72. J Biol Chem 
2011, 286(7):5717-5726. 
 243 
375. Chinchilla K, Rodriguez-Molina JB, Ursic D, Finkel JS, Ansari AZ, 
Culbertson MR: Interactions of Sen1, Nrd1, and Nab3 with multiple 
phosphorylated forms of the Rpb1 C-terminal domain in 
Saccharomyces cerevisiae. Eukaryot Cell 2012, 11(4):417-429. 
 
 
 CURRICULUM VITAE 
 
Melanie J. Fox  
 
EDUCATION 
Ph.D., Biochemistry & Molecular Biology (2015) 
Indiana University, Indianapolis, Indiana 
 
Bachelor of Arts, Biology (2008) 
Bluffton University, Bluffton Ohio 
 
RESEARCH EXPERIENCE 
Ph.D Graduate Student, Biochemistry and Molecular Biology 
Indiana University School of Medicine, Indianapolis, Indiana 
August 2010 – 2015 
Adviser: Dr. Amber Mosley 
Dissertation: The Role of Rtr1 and Rrp6 in RNAPII Transcription 
Termination 
Investigated the role of the RNA Polymerase II C-Terminal Domain 
(CTD) Phosphatase Rtr1 and the nuclear RNA exonuclease Rrp6 in 
transcription termination of short RNAs using genome- and 
transcriptome-wide sequencing 
Research Technician & Laboratory Manager, Medical & Molecular Genetics        
Indiana University School of Medicine, Indianapolis, Indiana 
June 2008 – August 2010 
Advisor: Dr. Brittany-Shea Herbert 
Investigated the effect of small molecular inhibitors and miRNAs 
targeting telomerase in breast and ovarian cancer cell lines, breast 
cancer mouse models, and circulating tumor cells in a clinical trial 
 
Undergraduate Research, Independent Study Program  
Bluffton University, Bluffton, Ohio 
August 2007 – May 2008 
Advisor: Dr. Stephen Steiner 
Investigated the role of Bowman-Birk protease inhibitors in legumes 
using basic techniques such as DNA isolation, Polymerase Chain 
Reaction (PCR), and molecular cloning 
 
Techniques Utilized 
Mammalian cell culture – culture maintenance, cell proliferation, colony 
formation, RNA isolation 
Yeast culture – genetic manipulation, DNA and RNA isolation, TAP- and 
FLAG-purification 
 Small animal handling – subcutaneous in vivo tumor models, 
subcutaneous and intraperitoneal injections 
Chromatin immunoprecipitation (ChIP), ChIP-Exo followed by DNA-
sequencing 
Northern and Western Immunoblotting 
Silverstaining of Protein Gels 
Immunofluorescence 
PCR, RNA-Sequencing 
Software: Integrative Genomics Viewer (IGV), Adobe Photoshop, Adobe 
Illustrator, Microsoft Office 
 
PEER REVIEWED PUBLICATIONS 
1. Fox MJ, Mosley AL. Rrp6: Integrated Roles in Nuclear RNA and 
Transcription. Wiley Interdisciplinary Reviews: RNA, In preparation. 
2. Fox MJ, Smith-Kinnaman WR, Hunter GO, Gao H, Liu Y, Mosley AL. 
Rtr1 Regulates RNA Polymerase II Transcription Termination 
Through the Nrd1-Nab3 Pathway. Manuscript in preparation. 
3. Fox MJ, Gao H, Smith-Kinnaman WR, Liu Y, Mosley AL. 
Characterization of Extended Transcripts by RNA-Seq suggests 
that Rrp6 regulates Nrd1-dependent Termination. PLoS Genetics, 
2015. 
4. Sauder CAM, Koziel JE, Choi M, Fox MJ, Grimes BR, Badve S, 
Blosser RJ, Radovish M, Lam CC, Vaughan MB, Herbert B-S, 
Clare SE. Phenotypic Plasticity in Normal Breast Derived Epithelial 
Cells. BMC Cell Biology. 15(20), 2014. 
5. Smith-Kinnaman WR, Berna MJ, Hunter GO, Hsu P, True JD, Cabello 
GI, Fox MJ, Varani G, Mosley AL. The Interactome of the Atypical 
Phosphatase Rtr1 in Saccharomyces cerevisiae. Molecular 
Biosystems. 10(7):1730-41, 2014. 
6. Koziel JE, Fox MJ, Steding CE, Sprouse AA, Herbert BS. Medical 
Genetics and Epigenetics of Telomerase. Journal of Cellular and 
Molecular Medicine. 15(3):457-67, 2011. 
7. Goldblatt E, Gentry E, Fox MJ, Gryaznov S, Changyu S, Herbert B-S. 
The Telomerase Template Antagonist GRN163L Alters MDA-MB-
231 Breast Cancer Cell Morphology, Inhibits Growth, and 
Augments the Effects of Paclitaxel. Molecular Cancer Therapeutics: 
2027-2035, 2009. 
 
POSTERS AND PRESENTATIONS 
1. Fox MJ, Gao H, Liu Y, Mosley AL. “RNA-Seq Analysis Reveals 
Transcriptome-wide Effects of RRP6 Deletion in Saccharomyces 
cerevisiae,” EMBO Conference Series: Gene Transcription in 
Yeast, Sant Feliu de Guixols, Spain, June 2014 
2. Fox MJ, Gao H, Liu Y, Mosley AL. Transcriptome-wide analysis of RNA 
processing defects in S. cerevisiae. Rustbelt RNA Meeting, 
Cleveland OH, October 2013. 
 3. Smith-Kinnaman WR, Fox MJ, Zimmerly M, Mosley AL. RNA 
Polymerase II and 3’ end processing machinery in S. cerevisiae. 
Rustbelt RNA Meeting, Cleveland, OH, October 2013. 
4. Fox MJ, Smith-Kinnaman WR, Hunter GO, Gao H, True JD, Fleharty B, 
Gogol M, Liu Y, Mosley A. The phosphatase Rtr1 regulates histone 
modification levels at transcription terminators. Walther Cancer 
Foundation Symposium, South Bend, IN, October 2013. 
5. Fox MJ, Zimmerly MA, Hunter GO, Berna MJ, Smith-Kinnaman WR, 
Mosley AL. The role of CTD phosphorylation on mRNA 3’end 
processing machinery. IUSM IBMG Program for PhD study 
interview weekend poster session. Indianapolis, IN, January 2012. 
6. Cabello G, Fox M, Hunter G, True J, Mosley A. The Role of Rtr1 in the 
Regulation of Genomic Integrity. Indianapolis Project Seed Summer 
Research Program Poster Session, Indianapolis, IN, July 2011. 
7. Marcum CA, Blosser RJ, Fox MJ, Badve S, Herbert BS, Clare SE. 
Hidden in Plain Sight: Phenotypic Plasticity in the Normal Breast 
and the Origin of Rare Malignant Histologies. J.K. Berman Essay 
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PROFESSIONAL ORGANIZATIONS 
2013 – Present Member, American Society of Biochemistry and Molecular 
Biology 
2013 – Present Student Member, Association of Science and Technology 
Centers 
 
AWARDS & HONORS 
2015: Erica Daniel Kepner Award for Scientific Achievement, Honorable 
Mention, IU School of Medicine 
2015 William M. Plater Civic Engagement Medallion, IUPUI Office of 
Community Engagement 
2014:  Honorable Mention, Poster Presentation, IU School of Medicine 
Department of Biochemistry & Molecular Biology Research Day 
2014:  IUPUI Graduate & Professional Student Government Educational 
Enhancement Grant 
 Awarded for travel to EMBO Transcription Conference, Sant Feliu 
de Guixols, Spain 
2010:  IU Graduate School University Fellowship Award, for outstanding 
incoming students 
 
 TEACHING EXPERIENCE 
 
Guest Lecturer 
(BIOC-848) Bioinformatic applications to proteomics and genomics 
Indiana University School of Medicine  
Indianapolis, Indiana 
Course Director: Dr. Amber Mosley 
Lecture Title: RNA-Sequencing 
Date: March 4, 2015 
 
Student Mentor 
Herbert and Mosley Labs, Indiana University School of Medicine 
Indianapolis, Indiana                                
September 2008 – January 2015 
• Supervised four laboratory interns, including two high school 
students and two undergraduate students 
• Mentored students through independent research projects and final 
poster presentations 
• Taught the biology behind the overall lab goals, techniques used in 
the lab, and troubleshooting approaches 
 
Guest Lecturer 
(BIOL-322) Genetics and Molecular Biology 
Indiana University Purdue University Indianapolis  
Indianapolis, Indiana 
Course Director: Dr. Kristin Chun 
Lecture Title: Molecular Biology of Transcription and RNA 
Processing 
Date: September 30, 2014 
 
Teaching Assistant 
(GRAD-716) Molecular Biology and Genetics 
Indiana University School of Medicine 
Indianapolis, Indiana 
August 2011 – December 2011 
• Tutored and led discussions with Ph.D. and M.D./Ph.D students for 
this semester-long class 
• Duties included holding office hours for two hours every week, 
student-outreach for struggling students, and proctoring four 
examinations throughout the semester 
 
 
 
 
 
 
 SERVICE 
 
Founder, Central Indiana Science Outreach 
Indianapolis, Indiana 
September 2014 – Present 
• Recruited fellow researchers to form professional group focused on 
communicating the importance of science to the public 
• Lead group members to build outreach networks, promote our 
activities, organize monthly planning meetings 
• Curate public events hosted by local science organizations and 
promote on social media and website 
 
Co-Founder & Co-Organizer, Student-Only Data Club, Indiana University 
School of Medicine 
Indianapolis, Indiana 
October 2013 – May 2015 
• Initiated the first student-only journal club and research group in the 
Biochemistry and Molecular Biology Department and secured 
funding and support from department chair 
• Promoted activities to reach an average participation rate of 
approximately 20 graduate students 
• Encouraged professional development, public speaking skills, and 
camaraderie amongst students by scheduling two 30-minute 
presentations twice monthly 
• Implemented social media to connect fellow students and 
encourage feedback and collaboration 
 
Student Representative to the Faculty, Indiana University School of 
Medicine 
Department of Biochemistry & Molecular Biology 
Indianapolis, Indiana University 
August 2012 – August 2013 
• Organized student volunteers for departmental events such as the 
yearly picnic, holiday party, and research day poster presentations 
• Communicated with students and faculty to address new ideas and 
implement new activities 
